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ABSTRACT 
 Receptor ROBO2 and its ligand SLIT2 are required for ureteric bud outgrowth 
during early kidney development. However, it is unclear if ROBO2 also plays a role 
during the late stage of kidney development and in the mature kidney.  
We performed immunohistochemistry and co-labelling assays and found that 
ROBO2 is a podocyte protein expressed on the basal cell surface of podocyte foot 
processes and co-localizes with slit-diaphragm protein nephrin/NPHS1. Biochemical 
analyses revealed that ROBO2 directly interacts with NCK, the adaptor protein that also 
binds to nephrin. We found that ROBO2, NCK, and nephrin form a complex that is 
enhanced by SLIT2 stimulation. Functionally nephrin signaling promotes actin 
polymerization but SLIT2-ROBO2 signaling inhibits nephrin-induced actin 
polymerization. Mouse genetic studies showed that knocking out Robo2 specifically in 
podocytes (Robo2 cKO) does not cause significant kidney defects but alleviates the 
abnormal podocyte phenotype in Nphs1 null mice. These results suggest that SLIT2-
ROBO2 signaling pathway acts as a negative regulator of nephrin signaling to influence 
podocyte foot process architecture. 
We hypothesized that SLIT2 and ROBO2 play a role during podocyte injury in 
 x 
the adult kidney. To test this hypothesis, we studied two acute glomerular injury mouse 
models, protamine sulfate (PS) perfusion and nephrotoxic serum (NTS) injection, and 
found that loss of Robo2 in podocytes protects mice from acute glomerular injury. Robo2 
cKO mice develop less podocyte structural defects and functional kidney impairment as 
compared with their littermate controls. In addition, the level of nephrin is upregulated in 
Robo2 cKO mice before and after injury. Interestingly we found that SLIT2 and ROBO2 
are upregulated in the human membranous nephropathy kidneys. These results suggest 
deleterious effects for SLIT2-ROBO2 in acute glomerular injury in mice and chronic 
kidney disease in human. 
In conclusion, my thesis research revealed SLIT2-ROBO2 pathway as a novel 
signaling component in podocytes, defined its cellular and molecular mechanism, and 
provided new knowledge for its function under normal and pathological conditions. 
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CHAPTER ONE: Introduction & Overview  
1.1 Kidney as a filtration organ 
Mammalian kidneys are bilateral vital organs located in the lower quadrants of the 
rear of the abdominal cavity in the retroperitoneal space. The main function of kidneys is 
to maintain homeostasis by means of performing blood filtration, regulating water and 
salt homeostasis, maintenance of the acid-base balance, as well as hormone secretion 
(erythropoietin, renin, calcitriol). 
Human kidneys are estimated to filter 180 liters of fluid a day. Renal filtration 
occurs in the glomerulus at the blood-urine filtration barrier. Urine production in the 
kidney is a complex, multistep process. The final filtration product, urine, is delivered 
through the ureters to the bladder, from where it is expelled to the outside environment 
through the urethra.  
1.1.1 General mammalian kidney development  
Kidney development is the tightly regulated process that is initiated in early 
gestation and continues until birth in humans or until the first two weeks of life in mice. 
Execution of the proper developmental scheme is crucial to kidney function and health, 
as a broad spectrum of kidney diseases are linked to abnormal organogenesis.  
The earliest step in the permanent kidney formation involves the outgrowth of the 
single metanephrogenic diverticulum, also called the ureteric bud (UB), from each of the 
two Wolffian ducts. This happens at about embryonic day 10.5 (E10.5) in mouse and in 
the fifth week of gestation in humans, when single ureteric bud invades the surrounding 
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metanephric mesenchyme (Vize et al., 2003).  
The uniform theme guiding the kidney development is the presence of the 
reciprocal interactions between the ureteric bud and surrounding mesenchymal tissues, 
which are indispensable to kidney branching and growth. Molecular mechanisms 
orchestrating ureteric bud outgrowth are controlled by multiple positive (e.g. GDNF, 
EYA1, PAX2, SALL1) and negative factors (e.g. ROBO2, SLIT2, BMP4, SPRY1) as 
well as extracellular matrix (ECM) and matrix-regulating proteins are implied in 
branching morphogenesis (as reviewed in (Dressler, 2006)). Glial derived nerve growth 
factor, GDNF, appears to be the master regulator, regulating UB outgrowth and precise 
location (Moore et al., 1996; Pichel et al., 1996; Sánchez et al., 1996). As the ureteric bud 
grows, it undergoes series of bifurcations at the ureteric bud tips and elongation at the 
stalk. Kidney development follows the inside-out growth, with new ureteric branches 
being added towards the kidney outer region, the cortex, for as long as one week post 
birth in mouse or until birth in humans (Nigam and Shah, 2009). The branching ureteric 
bud undergoes approximately 15 bifurcations events in humans (Nigam and Shah, 2009).  
Schematic illustration of the ureteric bud branching and nephron development is 
presented in Illustration 1. 
Ureteric bud tips are surrounded by the metanephric mesenchyme. Cells of the 
ureteric bud ultimately become the collecting duct system, while the metanephric 
mesenchyme is induced by a range of the secreted signals from UB, such as LIF, TGF-
beta, FGF2 and WNT9B, to forgo apoptosis and undergo the mesenchymal to epithelial 
transition (MET) (Michos, 2009; Vize et al., 2003). These cells eventually organize into 
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the pretubular aggregates, the renal vesicles, and give rise to c-shape bodies, s-shape 
bodies, which eventually organize and differentiate into all segments of the mature 
nephrons (Schedl, 2007). The proximal end of the s-shape bodies are destined to develop 
into glomerulus, while the distant end will eventually give rise to the distal tubule and 
connect the nephron to the collecting duct (Vize et al., 2003). The ureteric tips that are 
connected to the nephron cease to branch further (Nigam and Shah, 2009). The precise 
molecular mechanisms regulating nephron development and patterning are incompletely 
understood.  
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Illustration 1: From the ureteric bud tree to nephron- schematic overview of the 
kidney development 
 
Tips of the branching urinary tree (green) are surrounded by thin layer of metanephric 
mesenchymal cells (violet). As the urinary tree grows, these cells undergo mesenchymal 
to epithelial transition and form a pretubular aggregates (PTA), which organize into renal 
vesicles (RV). These structures will eventually form comma shape bodies (CSB, also 
called c-shape bodies) and s-shaped bodies (SSB). Glomerular blood vessels (GBV) are 
recruited into future nephron proximal domain (p) and future nephron - collecting duct 
connection will form at the distal end (d).  
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1.1.2 The nephron as a basic filtration unit 
The nephron, the basic building unit of the kidney, is a continuous tubular 
structure composed of several physiologically distinct regions. Each kidney contains 
about 1 million nephrons, whose number is established at birth and determined by the 
number of the UB branching events. At the proximal region of the nephron is the renal 
corpuscle, which is composed of the glomerulus and the surrounding Bowman’s capsule, 
carries out blood filtration. The renal corpuscle is a polarized structure with two distinct 
poles: the vascular pole, where the blood vessels enter; and the urinary pole, which 
continues from the glomerulus to the proximal tubule. The proximal tubule is lined by the 
specialized brush border epithelium and is the main site of water, electrolyte and small 
molecule reabsorption. The proximal tubule is continuous with the Loop of Henle region, 
which spans into the medullar region and is the main site of the sodium gradient 
production in the nephron. This regions spans back into the cortical region and continues 
into the distal tubule region, which is a primary site responsible for hormone regulation 
of calcium reabsorption in response to the level of parathyroid hormone.   
1.1.3 Glomerulus - structure and function  
Glomerular filtration provides a mechanism to rid of the body of the metabolic 
waste products, excess water, electrolytes, small peptide hormones and nutrients that 
continuously circulate in the blood. Glomerular filtration is the first step in urine 
production. The filtrate which passes from the blood vessels is called primary ultrafiltrate 
and fills the Bowman’s space before flowing through the rest of the nephron. 
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1.1.3.1 Glomerular structure  
The renal corpuscle, which is composed of glomerulus and Bowman’s capsule, is 
the most proximal segment of nephron. The glomerulus represents a tight bundle of 
vasculature, which is divided into six to eight loops of afferent arterioles and the efferent 
vessels. The outer side of these vessels is occupied by podocytes, which, among other 
functions, add support and resistance to the blood vessels.  
To allow for efficient blood clearance the glomerulus is tightly enclosed in the 
Bowman’s capsule. The Bowman’s capsule is composed of a single outer layer of the 
squamous epithelium (also called the parietal epithelium) that is continuous with the rest 
of the proximal tubule. An inner layer of the visceral epithelium (i.e. the podocyte) lines 
the glomerular capillaries inside the Bowman’s capsule. Parietal and visceral epitheliums 
are in contact with each other at the base of the glomerular stalk. Experimental evidence 
suggests that the parietal epithelial cells might be a progenitor cell pool responsible for 
regeneration of the podocytes (Appel et al., 2009).  
1.1.3.2 Blood-urine barrier 
The glomerular filtration barrier, or blood-urine barrier, is a size and charge 
specific filter composed of three layers of structure - the fenestrated endothelial cells, the 
glomerular basement membrane (GBM) and the podocytes. Evidence suggests that 
dysfunction of the glomerular filtration barrier could result in proteinuria or hematuria 
phenotype (Haraldsson et al., 2008; Menon et al., 2012; Ronco, 2007).  
Mature endothelial cells which line the insides of the glomerular vasculature 
contain large pores, or fenestrae, in the peripheral cytoplasm, which allow for the 
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efficient filtration (Satchell and Braet, 2009). Fenestrated endothelium contains a rich 
negatively charged glycocalyx, consisting largely of heparan sulfates and hyaluronic acid 
to sialoproteins (Weinbaum et al., 2007). These two features of glomerular endothelial 
cells contribute to selective permeability of the glomerular filtration barrier.  
GBM is an amorphous, 300- to 350-nm thick mesh of specialized extracellular 
matrix (Miner, 2012; Rayat et al., 2005). GBM is formed via the fusion of the endothelial 
and podocytic basement membranes and has three layers - lamina rara interna which 
faces the fenestrated endothelial cells, lamina densa, and lamina rara externa which is 
adjacent to the podocytes (Miner, 2012).  Mature GBM is therefore contributed by two 
distinct cell populations and has a complex molecular composition. The main constituents 
are the α3, α4, and α5 type IV collagens, laminin, agrin, nidogen and perlecan. The 
glomerular basement membrane serves as a size and charge barrier layer in the process of 
glomerular filtration (Miner, 2012).  
The third and last layer of glomerular filtration apparatus is the podocytes, which 
form the foot process structure and the slit diaphragms covering the GBM. Combination 
of high-resolution crystallography and electron micrography shows that the slit 
diaphragm is a multilayer barrier, approximately 40 nm in width (Aaltonen and 
Holthöfer, 2007; Rodewald and Karnovsky, 1974; Wartiovaara et al., 2004). Although 
originally believed to be a relatively static structure, it is now thought that the slit 
diaphragm is a dynamic structure (Aaltonen and Holthöfer, 2007). The foot process and 
slit diaphragm connections serve as a structural component, that are anchored to the 
podocyte actin cytoskeleton, and are crucial signaling platform to regulate podocyte 
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structure and function, as reviewed in detail in (Grahammer et al., 2013) . The slit 
diaphragm is composed of multiple molecules and more new molecules are being 
continuously discovered.  
1.1.3.2.1 Structural components of the slit diaphragm 
The first molecule to be discovered, and the most crucial and abundant constituent 
of the slit diaphragm is the transmembrane protein nephrin (Ruotsalainen et al., 1999). 
The extracellular portion of nephrin is composed of eight immunoglobulin-like domains 
followed by a fibronectin type III motif (Ruotsalainen et al., 1999). Nephrin spans an 
estimated 35 nm into the depth of the slit diaphragm (Wartiovaara et al., 2004). Therefore 
nephrin protruding from neighboring podocyte foot processes might perform trans-
interaction and cross link with each other in a zipper-like manner (Wartiovaara et al., 
2004).  
Another protein moiety in the slit diaphragm is nephrin-like family of proteins, 
NEPH1, NEPH2 and NEPH3 (Sellin et al., 2003). NEPH proteins contain only five 
extracellular IgG domains, but are shown to perform cis- and trans- interactions with 
nephrin and podocin, and are important for recruitment of the intracellular adaptor 
proteins (e.g. NCK) to nephrin (Liu et al., 2003a; Sellin et al., 2003).  
Podocin is yet another crucial component of the slit diaphragm. It is a membrane 
anchored protein whose N- and C- termini are facing the cytoplasm (Schwarz et al., 
2001). Podocin directly interacts with nephrin, CD2AP as well as with the NEPH1, and 
facilitates nephrin localization to the lipid rafts (Schwarz et al., 2001). Podocin also 
serves as a scaffolding protein.  
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The slit diaphragm is also composed of the cadherin family of proteins, namely P-
cadherin, FAT1 and vascular endothelial cadherin (VE- cadherin) (Reiser et al., 2000; 
Yaoita et al., 2002). Although the function of the P-cadherin and VE-cadherin functions 
is less clear, the FAT1 proto-cadherin appears to be crucial for the development and 
function of the slit diaphragms, as Fat1 knockout mice lack slit diaphragms and exhibit 
severe foot processes effacement (Ciani et al., 2003).    
1.1.4 Proteinuria as a hallmark of glomerular filtration dysfunction  
Proteinuria is defined as the presence of the excessive amounts of protein in the 
urine. The glomerular filtration barrier is an efficient filter for proteins equal to or larger 
than 72kDa (size of albumin is approximately 67kDa). Thus the presence of albumin, the 
main globular protein component of the blood, in the urine is indicative of the glomerular 
filtration barrier defects. With respect to the amount of albumin in the urine, albuminuria 
can be classified as the microalbuminuria when albumin content is mildly elevated 
corresponding to the range of 30-300 mg/day in the human urine; non-nephrotic 
proteinuria as the output of albumin more than 300 mg/day; and nephrotic range 
proteinuria when albumin excretion is more than 3 g/day (Basi et al., 2008), American 
Diabetes Association).  
1.2 Podocyte biology 
1.2.1 Podocyte development 
Podocyte precursors, as well as the rest of the nephron, are derived from the 
condensed mesenchymal cells that are adjacent to the tips of the developing ureteric buds. 
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These cells undergo mesenchymal to epithelial transition and give rise to all segments of 
the nephron. The premature podocyte population secretes factors such as the VEGF to 
attract the endothelial cell progenitors (Eremina et al., 2003). Portion of the cells located 
on the proximal end of the S-shaped body retains the Wilm’s tumor protein 1 (WT1) 
expression and eventually matures to become podocytes. Early podocytes can be 
recognized as a single columnar epithelial layer of cells around the glomerular 
vasculature, attached to immature GBM and laterally to each other. As podocytes mature 
they lose the lateral attachments and are thought to migrate along the vasculature and 
cover the entire glomerular basement membrane and capillary structure.  
Network of the elaborate podocyte extensions, called foot processes, is the 
hallmark of mature podocytes. Order of the events leading to the development of the foot 
processes is a subject under debate over two predominant models. The first one suggests 
that foot processes form as the modification of the traditional cadherin junctions while 
cell bodies are still attached. Proponents of the second model argue that podocyte cells 
become independent of each other first and then foot processes begin to extend and 
interdigitate along the outer surface of vasculature.  
1.2.2 Mature podocyte function and structure 
Podocytes are integral structure of the filtration barrier and as such refine the 
blood-urine filtration barrier. In addition podocytes function as a structural support for 
glomerular capillaries, maintain the fenestrated endothelium, and contribute to the 
continued maintenance of the glomerular basement membrane.  
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Mature podocytes have very complex architecture with distinct domains. Large 
cell bodies are suspended in the Bowman’s space, and their attachment to the GBM is 
mediated by the network of the primary, secondary and tertiary processes. Elaborate 
system of the tertiary processes, also known as the foot processes, wrap tightly around the 
glomerular capillaries. Through yet unknown mechanism, foot processes from the same 
podocyte do not directly contact each other, rather the slit diaphragms form only between 
interdigitating foot processes from another podocyte. Architecture of the podocyte, and in 
particular the elaborate foot process network, can be appreciated by viewing the 
Illustration 2.  
Podocytes have highly negatively charged glycocalyx, as podocyte membrane is 
covered by multiple highly glycosylated, sulfated sialylated proteins, such as 
podocalyxin, podoplanin, podoendin, glypican-1, and syndecan-4 (Huang and Langlois, 
1985; Kerjaschki et al., 1984; Matsui et al., 1999; Pyke et al., 1997). The membrane 
charge is involved in the maintenance of the podocyte foot process shape as well as in 
maintaining repulsion between podocytes and closely located parietal cells. Reduction in 
podocyte surface charge, either by genetic or experimental means, results in podocyte 
cytoskeleton modification, foot process effacement, and subsequent filtration barrier 
dysfunction (Seiler et al., 1975; Takeda et al., 2001).  
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Illustration 2: Podocytes have elaborate cell architecture with their foot processes 
interdigitating with each other on the outer surface of the glomerular capillaries.  
 
Scanning electron micrograph of the pseudo colored podocytes showing elaborate 
network of the foot processes and their zip-like interaction pattern. As indicated by 
different pseudo colors, foot processes from the same podocyte do not come in contact 
with each other.   
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1.2.3 Cytoskeleton in podocytes 
The structure of the podocytes, in particular the structure of the foot processes, is 
highly correlated with their function in the blood-urine barrier and therefore is of interest 
in the field of basic science and translational medical research. Podocyte cytoskeleton 
organization is a complex arrangement. Within cell bodies there are predominantly 
localized intermediate filament proteins, such as vimentin and desmin (Zaitsev, 1992). 
Microtubules and the intermediate filaments are essential for the development and 
maintenance of the major podocyte foot processes as they provide means of efficient 
transport and communication between the cell body and foot processes. The major 
cytoskeleton in the foot processes is the actin microfilament network. Actin cytoskeleton 
through the podocyte provides important structure and function and is integrally 
regulated and affected by the signaling from glycocalyx, slit diaphragm, and glomerular 
basement attachment, which allow podocytes to integrate the environmental cues into 
appropriate cellular responses (Endlich et al., 2001; Garg et al., 2010; George et al., 2012; 
Kubosawa and Kondo, 1994; Takeda et al., 2001; Teng et al., 2012; Verma et al., 2006). 
Mutations in several proteins regulating either actin polymerization or microfilament 
dynamics in podocytes have been shown to cause proteinuric kidney diseases (Faul et al., 
2007).  
1.2.3.1 Actin cytoskeleton organization in the foot processes 
Transmission electron microscopy shows that individual foot processes have a 
narrow, dome-like structure. Podocyte foot processes directly attach to the glomerular 
basement membrane through their basal domain and to each other on the lateral domain 
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to form the silt diaphragm. Intricate and dynamic structure of the foot processes are made 
possible by the actin cytoskeleton, consisting of the well-organized actin bundles and 
short branched cortical actin filaments (Ichimura et al., 2003). Reorganization of these 
microfilaments occurs as the consequence of podocyte injury and podocytopathy, and is 
regarded as the basis for podocyte foot process broadening or effacement (Bertani et al., 
1982; Garg et al., 2010; George et al., 2012; Kos et al., 2003; Krendel et al., 2009; Seiler 
et al., 1975; Shirato, 2002; Takeda et al., 2001; Yuan et al., 2002).  
Actin bundles in the foot processes are connected to the microtubules and 
intermediate filaments in the secondary processes to maintain the cytoskeleton across the 
podocyte. Actin bundles in podocytes are maintained by actin cross-linking proteins, such 
as actinin-4 (Kos et al., 2003). Cortical actin in the podocyte foot processes forms a 
network of short branched actin filaments, and is responsible for the high dynamics of the 
podocyte foot process (Schell et al., 2013).  
Podocyte foot processes are known to counteract the oscillations in glomerular 
vessels diameter and as such are equipped with a set of fully functional contractile 
apparatus, consisting of actin bundles, alpha-actinin-4, MYH9, MYO1E and 
synaptopodin (Asanuma et al., 2005; Drenckhahn and Franke, 1988), which allows them 
to regulate cell shape in response to mechanical stress (Endlich et al., 2001). Contractile 
apparatus in podocytes has been demonstrated to play a role during development and in 
adulthood, under physiological normalcy and in disease (Endlich et al., 2001; Johnstone 
et al., 2011; Krendel et al., 2009; Miura et al., 2013).  
  
15 
1.2.3.2 Actin polymerization at the slit diaphragm 
Nephrin plays a crucial role in mammalian podocytes, serving both as a structural 
component of the slit diaphragm, as well as a signaling hub, as elegantly reviewed in 
(Grahammer et al., 2013). Nephrin is the main factor driving actin polymerization at the 
slit diaphragm. Nephrin is known to associate with multiple binding partners, including 
NCK1, CD2AP, and podocin (Jones et al., 2006; Schwarz et al., 2001; Shih et al., 2001; 
Verma et al., 2006). The nephrin cytoplasmic domain contains eight tyrosine 
phosphorylation sites (Lahdenperä et al., 2003). Events that initiate nephrin signaling are 
not known but in vitro studies demonstrate that clustering of the nephrin extracellular 
domains induces phosphorylation of tyrosine residues at multiple cytoplasmic locations, 
which is sufficient to recruit downstream effectors, such as NCK1 (Lahdenperä et al., 
2003).  
NCK1 is composed of the C-terminal Src-homology (SH2) domain, which 
preferably interacts with the phosphorylated tyrosine motifs, and three N-terminal SH3 
motifs that interact with proline-rich motifs (Chen et al., 1998). Phosphorylation of 
nephrin at tyrosine residues 1176, 1193 and 1217 results in recruitment of the NCK1 
through the SH2 domain, while the SH3 domains are necessary for the recruitment of and 
binding to the actin cytoskeleton regulators such as neuronal Wiskott–Aldrich syndrome 
protein (N-WASP) and actin-related proteins (Arp) 2/3 complex, which mediates actin 
polymerization (Jones et al., 2006; Verma et al., 2006). 
Additional actin polymerization might be initiated from the other components of 
the slit diaphragm complex, such as FAT1 protocadherins, P-cadherins, NEPH proteins, 
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and JAM4 (Faul et al., 2007), all of which result in maintenance of the dynamic actin 
cytoskeleton of the podocyte foot processes. 
1.2.3.3 Podocyte-GBM attachments are anchored to the actin cytoskeleton   
Podocytes and extracellular matrix (ECM) attachments are maintained by two 
families of proteins, namely integrins and dystroglycans (Kerjaschki et al., 1989). The 
major integrins mainly expressed in the podocytes are α3β1 integrins. Integrins provide a 
link between the ECM and actin cytoskeleton through the broad range of the intermediate 
proteins, including integrin linked kinase (ILK), paxilin, talin, PINCH1, filamin, MAGI-1 
(Drenckhahn and Franke, 1988; Faul et al., 2007).  
1.2.3.4 Actin cytoskeleton- glycocalyx connection  
Podocalyxin and GLEPP1/PTPRO are the main components of the podocyte 
apical membrane and offer the link between the external environment and the actin 
cytoskeleton (Orlando et al., 2001; Yang et al., 1996). Podocalyxin is the transmembrane 
receptor connecting to the actin cytoskeleton via Ezrin and Na+/H+ exchanger regulatory 
factor 2 (NHERF2), which lead to activation of RhoA GTPase (Orlando et al., 2001). 
Podocalyxin-NHERF2-Ezrin complex is documented to dissociate from actin under 
conditions of experimentally induced injury (Takeda et al., 2001). GLEPP1 is a 
transmembrane protein with large, highly glycosylated extracellular domain, 
transmembrane domain, and a cytoplasmic tail which has intrinsic phosphatase activity 
(Thomas et al., 1994). The direct association between GLEPP1 and the cytoskeleton is 
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not well understood but phosphatase activity has been implied in the regulation of 
cytoskeleton structure (Kim et al., 2002).    
1.2.4 Podocyte injury  
Podocytes are terminally differentiated cells with very limited regenerative 
potential (Appel et al., 2009; Becker et al., 2007; Ronconi et al., 2009). Multiple stimuli, 
including congenital genetic (e.g. nephrin deficiency), chemical (e.g. puromycin 
aminonucleoside, protamine sulfate), physical (e. g. sheer stress, glomerular 
hypertension), and biological factors (e. g. nephrotoxic serum, HIV virus), can injure the 
podocytes (Mundel and Shankland, 2002). Flattening and retraction of podocyte foot 
processes (also called effacement) is a uniformly recognized phenotype of podocyte 
damage and underscores global changes to actin cytoskeleton observed after injury 
(Mundel and Shankland, 2002). Proteinuria is commonly associated with local or global 
podocyte foot effacement (Bertani et al., 1982; Kerjaschki, 2001; Tryggvason et al., 
2006) and changes in gene expression (Boerries et al., 2013). In particular, down-
regulation of nephrin is recognized as a hallmark in several experimentally induced 
podocyte injury models and in proteinuric kidney disease (Luimula et al., 2000; Piper et 
al., 2000; Putaala et al., 2001; Yogavijayan Kandasamy, 2014; Yuan et al., 2002). 
Podocytes exhibit high degree of plasticity, manifesting in their ability to 
withstand injury. Depending on the nature and strength of injury, damaged podocytes can 
either recover, remain damaged with impaired function, or detach from the glomerular 
basement membrane to the urine (Saleem, 2015). In the event of podocyte loss, 
surrounding survived podocytes can undergo hypertrophy and attempt to cover the 
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denuded glomerular basement membrane area (Kriz and Endlich, 2005; Wiggins et al., 
2005).  
1.2.4.1 In vivo podocyte injury models  
To study the molecular events taking place during podocyte injury in vitro, 
several immortalized podocyte cell lines can be utilized (Shankland et al., 2007). 
However, cultured podocytes do not recapitulate the in vivo podocyte phenotypic 
features, the notably elaborate network of the foot processes as well as gene expression 
modifications such as lower nephrin expression (Katsuya et al., 2006). Thus to better 
understand podocyte pathobiology, several in vivo inducible rodent models of podocyte 
injury have been described (Pippin et al., 2009). With respect to my thesis research, two 
podocyte injury models are of particular importance: the protamine sulfate perfusion and 
nephrotoxic serum injection. Both models effectively and reliably induce prompt 
podocyte effacement responses and have been adopted to study podocyte injury in mice 
(Garg et al., 2010; George et al., 2012).  
1.2.4.2 Protamine sulfate (PS) injury model 
Protamine sulfate (PS) is highly positively charged molecule which induces 
podocyte damage by neutralizing the negative charge of glycocalyx on podocytes (Seiler 
et al., 1975). The protamine sulfate perfusion model is dose and time dependent 
(Andrews, 1978). Aortal perfusion of protamine sulfate solution induces severe actin 
cytoskeleton changes in podocytes, as severe foot processes effacement response is noted 
in a matter of minutes of injury induction in rats as well as in mice (Andrews, 1978). 
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Additionally protamine sulfate injury in podocytes results in a global increase in the level 
of protein phosphorylation and increase in the cytoplasmic calcium concentration 
(Kerjaschki, 1978). The significance of actin cytoskeleton involvement in this injury is 
shown by the fact that depolymerization of actin cytoskeleton prevents protamine sulfate 
injury (Kerjaschki, 1978). This injury model has been used to understand the role of 
several podocyte specific proteins, particularly those involved in actin cytoskeleton 
regulation (Garg et al., 2010; George et al., 2012).   
1.2.4.3 Nephrotoxic serum (NTS) injury model 
Another useful model to study podocyte injury is based on injection of sheep 
derived mixture of antibodies directed against rat glomerular extracts (Salant and 
Cybulsky, 1988). In this model, full serum or specific antibody fractions can be used. 
Classically this model has been used to study the impact of immune system in podocyte 
injury, as NTS is shown to be complement and neutrophil dependent (Lin et al., 2002; 
Salant and Cybulsky, 1988). However, more recently it was shown that early NTS 
induced proteinuria can be complement and neutrophil independent (Chugh et al., 2001; 
Holdsworth et al., 1985). The podocyte reaction to the NTS is dose and time dependent 
(Holdsworth et al., 1985). NTS injury can be divided into two phases, the heterologous 
and the autologous. Damage in the heterologous phase is induced by the binding of sheep 
antibodies to their endogenous targets in the glomerulus. NTS was shown to recognize 
several podocyte specific targets, such as aminopeptidase A, gp-330, alpha3beta1 
integrin, GLEPP1 (Chugh et al., 2001). Interestingly, unpublished data from our 
laboratory indicates that ROBO2 receptor is also a target of NTS (Dr. Xueping Fan, 
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personal communication). In 5-7 days post NTS injection, innate immune system that is 
activated by the planted sheep IgG, initiates the autologous phase of the NTS injury. The 
NTS induced damage to podocytes is marked by significant reorganization of the actin 
cytoskeleton, foot process effacement, and proteinuria shortly after the NTS injection 
(Lin et al., 2002).  
1.2.5 Relevance of Podocyte dysfunction to kidney disease  
Podocytopathy can be defined as a progressive dysfunction of podocytes as 
pertains to kidney function impairment and disease (Wiggins, 2007). Podocyte 
dysfunction can have an idiopathic, genetic, environmental or reactive etiology. The 
spectrum of kidney diseases with known podocyte involvement, also classified as 
glomerular diseases, is broad and includes entities such as focal segmental 
glomerulosclerosis, glomerulonephropathies, Alport syndrome, diabetic nephropathy, 
hypertensive nephropathy, membranous nephropathy, as well as aging (Barisoni et al., 
2009; Wiggins, 2007).  
As mentioned previously, injured podocytes can react in several ways, depending 
on the nature and strength of the injury. With respect to podocytopathies, the effects of 
podocyte injury can be broadly classified into two categories: injuries without podocyte 
loss but reorganization of the foot processes and subsequent effacement, and injuries 
resulting in podocyte detachment and loss. Podocyte loss in injury can proceed through 
one of the multiple mechanisms, such as apoptosis, necrosis, and podocyte de-
differentiation. Additionally, while not technically representing direct insult to podocytes, 
enlargement of the glomerular vesicular area can also lead to decrease in podocyte 
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density and thus injury to the existing podocytes (Mundel and Shankland, 2002; 
Pavenstädt et al., 2003). In event of podocyte loss, remaining podocytes initiate series of 
adaptive events to compensate for the lost cells (Pagtalunan et al., 1997). Such events 
include cell hypertrophy to cover the denuded GBM, as well as in some cases reentering 
the cell cycle and proliferation (Nangaku et al., 2005).  
Experimental evidence demonstrated that even a single event of podocyte injury 
might exacerbate into nephron-wide injury and even induce chronic kidney disease 
(Macconi et al., 2006; Matsusaka et al., 2011; Morioka et al., 2001). Several groups 
proposed a vicious cycle theory of injury propagation. In this conceptual frame, injury to 
even individual podocytes can cause injury in the remaining podocytes, nephrons and 
remaining surrounding glomeruli. Even without the loss of podocytes, foot process 
effacement commonly observed in injury, affects podocyte attachment to the GBM and 
filtration barrier. The impairment of the glomerular structure is thought to diminish 
podocyte ability to counterbalance the intracapillary hydrostatic pressure, which exposes 
the remaining podocytes to the increased mechanical stress (Kriz et al., 1994; Nagata and 
Kriz, 1992; Nagata et al., 1992). Moreover, albumin passed through the leaky slit 
diaphragm is injurious to podocytes and increases their susceptibility to injury (Okamura 
et al., 2013). On the molecular level it was shown that exposure of podocytes to serum 
albumin prompts podocyte endocytosis, increases derogatory TGF-beta and p38 MAPK 
signaling pathways, and causes down-regulation of several components of the slit 
diaphragm, such as CD2AP and synaptopodin (Yoshida et al., 2008). Podocyte injury can 
also have consequences for the structure and composition of the GBM and health of the 
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adjacent fenestrated endothelium (Wolf et al., 2005). In most concise view, podocyte 
injury/loss can result in the presence of excessive albumin in the urine; which causes 
additional injury and function impairment in the proximal tubules.  
Animal studies demonstrate that podocyte loss is associated with glomerular 
damage which involves endothelial cell swelling, mesangiolysis, expansion of mesangial 
matrix, impairing parietal epithelial cells, and inducing glomerular sclerosis (Matsusaka 
et al., 2011). These changes might eventually lead to the decrease of functional glomeruli 
number, posing increased filtration pressure on remaining glomeruli.  
1.2.5.1 Glomerular kidney diseases  
The kidney has remarkable ability to withstand the glomerular injury. Animal 
studies using targeted diphtheria toxin to deplete podocytes show that loss of up to 20% 
of glomerular podocytes has only transient proteinuric effect (Wharram et al., 2005). The 
glomerulosclerosis and irreversible glomerular changes occur only after more than 40% 
of podocytes are lost (Wharram et al., 2005).  
While the modern medicine has conquered many of the diseases, the prevalence of 
the glomerular kidney disease in population follows the increasing trend. There are 
multiple factors contributing to these epidemics, including increasing population age, 
prevalence of obesity, diabetes, high blood pressure and other environmental factors. 
Statistical data from 2003 estimated that glomerular diseases account for 90% of the end 
stage renal disease cases in US and cost an estimated $20 billion a year in healthcare 
(Wiggins, 2007). High levels of proteinuria are correlated with the progression of the 
kidney disease and lowering of the urinary protein levels positively correlates with 
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slowing glomerular disease progression (Ruggenenti et al., 2001). Understanding the 
molecular mechanisms causing podocyte injury can lead us closer to prevention and 
effective treatments of glomerular kidney diseases.   
 
1.3 SLIT-ROBO signaling 
1.3.1 Guidance cue SLITs and their ROBO receptors  
SLIT-ROBO signaling pathway is a highly conserved signaling pathway, where 
upon binding to its receptor ROBO, SLIT ligand elicits intracellular responses leading to 
diverse outcomes such as cell migration, axon pathfinding, axon branching, and 
regulation of cell fate, and proliferation (Brose et al., 1999; Dallol et al., 2002; Dickinson 
and Duncan, 2010; Dickinson et al., 2008; Dickson and Gilestro, 2006; Domyan et al., 
2013; Gibson et al., 2014; Prasad et al., 2007a; Rhee et al., 2007; Wu et al., 2001; 
Ypsilanti et al., 2010). Classical view of the SLIT-ROBO signaling pathway is shown in 
Illustration 3.  
Years since it was first described, SLIT-ROBO signaling has been found to 
regulate the development of several organ systems, as well as the homeostasis in the adult 
organism. 
1.3.1.1 ROBO receptors  
The prototypical Roundabout receptors (ROBO) have originally been discovered 
in Drosophila to regulate the midline crossing of the commissural axons (Kidd et al., 
1998). ROBO, or Roundabout receptor was named following a phenotype observed in 
Robo Drosophila mutants, where commissural neurites cross and recross midline multiple 
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times, giving the appearance of the traffic roundabout (Brose et al., 1999). In the 
invertebrates there are three ROBO genes (ROBO1-3) and four genes are found in the 
vertebrates (ROBO1-4) (Kidd et al., 1998).  
ROBO receptors are classified to the immunoglobulin superfamily based on the 
fact that the extracellular domains contain variable number of immunoglobulin motifs. In 
ROBO1 extracellular domain, there are five immunoglobulin domains followed by three 
fibronectin type III (FN-3) motifs. The intracellular domains of ROBO receptors contain 
four highly conserved short sequences designated cytoplasmic conserved motifs (CC0-
CC3) (Ypsilanti and Chedotal, 2014). Domains CC0 (TVYGDVD) and CC1 (TPYATT) 
are the highly conserved tyrosine residues, while CC2 and CC3 are proline rich motifs. 
Vertebrate ROBO1 and ROBO2 share the highest degree of amino acid conservation, 
whiles ROBO3 lacks the CC1 motif (Kidd et al., 1998). The most structurally divergent 
ROBO receptor, ROBO4, contains two extracellular Ig domains and two fibronectin type 
III domains, and only intracellular CC0 and CC2 domains (Huminiecki et al., 2002). 
Extensive mutation studies, as well as the partial crystal structure revealed that the SLIT 
binding site on ROBO receptor is the first N- terminal Ig domain (Morlot et al., 2007a; 
Morlot et al., 2007b). None of the ROBO receptors possesses the intrinsic catalytic 
activity and the signal activation recruits downstream signaling molecules for 
transduction (Kidd et al., 1998). Homophilic and heterophilic interactions between 
ROBO receptors have also been shown to regulate SLIT-ROBO signaling outcome 
(Camurri et al., 2005; Hivert et al., 2002). 
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1.3.1.2 SLIT ligands 
SLITs are the family of secreted extracellular molecules (Ypsilanti and Chedotal, 
2014) first identified in a screen for genes involved in the midline crossing defects (Brose 
et al., 1999; Seeger et al., 1993). Like ROBO receptors, SLITs are also highly conserved 
across the evolution (Brose et al., 1999). In the mammalian genome there are three 
distinct SLIT genes (SLIT 1-3). Structurally the SLIT proteins contain several distinct 
motifs, including four leucine rich repeats (LRR) followed by the seven to nine epidermal 
growth factor-like (EGF) motifs, ALPS domain containing Agrin, Laminin, Perlecan, and 
Slit homology sequences and LNS motif (for Laminin, Neurexin, Slit homology 
sequences) or laminin-G - neurexin motif (Brose et al., 1999). Partial crystal structure of 
SLIT2 deposited in the protein database (PDB, access number PDB2V70) shows a 
picture of a molecule with a complicated, three-dimensional architecture. SLIT ligands 
are subject to extensive posttranslational modification, as well as a proteolytic cleavage 
by yet unidentified protease which generates two fragments: large, 140 kDa SLIT-N and 
smaller, ~60 kDa SLIT-C fragments that differ with respect to their biological activity 
(Brose et al., 1999; Wang et al., 1999). The full length SLIT and SLIT-N possess the 
ROBO binding motif and thus can both bind ROBO receptors and activate ROBOS 
(Chen et al., 2001), whiles SLIT-C is inactive for ROBO activation (Chédotal, 2007). It 
was recently reported that SLIT-C can bind and activate PlexinA1, another axon 
guidance receptor for secreted protein Semaphorin 3A (Delloye-Bourgeois et al., 2015). 
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1.3.2 SLIT-ROBO functions in different systems 
1.3.2.1 Nervous system 
Roles of SLIT and ROBO have been well-documented and characterized in the 
nervous system (Ypsilanti and Chedotal, 2014). They were originally found in 
Drosophila then in mice to regulate commissural neurites crossing of the midline. 
Subsequently it was shown to be involved in axon pathfinding, neuronal migration, and 
neurite branching and proliferation in the developing nervous system.    
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Illustration 3: Representation of ROBO receptor structure and function in the 
nervous system  
 
Roundabout (ROBO) receptor structure is highly evolutionary conserved single 
transmembrane spanning receptor. Extracellular domain is composed of five IgG 
domains (green), and three fibronectin type III motifs (blue). Intracellular tail does not 
possess intrinsic catalytic activity but includes four cytoplasmic conserved (CC) motifs 
(indigo).  
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1.3.2.2 Kidney and urinary tract 
ROBO1, ROBO2, as well as SLIT1 and SLIT2 expression have been 
demonstrated in the developing kidneys (Piper et al., 2000). Genetic ablation of either 
ROBO2 receptor or the SLIT2 ligand causes supernumerary ureteric budding from the 
Wolffian duct and results in congenital anomalies of the kidney and urinary tract 
(CAKUT) in mouse models (Grieshammer et al., 2004). Through the unknown 
mechanisms, SLIT2 and ROBO2 were found to inhibit the GDNF expression domain in 
the anterior region of the nephrogenic mesenchyme. Robo2 or Slit2 knockout mice are 
born with multiple ureters, blind ureters, duplex kidneys, shorter ureters and 
hydronephrosis (Grieshammer et al., 2004). These defects cause perinatal lethality in the 
genetically modified mice. Patients with CAKUT have been found to harbor ROBO2 
mutation (Bertoli-Avella et al., 2008; Hwang et al., 2014; Lu et al., 2007).  Further study 
found that in vitro overexpression of the Robo2 in the embryonic kidney explants reduced 
UB branching and decreased overall glomerular number (Ji et al., 2012).  
1.3.2.3 Cardiovascular system 
ROBO1, ROBO2, SLIT2 and SLIT3 are expressed in the developing heart 
(Medioni et al., 2010). Phenotypic analysis of the Slit3 knockout mice revealed the 
presence of an enlarged right ventricle (Liu et al., 2003). This finding stimulated research 
into the function of the SLIT-ROBO in heart development. It was found that in 
Drosophila Robo1 and Robo2 guide migrating cardioblasts and pericardial cells in the 
dorsal midline, mediating cell attachment in the ventricular lumen during the heart 
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development (Medioni et al., 2008; Santiago-Martínez et al., 2008). This is achieved 
through antagonizing of the cadherin activity (Santiago-Martinez et al., 2008). Further 
anatomical defects in pericardium, myocardium, and caval veins were found in Robo1 
and Robo1/2 double mutant mice (Mommersteeg et al., 2013; Mommersteeg et al., 2015).  
1.3.2.4 Pulmonary system 
ROBO1, ROBO2, SLIT2, and SLIT3 are expressed in the developing lung 
(Anselmo et al., 2003). Ablation of Robo1 results in a decrease in the lung branching, 
severe congenital lung defects, and high incidence of neonatal death (Xian et al., 2001). 
In addition, ROBO has been found to regulate separation of the foregut from the body 
wall, as Robo1-/-;Robo2-/- double knockout mice often present with severe congenital 
diaphragmatic hernia phenotypes (Domyan et al., 2013).  
1.3.2.5 Mammary gland 
Loss of Robo1 has been found to increase mammary gland branching. SLIT2 and 
ROBO1 have been shown to regulate myoepithelial basal cell proliferation through 
shuffling the localization of beta-catenin from the nucleus and cytoplasm to the signaling-
quiescent cell membrane pool (Macias et al., 2011). Further research showed that in 
addition to ROBO1, ROBO2 is important in mammary gland development. In the 
absence of either Slit or Robo2, there is an increase in the amount of the nuclear β-catenin 
(Harburg et al., 2014).  
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1.3.2.6 Immune system 
The function of SLIT and ROBO is also critically important in immune system. 
Leukocytes express ROBO1 and activation of SLIT-ROBO signaling pathways has been 
shown to inhibit chemotaxis to leukocyte stimulatory factors, such as fractalkine, 
RANTES, or fMLP (Kanellis et al., 2004).  In addition, chemotaxis was reduced in T-
cells stimulated by CXCL12 in response to SLIT2 stimulation (Prasad et al., 2007b). 
Furthermore, several studies also linked SLIT-ROBO pathway to pathogenesis of 
inflammation and cancer (Gara et al., 2015).  
1.3.2.7 SLIT ligands and ROBO receptors in pathophysiology of adult organism 
In addition, SLITs and ROBOs have been found to regulate cellular processes 
during conditions, such as neo-angiogenesis and pancreatic beta cell survival (Wang et 
al., 2003; Yang et al., 2013). With respect to tumor genesis, SLITs and ROBO receptors 
have been shown to regulate angiogenesis, tumor growth, cell adhesion, migration and 
metastasis (Gara et al., 2015). 
1.3.3 Mechanism of the SLIT-ROBO signaling 
To date SLIT 1, 2, and 3 ligands are considered to be functionally equivalent in 
activating ROBO signaling pathways (Brose et al., 1999). Archetypal member of the 
ROBO family, ROBO1, is by far the most extensively studied ROBO receptor. With high 
degree of structural homology among ROBO proteins, these receptors share the same 
signaling components upon activation by SLITs.  
SLIT-ROBO signaling is initiated upon the second LRR domain of SLIT binding 
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to the first Ig domain in ROBO receptor (Howitt et al., 2004; Morlot et al., 2007b). 
Structural crystallization of the minimal SLIT2-ROBO1 complex demonstrates a hand 
and glove-like, three-dimensional fit of the two domains. With engagement of SLIT, 
stereological changes of ROBO receptor affect the intracellular portion and presumably 
allow for recruitment or more efficient association with downstream effectors (Morlot et 
al., 2007b). Additionally it is now recognized that SLIT-ROBO signaling affects the 
local, intracellular calcium gradient, and cyclic nucleotide levels (Zheng and Poo, 2007).     
1.3.4     Downstream effectors of SLIT-ROBO signaling 
SLIT-ROBO signaling pathways have been shown to negatively regulate the 
cytoskeleton. The best studied effectors of the SLIT2-ROBO1 signaling pathways are 
Slit-Robo GTPase activating proteins (srGAPs), Dreadlocks (DOCK), Enabled (ENA) 
and Abelson (ABL) kinases (Bashaw et al., 2000; Fan et al., 2003; Wong et al., 2001). 
The srGAPs have been found to directly interact with ROBO receptor within the CC3 
region (Wong et al., 2001). It was further found that upon binding to ROBO, srGAP1 
gets activated and hydrolyzes GTP-Cdc42 to its inactive form, GDP-Cdc42, which in turn 
decreases the level of active form of N-WASP and leads to decreased level of active form 
of Arp2/3 complex, and thereby inhibits actin polymerization (Wong et al., 2001) . Those 
changes are local activities and thus explain how SLIT-ROBO signaling inactivates local 
actin polymerization.      
DOCK protein has been shown to bind to the CC3 region of ROBO1 in 
Drosophila (Fan et al., 2003). This association is increased upon SLIT stimulation. 
Proposed model suggests that DOCK binds ROBO1, and simultaneously interacts with 
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Pak, which is known to interact with Rac1, the member of Rho GTPase family. However, 
which protein mediates the activation of Rac1 and how does it fit into SLIT- ROBO 
pathway is not known (Fan et al., 2003). The mammalian homolog of DOCK is NCK.  
Drosophila ROBO1 directly interacts with Abl and Ena tyrosine kinases (Bashaw 
et al., 2000). Overexpression of Abl antagonizes ROBO signaling while Ena 
overexpression has agonistic effect to Slit-ROBO signaling (Bashaw et al., 2000). Abl is 
reported to be constitutively associated with ROBO1 (Rhee et al., 2002), and both 
ROBO1 and Ena are targets for Abl kinase phosphorylation (Bashaw et al., 2000). Ena 
and Abl have been proposed to be the link between signal transduction and actin 
cytoskeleton (Lanier and Gertler, 2000). Abl is involved in regulation of actin 
polymerization by modulation of downstream effectors, such as Ena. In addition, Abl can 
interact with Cables and provide a link between SLIT-ROBO signaling and beta-catenin 
signaling pathway (Zukerberg et al., 2000). Ena can directly bind actin and through 
profilin positively affects actin polymerization (Lebrand et al., 2004).  
1.3.5     Regulation of SLIT-ROBO signaling  
Activation of the signaling pathways needs to be tightly controlled to achieve the 
maximum spatial and temporal sensitivity and accuracy in response to the environmental 
cues. Several levels of control are known to occur for regulation of the SLIT-ROBO 
pathway, which involve: regulation of the protein expression at the level of transcription, 
translation, cell trafficking, posttranslational modifications, and degradation. 
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1.3.5.1     Epigenetic, Transcriptional and Translational Regulation of SLIT and ROBO 
ROBO1 and ROBO2 were initially considered to be the tumor suppressor genes 
because ROBO and SLIT have high incidence of epigenetic silencing in the wide panel of 
cancers, including lung, pancreatic ductal adenocarcinoma, breast, ovarian, cervical , 
brain, kidney and head and neck (Gara et al., 2015). The epigenetic mechanism most 
frequently affecting SLIT and ROBO expression is the CpG island promoter methylation 
(Dallol et al., 2002; Dallol et al., 2003; Zhou et al., 2011). Additionally, loss of 
heterozygosity is a common event in tumors as well as in several cancer cell lines (Zhou 
et al., 2011).   
Several transcription factors are known to affect the transcription of the SLIT2 
and ROBO genes in vertebrates. In particular, ROBO2 in the nervous system is known to 
be regulated by the variety of factors, including HOXA2 and NKX2.9 (Bravo-Ambrosio 
et al., 2012; Geisen et al., 2008). 
Additionally, microRNAs have been shown to regulate the expression of the SLIT 
ligands and ROBO receptors (Alajez et al., 2011; Fish et al., 2011; Zhang et al., 2011).  
1.3.5.2     Regulation of SLIT-ROBO signaling by the receptor localization regulation   
SLIT2 is the secreted extracellular protein. To achieve its function, ROBO 
receptor has to be expressed on the cell membrane of the growth cone, which is the most 
distal part of neuron. In Drosophila, single midline crossing by the commissural neurites 
is a crucial step in the nervous system development. Prior to crossing the midline and 
whilst crossing, commissural neurites are insensitive to SLIT ligands (Keleman et al., 
2002). The reason is that the ROBO1 protein is not present at the growth cone membrane, 
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but rather it is concentrated in the cytoplasm in the cell body. Commissureless (Comm) 
protein is required for this cellular distribution pattern of ROBO1. In the presence of both 
proteins, Comm binds ROBO1 and regulates ROBO1 sorting in the trans-Golgi network 
to late endosomes and lysosomes, so that ROBO1 is not delivered to the growth cone 
membrane (Keleman et al., 2005; Slováková et al., 2012). Another protein, Canoe (Cno) 
might facilitate recycling of ROBO1 from the membrane (Slováková et al., 2012). 
Neurites that successfully crossed the midline and deemed to become the longitudinal 
tracts, reestablish the expression of the ROBO1 at the growth cone surface to prevent the 
midline re-crossing.  
In the commissural neurons in the mammalian nervous system, ROBO1 is 
expressed on the cell membrane and undergoes high rate of turnover (Yuasa-Kawada et 
al., 2009a; Yuasa-Kawada et al., 2009b).  The search for the mammalian homolog of the 
Comm protein was not successful until the research group at Northwestern University 
found that ROBO1 can directly interact with the ubiquitin specific protease 33 (USP33) 
(Yuasa-Kawada et al., 2009a; Yuasa-Kawada et al., 2009b). Association of ROBO1 and 
USP33 in these cells serves to stabilize membrane bound pool of the ROBO1 by 
protecting it from proteasomal degradation and/or facilitating its endosomal recycling.   
1.3.6     SLIT-ROBO signaling pathway crosstalk with beta catenin signaling 
Beta-catenin signaling pathway initiation relays on extracellular ligand of the Wnt 
family to bind to Frizzled receptor on the responding cell. This ligand-receptor 
interaction leads to cellular signal cascade resulting in inhibition of beta-catenin 
destruction, allowing the increased amount of beta-catenin in the cytoplasm and its 
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subsequent translocation into the nucleus, where beta-catenin can bind to its partners to 
regulate transcription of responsive genes (MacDonald et al., 2009).  
Previous studies have shown that SLIT-ROBO signaling inhibits cadherin-
mediated cell adhesion by targeting the phosphorylated beta-catenin to the nucleus to 
activate gene transcription (Rhee et al., 2007; Rhee et al., 2002). Activation of SLIT-
ROBO signaling in retinal neurons leads to activation of beta-catenin dependent gene 
transcription and dissociation of cell-cell junctions. Recently, activation of SLIT-ROBO 
signaling has also been shown to prevent E-cadherin mediated cell adhesion through 
beta-catenin (Santiago-Martínez et al., 2008). 
1.3.7     SLIT-ROBO signaling in the kidney 
SLIT-ROBO signaling pathways in vertebrates have been shown to function in 
multiple organs during development as well as in mature systems including the kidney. 
The function of SLIT-ROBO in the kidney is briefly summarized below. 
1.3.7.1     Expression pattern during kidney development  
At the time of ureteric bud invasion into the nephrogenic mesenchyme, SLIT1, 
SLIT2 and SLIT3 mRNAs are detectable in the nephrogenic mesenchyme surrounding 
the nephric ducts (SLIT1, SLIT3) and in the ureteric tree itself (SLIT2), while ROBO1 
and ROBO2 mRNAs are expressed in the metanephric mesenchyme (Piper et al., 2000). 
At the initial stages of nephron formation, when pretubular aggregates are formed from 
the condensing mesenchyme, ROBO1 mRNA is detected in the pretubular aggregates, 
while ROBO2 mRNA is retained at the condensing mesenchyme around the tips of the 
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developing ureteric buds. During the comma and s-shape stages of nephrogenesis, 
ROBO1 is detected in the distal end of the developing nephron, while the ROBO2 
mRNA is present in the proximal region of the future nephron. SLIT1 and SLIT3 ligands 
are co-expressed in the proximal end (Piper et al., 2000).    
1.3.7.2     Relevance of the SLIT-ROBO pathway in kidney disease  
Congenital abnormalities of the kidney and urinary tract (CAKUT) accounts for 
20-30% of all prenatally detected fetal anomalies (Caruana and Bertram, 2015; 
Rodriguez, 2014). CAKUT has a wide spectrum of phenotypes and involves any part of 
the urinary tract. Malformations of the kidney (e.g. duplex kidneys, dysplastic or 
hypoplastic kidneys, hydronephrosis), the ureter ( e.g. multiple ureters, megaureters), and 
the bladder (e.g. abnormalities of the ureterovesical-junction, vesicourinary reflux) are 
amongst the common clinical findings in CAKUT patients (Rodriguez, 2014). A 2001 
study showed that CAKUT is implied in 30-50% of pediatric end stage renal disease in 
the US (Seikaly et al., 2003). Mutations of Slit2 and Robo2 are causative to CAKUT in 
mouse models and in humans (Bertoli-Avella et al., 2008; Grieshammer et al., 2004; Lu 
et al., 2007). 
With respect to SLIT-ROBO involvement in the pathology of mature kidney, a 
recent study demonstrated that delivery of recombinant SLIT2 in mice offers kidney 
protection in the ischemia and reperfusion kidney injury (IRI) (Chaturvedi et al., 2013). 
IRI is the acute kidney injury model in which initial obstruction of the blood vessels to 
the kidney and subsequently re-established blood flow causes renal ischemia and 
oxidative stress. Renal proximal tubules are the main target of the IRI and inflammation 
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plays crucial role in the pathogenesis of IRI. ROBO1 receptor has been shown to be 
expressed in the circulating immune cells, such as neutrophils, macrophages, T 
lymphocytes, and dendritic cells (Guan et al., 2003; Prasad et al., 2007a; Tole et al., 
2009; Wu et al., 2001) . It is proposed that beneficial effects of recombinant SLIT2 in IRI 
is mediated through the reduced recruitment of ROBO1-positive inflammatory cells 
(Chaturvedi et al., 2013).  
Additional study showed that levels of ROBO2 mRNA are down-regulated in 
glomeruli of patients with diabetes as compared to levels in normal pre-transplant 
kidneys, while no significant expression difference was found in patients with FSGS, 
membranous glomerulonephropathy (MGN) or nephrosclerosis (NSC). However, this 
finding has not been further confirmed by other groups (Lindenmeyer et al., 2010).  
Therefore the role of ROBO receptors and SLIT ligands in the adult kidney 
disease is still not clear and further research is warranted. 
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CHAPTER TWO: General Hypotheses 
SLIT molecules are the ligand for the single transmembrane ROBO receptors 
(Brose et al., 1999; Kidd et al., 1999; Kidd et al., 1998). SLITs and ROBOs were initially 
found to regulate axon guidance and neuronal migration during the development of the 
nervous system. Subsequently they have been shown to regulate numerous cellular 
processes during development as well as the mature organs beyond the nervous system 
(Ypsilanti and Chedotal, 2014; Ypsilanti et al., 2010).  
ROBO2 and SLIT2 are expressed in the early developing kidneys (Grieshammer 
et al., 2004; Piper et al., 2000). Genetic ablation or mutations in either proteins results in 
the congenital abnormalities of the kidney and urinary tract (CAKUT) phenotype, 
manifesting in several architectural abnormalities of urinary tract, including multiple 
ureters, multiple kidneys, and improper ureter-bladder junction (Grieshammer et al., 
2004; Lu et al., 2007; Wang et al., 2011). In the late stage of the embryonic kidney, 
ROBO2 is expressed in the condensing mesenchyme at the tip of the ureteric tree (Piper 
et al., 2000). Through the series of elaborate molecular changes, the condensing 
mesenchyme undergoes mesenchymal to epithelial transition, gives rise to renal vesicles 
which develop into c- and then s-shaped bodies, and ultimately generates all segments of 
the nephron (Dressler, 2006). Our preliminary data demonstrates that ROBO2 is 
expressed in the mature glomerulus leading us to hypothesize that ROBO2 plays a role in 
the physiology or pathophysiology of the mature kidney.  
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Specific Aims 
 
Aim 1: To elucidate a) the temporal and spatial expression pattern of SLIT2 and 
ROBO2,  b) molecular details of the SLIT2-ROBO2 signaling in the glomerulus 
under normal physiological condition and c) functional consequences of the Robo2 
deletion in mice.  
We hypothesized that SLIT2 and ROBO2 plays a role during the late stages of 
kidney development and/or in the adult kidney and so we set out to perform 
immunohistochemistry to define ROBO2 expression in the kidneys at different 
developmental stages. We will perform the immune co-labelling with cell specific 
markers to determine the identity of the ROBO2 expressing cells. If we find that the 
ROBO2 receptor is expressed during the late stages of kidney development or in the adult 
kidney, we plan to analyze the expression pattern of SLIT2, the ligand for the ROBO2 
receptor, to determine when signaling may be occurring. 
After specifying the ROBO2 expression pattern in the glomerulus, we will extend 
this study to investigate the SLIT2-ROBO2 signaling pathway in the kidney. In 
Drosophila, SLIT activated ROBO recruits DOCK to inhibit actin polymerization (Fan et 
al., 2003). Interestingly the mammalian homolog of DOCK, NCK, was shown to be 
expressed in the kidney and NCK constitutes a crucial component in the nephrin 
signaling pathway in glomerular podocytes. Upon nephrin activation, nephrin recruits 
NCK to induce actin polymerization (Jones et al., 2006; Verma et al., 2006). Using the 
yeast two hybrid assay we will investigate if NCK is capable of binding ROBO2 
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receptor. If the assay shows a positive interaction, we will further investigate if NCK is 
involved in the SLIT2-ROBO2 signaling pathway in mammalian kidney cells by co-
precipitation. To better characterize the interaction between SLIT2-ROBO2 signaling 
pathway and NCK we will examine the potential triple interaction among ROBO2, NCK, 
and nephrin. 
Nephrin-NCK signaling pathway leads to actin polymerization while the SLIT-
ROBO signaling is shown to inhibit actin polymerization (Fan et al., 2003; Yang and 
Bashaw, 2006). If ROBO2, NCK, and nephrin are capable of the triple complex 
formation, it would be suggestive of the signaling pathways crosstalk. To extend our 
understanding of the function of the triple complex, and how does it affect nephrin 
induced actin polymerization, we will perform cell-based actin polymerization assays. If 
we detect the effect of signaling pathways crosstalk in these assays, we will examine 
whether the SLIT2-ROBO2 pathway affects the nephrin signaling in vivo using the 
kidney extracts. 
To validate our observations obtained from SLIT2-ROBO2 signaling study, we 
will generate Robo2 knockout mice, and possibly the cell type specific Robo2 knockout 
mice to further investigate role of the signaling pathway in vivo. If ROBO2, NCK, and 
nephrin form a complex, we will perform a genetic interaction assay to find out the 
functional co-relation between ROBO2 and nephrin by generating the double knockout 
mice of the two genes. 
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Aim 2: To examine a) the role of SLIT2 and ROBO2 during podocyte injury in mice 
and b) the expression of SLIT2 and ROBO2 in normal and diseased human kidneys. 
Since preliminary data shows that SLIT2 and ROBO2 are found in the mature 
mouse glomeruli, we will further investigate their function in the glomerular pathology. 
To determine to what extent ROBO2 deficiency will alter podocyte injury responses, we 
will induce glomerular disease using two different models in wild-type and Robo2 cKO 
mice. We will use the protamine sulfate (PS) perfusion and nephrotoxic serum (NTS) 
injection models which cause acute and podocyte specific injury through two distinct 
mechanisms. The protamine sulfate model causes a toxic injury to podocytes 
characterized by calcium influx and subsequent loss of the actin cytoskeletal structure 
while the NTS model results in an immune-mediated podocyte injury. In both injury 
models we will analyze the podocyte ultrastructure, and in the NTS model mice we will 
measure the albuminuria as a marker of for podocyte barrier function. 
Nephrin, as a crucial structural and signaling component of podocytes is known to 
be downregulated during podocyte injury and in several kidney diseases (Luimula et al., 
2000; Putaala et al., 2001; Yogavijayan Kandasamy, 2014). To elucidate what constitutes 
the difference in injury response between the Robo2 cKO and WT mice, we will analyze 
the levels of nephrin mRNA and protein in the kidney lysates of NTS injured mice using 
the TaqMan and Western blot assays.  Meanwhile, the expressions of SLIT2 and ROBO2 
will also be analyzed using the same strategy. 
Correlation between podocyte injury and progression to chronic kidney disease 
has been well documented (Kriz et al., 1994; Lemley et al., 2002; Pagtalunan et al., 
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1997).  Membranous nephropathy (MN) is a chronic kidney disease with known and 
significant podocyte involvement characterized by the immune damage directed against 
podocyte antigens (Chugh et al., 2001; O'Meara et al., 1992; Salant et al., 1980; Yuan et 
al., 2002). Phenotypically MN patients present with proteinuria and significant podocyte 
foot process effacement (Beck and Salant, 2010, 2014; Nangaku et al., 2005). In addition, 
immune involvement in pathology of MN resembles the experimental NTS injury model 
that I plan to use for the transient injury model in mice. The experiments outlined in the 
Specific Aim 2 will provide the answer as to whether SLIT2-ROBO2 signaling pathway 
is important in the pathology of induced podocyte injury in mice.  
To extend our understanding of the SLIT2-ROBO2 pathway significance in the 
kidney, we will seek to understand if this signaling pathway plays a role in human 
chronic proteinuric diseases, such as membranous nephropathy. To test if SLIT2 and 
ROBO2 are involved in MN pathology, we will assess the protein levels and cellular 
distribution patterns of ROBO2 and SLIT2 in the kidney biopsy samples from the MN 
patients compared with the healthy control subjects.  
 
Aim 3: To investigate the effect of ROBO2 overexpression on kidney development 
and podocyte biology by generating ROBO2 overexpressing transgenic mice 
To better understand the function of SLIT2-ROBO2 signaling in the kidney, we 
plan to generate ROBO2 overexpressing transgenic mice. The kidney has been shown to 
expresses two ROBO2 isoforms (Lu et al., 2007). These isoforms differ by the presence 
of the alternatively spliced exon 24B. Exon 24B encodes 93 amino acids of the 
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intracellular of ROBO2, including the highly conserved cytoplasmic CC3 motif (Lu et 
al., 2007). In order to understand the significance of both ROBO2 isoforms, we will 
attempt to make two independent transgenic overexpressing mouse models, the 
ROBO2+24B and ROBO2-24B. Since over-expression of ROBO2 is lethal in Drosophila 
(personal communication with Dr. Xueping Fan), we will use the spatially and temporally 
controlled conditional transgenic overexpression mouse model. To achieve this goal we 
will use the Tet-On system (Gossen and Bujard, 1992). In this system, successful 
expression of the transgene depends on three crucial elements: 1) presence of the target 
transgene (ROBO2+24B or ROBO2-24B) cloned under transcriptional tetracycline 
responsive elements, 2) presence of the transactivator protein (reverse tetracycline 
transactivated activator protein, rtTA), and 3) exposure to doxycycline, which permits 
target transgene expression. For the experimental plan, we will a) Insert the cDNA into 
the expression vector that will be injected into mouse ES cells and b) confirm that 
expression occurs and is regulated by doxycycline in the HEK cells, and c) collaborating 
with the transgenic core to generate the transgenic overexpressing mice. rtTA 
overexpressing mice are commercially available and can be purchased from the Jackson 
Laboratory. Our plan to generate ROBO2 transgenic mice is represented in Illustration 4. 
Once the ROBO2+24B and ROBO2-24B transgenic overexpressing mice are 
generated, we will analyze their phenotype by focusing on kidney histology, podocyte 
ultrastructure and proteinuria as the marker of the kidney function. We will additionally 
seek to measure the crucial glomerular gene expression levels, such as nephrin.  
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Illustration 4: Schematic plan of generation of ROBO2 transgene overexpressing 
mice   
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CHAPTER THREE: Inhibitory Effects of ROBO2 on Nephrin: A Crosstalk 
between Positive and Negative Signals Regulating Podocyte Structure 
  
The text of this thesis chapter, with minor modifications, has been previously published 
and appears in Cell Reports 2012 Jul 26; 2(1): 52–61.  
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Summary 
ROBO2 is the cell surface receptor for the repulsive guidance cue Slit and is 
involved in axon guidance and neuronal migration. Nephrin is a podocyte slit-diaphragm 
protein that functions in the kidney glomerular filtration barrier. Here we report that 
ROBO2 is expressed at the basal surface of mouse podocytes and co-localizes with 
nephrin. Biochemical studies indicate that ROBO2 forms a complex with nephrin in the 
kidney through adaptor protein NCK. In contrast to the role of nephrin that promotes 
actin polymerization, SLIT2-ROBO2 signaling inhibits nephrin-induced actin 
polymerization. In addition, the amount of F-actin associated with nephrin is increased in 
Robo2 knockout mice that develop an altered podocyte foot process structure. Genetic 
interaction study further reveals that loss of ROBO2 alleviates the abnormal podocyte 
structural phenotype in nephrin null mice. These results suggest that ROBO2 signaling 
acts as a negative regulator on nephrin to influence podocyte foot process architecture.  
  
Introduction 
In the normal kidney, the trilaminar glomerular capillary wall, composed of 
fenestrated endothelial cells, basement membrane and podocytes, restricts the 
permeability to plasma proteins. Podocytes are specialized epithelial cells that extend 
primary and secondary processes to cover the outer surface of the glomerular basement 
  
47 
membrane. The actin-rich interdigitating secondary processes, or foot processes, from 
neighboring podocytes create filtration slits bridged by a semi-porous slit-diaphragm that 
forms the final barrier to protein permeation. Whereas genetic mutations of podocyte slit-
diaphragm proteins such as nephrin and others are associated with hereditary forms of 
proteinuric kidney disease (Tryggvason et al., 2006), it has become evident that the 
proteins that make up and associate with the slit-diaphragm are more than a simple 
structural barrier. These proteins form a balanced signaling network that may influence 
podocyte foot process structure and function through interaction with the F-actin 
cytoskeleton (Faul et al., 2007; Jones et al., 2006; Verma et al., 2006).   
Roundabout (ROBO) family proteins are cell surface receptors for the secreted 
ligand SLITs (Dickson and Gilestro, 2006), which were originally found as repulsive 
guidance cues for axon pathfinding and migrating neurons during nervous system 
development (Guan and Rao, 2003). The transmembrane protein ROBO2 contains five Ig 
motifs and three fibronectin type III (FNIII) repeats in its extracellular domain (Dickson 
and Gilestro, 2006). While both immunoglobulin (Ig) motifs 1 and 2 interact with SLIT2, 
the first Ig1 motif of ROBO2 is the primary binding site for SLIT2 (Dickson and 
Gilestro, 2006). The intracellular domain of ROBO2 has four cytoplasmic conserved 
(CC) sequences named CC0 to CC3 (Dickson and Gilestro, 2006). CC0 and CC1 contain 
conserved tyrosine residues, while CC2 and CC3 are proline-rich stretches. The repulsive 
SLIT2-ROBO2 signaling inhibits actin polymerization (Guan and Rao, 2003) or induces 
F-actin depolymerization (Piper et al., 2006). 
SLIT2-ROBO2 signaling also plays crucial roles during early kidney induction 
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and ureteric bud outgrowth. Mouse mutants that lack SLIT2 or ROBO2 develop 
supernumerary ureteric buds, which leads to a broad-spectrum of urinary tract anomalies 
(Grieshammer et al., 2004; Lu et al., 2007). Disruption of ROBO2 in humans causes 
congenital anomalies of the kidneys and urinary tracts (CAKUT), and point mutations of 
ROBO2 have been identified in patients with vesicoureteral reflux (VUR) (Lu et al., 
2007). We recently showed that ROBO2 is crucial for the formation of a normal ureteral 
orifice and for the maintenance of an effective anti-reflux mechanism (Wang et al., 
2011). However, it is not known if ROBO2 also plays a role in the kidney after ureteric 
bud outgrowth.  
Here, we report that ROBO2 is a novel podocyte protein expressed at the basal 
surface of kidney podocytes and co-localizes with nephrin and podocin. ROBO2 interacts 
directly with adaptor protein NCK SH3 domains and forms a complex with nephrin. In 
addition, ROBO2 signaling inhibits actin polymerization induced by nephrin. Whereas 
Robo2 knockout mice develop altered podocyte foot processes, the loss of Robo2 
alleviates the foot process structural abnormalities that are seen in nephrin null mice. 
These results suggest that ROBO2 signaling acts as a negative regulator on nephrin 
signaling to influence podocyte foot process architecture. 
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Results 
ROBO2 is a Novel Podocyte Protein Localized to the  
Basal Cell Surface of Mouse Podocytes  
During kidney development, ROBO2 mRNA is expressed in the metanephric 
mesenchyme surrounding the ureteric bud and later in the proximal end of the S-shaped 
body (Piper et al., 2000), the location of primordial podocytes. This raises the possibility 
that ROBO2 may also be involved in podocyte biology in addition to its role in early 
kidney induction. To investigate this, we performed in situ hybridization and found 
ROBO2 mRNA was expressed in the capillary loop stage of developing glomeruli of 
mouse embryos at embryonic day 16.5 (E16.5) (Figure 2A and 2B). ROBO2 protein 
became detectable by immunofluorescence staining in the developing glomerulus around 
E14.5 and reached peak expression at E16.5 (Figure 2C─2E). Although the expression 
decreased after E17.5 (Figure 2F), ROBO2 expression was maintained in glomeruli after 
birth and was detectable in adult mice at 5 weeks of age (Figure 2G-2H and 2L-2M).  
To determine the cellular localization of ROBO2 in the developing glomerulus, 
we performed dual-label immunohistochemistry with glomerular cell type specific 
markers. We found that ROBO2 protein was co-localized with nephrin (Figure 1A─1C) 
and podocin (Figure 1D─1F), two podocyte slit-diaphragm associated proteins. ROBO2 
was also co-expressed in the glomeruli with the nephrin-interacting adaptor protein NCK 
(Figure 1G─1I) and with WT1, a constituent of podocyte nuclei (Figure 2H-2K). Dual-
labeling with antibodies against nidogen, a basement membrane marker (Figure 1J─1L 
and 1P) and PECAM1, an endothelial cell marker (Figure 1M─1O; Figure S1M) showed 
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that ROBO2 was localized adjacent to the external surface of the glomerular basement 
membrane and absent from endothelial cells. High-resolution confocal microscopy 
further demonstrated that subcellular ROBO2 was most abundant on the basal surface of 
podocytes (Figure 1Q). Immunogold electron microscopy of postnatal mouse kidneys 
with an antibody against the cytoplasmic domain established that ROBO2 was localized 
to podocyte foot processes near to the cytoplasmic face of the slit-diaphragms (Figure 
1R). These results demonstrate that ROBO2 is a podocyte protein and its basal 
subcellular localization in the foot processes suggests that it may play a role in regulating 
podocyte foot process structure. 
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Figure 1: ROBO2 is expressed and localized to the basal cell surface of podocytes. 
 
All immunostainings in (A-Q) are performed at mouse E16.5 days at 600X magnification 
(see Figure S1 for immunostainings in adult mouse glomeruli). 
(A─C) ROBO2 co-localizes with podocyte slit-diaphragm protein nephrin. 
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(D─F) ROBO2 co-localizes with podocyte slit-diaphragm protein podocin. 
(G─I) ROBO2 co-localizes with adaptor protein Nck in glomeruli.  
(J─L) ROBO2 is expressed on the basal podocyte surface adjacent to glomerular 
basement membrane protein nidogen.  
(M─O) ROBO2 does not co-localize with glomerular endothelial cell protein marker 
Pecam1.  
(P) The enlarged region boxed in (L) shows that ROBO2 (red) is expressed 
predominantly on the basal cell surface (arrow) of podocytes (p) adjacent to glomerular 
basement membrane marker nidogen (green). ROBO2 is weakly expressed in the apical 
and lateral cell surfaces (arrowheads) of podocytes.  
(Q) ROBO2 is expressed predominantly on the basal cell surface (arrows) of podocytes 
(p) and is weakly expressed on the apical or lateral cell surfaces (arrowheads).  
(R) Immunogold electron microscopy shows localization of gold partials (arrows) 
conjugated to ROBO2 antibody in the foot process (fp) of a podocyte from a 3-week old 
mouse. GBM, glomerular basement membrane. Magnification: 50,000X. See also Figure 
2. 
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Figure 2:  ROBO2 is expressed in the developing and adult glomeruli.  
Related to Figure 1.  
 
(A and B) In situ hybridization analysis shows that ROBO2 transcripts are expressed in 
developing glomeruli (arrows) at E16.5. Magnification: 60X (A) and 200X (B).  
(C-F) Immunohistochemistry (IHC) studies reveal that ROBO2 is expressed during 
developing glomeruli from E14.5 to E17.5. Magnification: 600X. 
(G) IHC shows that ROBO2 (Red) is specifically expressed in adult mouse glomeruli at 5 
weeks of age (G). DAPI (blue) marks cell nuclei in the kidney. Magnification: 400X.  
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(H) IHC co-localization stainings of 5w kidney show ROBO2 is co-expressed in the 
glomerulus with podocyte marker Wt1. Magnification: 600X. 
(I-K) ROBO2 and WT1 are co-expressed in the mouse glomerulus at E16.5. 
Magnification: 600X. 
(L and M) IHC co-localization stainings of 5w kidney show ROBO2 is co-expressed in 
the glomerulus with mesangial cell marker Pdgfrb (L), and endothelial cell marker 
Pecam1 (M). Magnification: 600X. 
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ROBO2 Intracellular Domain Interacts Directly with  
SH3 Domains of the Adaptor Protein NCK  
Nephrin extracellular domain engagement leads to tyrosine phosphorylation of its 
intracellular domain by Src kinases and recruitment of the SH2 domain of the adaptor 
protein NCK, which in turn induces actin polymerization (Jones et al., 2006; Verma et 
al., 2006). NCK harbors one SH2 domain in the C-terminus and three SH3 domains near 
the N-terminus. Actin polymerization is mediated by the SH3 domains of NCK (Rivera et 
al., 2004), which may recruit various cytoskeleton regulators including N-WASP and 
PAK (Jones et al., 2006). Interestingly, previous studies have shown that the SH3 
domains of the Drosophila Nck homolog Dreadlock (Dock) also directly interact with the 
intracellular domain of ROBO to inhibit actin polymerization (Fan et al., 2003). This 
prompted us to question whether mammalian NCK can also interact directly with 
ROBO2 in the podocyte to regulate the F-actin cytoskeleton.  
To address this possibility, we used a yeast two-hybrid assay to examine if 
ROBO2 interacted with NCK. Since two mammalian NCKs (i.e. NCK1, NCK2) share 
similar structure and function in kidney development (Jones et al., 2006), we used NCK1 
in this study and observed that the intracellular domain of ROBO2 directly interacted 
with NCK1 (Figure 3A-3C). Binding site mapping in ROBO2 for NCK1 showed that the 
sequence from amino acid 1085 to 1301, which contain 4 proline-rich motifs, was crucial 
for the interaction (Figure 3A and 3C). Absence of this proline-rich region prevented its 
interaction with NCK1 (Figure 3A). Binding site mapping in NCK1 for ROBO2 showed 
that the first two SH3 domains were required for its interaction with ROBO2 because 
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deleting either or both of them abrogated the interaction (Figure 3B). Thus, ROBO2 and 
NCK1 interaction was mediated by two well-characterized protein domains: the SH3 
domains and proline-rich motifs (Figure 3C). CD2AP, another podocyte adaptor protein, 
also bears three SH3 domains in its N-terminus (Shih et al., 2001), but we did not detect 
any interaction between CD2AP and ROBO2 in either the yeast two-hybrid or co-
precipitation assays (data not shown). These observations suggest that the binding 
between ROBO2 and NCK1 in the podocyte is a specific interaction.  
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Figure 3: ROBO2 interacts with the adapter protein NCK and forms a complex 
with nephrin. 
 
(A) Yeast two-hybrid assays show a positive interaction between ROBO2 intracellular 
domain (ROBO2-ICD) and Nck1. LacZ reporter (X-gal): +++, yeast turned dark blue; 
++, light blue; -, white in 24 hours. Leucine reporter (-Leu): +, yeast grew; -, yeast did 
not grow. CC, cytoplasmic conserved region. Numbers indicate residue positions in the 
full-length protein. 
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(B) Yeast two-hybrid assays show the first two SH3 domains of Nck1 are required for its 
interaction with ROBO2-ICD.  
(C) Yeast two-hybrid assays show the potential binding domains that mediate ROBO2 
and Nck1 interaction. The sequence is the potential binding region in ROBO2 for Nck1. 
Proline-rich regions are highlighted in red.  
(D) Co-precipitation of ROBO2 and Nck. Cell lysates in lane 5 are collected from His-
myc-ROBO2 transfected cells (used in lanes 1 and 2); Cell lysates in lane 6 are collected 
from His-myc-ROBO2-ΔNBD transfected cells (used in lanes 3 and 4). 
(E) Co-precipitation of ROBO2, Nck, and nephrin.  
(F) A similar co-precipitation as (E) except that His-myc-nephrin is pulled-down instead 
of His-myc-ROBO2.  
(G) Co-immunoprecipitation of kidney endogenous ROBO2, Nck, and nephrin.  
(H) A similar assay as (G) except that precipitates are prepared using mouse anti-nephrin 
antibody.  
(I) Slit2 enhances ROBO2-Nck-nephrin complex formation. His-myc-ROBO2, nephrin, 
and Fyn are expressed in HEK cells that are stimulated with Slit2 conditioned medium 
(lanes 1, 3) or control conditioned medium (lane 2, 4).  
(J) Intensity quantification of (I). Data are represented as mean ± SEM; n=7, *p < 0.05, 
**p < 0.01 compared with the control, paired student’s t-test. See also Figure S2. 
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Figure 4:  ROBO2 interacts with NCK and forms a complex with nephrin, which is 
enhanced by SLIT2 stimulation.  
Related to Figure 2. 
 
(A) Co-IP of ROBO2 and nephrin with endogenous Nck. ROBO2, nephrin, and Fyn are 
expressed in HEK cells and stimulated by Slit2. The endogenous Nck is 
immunoprecipitated by an anti-Nck antibody. The mouse IgG is used as a control. The 
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complex formation with nephrin is enhanced by Slit2 and Fyn expression. 
(B and C) Slit2 is expressed in the newborn mouse glomeruli by Immunoperoxidase 
staining (B) and is co-expressed in the glomerulus with the podocyte marker 
Synaptopodin (C). Magnification: 600X. 
(D and D’) CD16/7-NCD is co-expressed with ROBO2 in HEK cells in the presence of 
Slit2, treated with anti-CD16 antibody and rhodamine-conjugated anti-IgG antibody, then 
fixed and stained with anti-ROBO2 antibody. CD16/7-NCD clusters co-localize with 
ROBO2 (D) but no colocalization is observed in control CD16/7-HA clusters (D’). Scale 
bar: 5 µm. NCD: nephrin cytoplasmic domain.  
(E and E’) Deletion of Nck binding domain (NBD) in ROBO2 impairs its co-localization 
with CD16/7-NCD in the presence of Slit2. CD16/7-NCD clusters co-localize with 
ROBO2 (E) but no colocalization is observed in ROBO2-ΔNBD clusters (E’). Scale bar: 
5 µm. 
(F and F’) Slit2 stimulation enhances CD16/7-NCD and ROBO2 co-localization in HEK 
cells. CD16/7-NCD clusters co-localize with ROBO2 in the presence of Slit2 (F) but not 
with control conditioned medium (F’). Scale bar: 5 µm. 
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Full-Length ROBO2 Forms a Complex with Nephrin through NCK  
We confirmed the interaction between ROBO2 and NCK by pull down and co-
precipitation assays. His- and myc-tagged human full-length ROBO2 (His-myc-ROBO2) 
or his- and myc-tagged human ROBO2 with a deletion of the NCK1 binding domain 
(His-myc-ROBO2-ΔNBD) were expressed in HEK (293T) cells. Transfected HEK cells 
were stimulated with SLIT2 conditioned medium (prepared from SLIT2 stably 
transfected cells) to activate ROBO2 and increase NCK binding (Fan et al., 2003). NCK 
was pulled down with His-myc-ROBO2 from the HEK cell lysates using Ni-NTA beads 
but not with His-myc-ROBO2-ΔNBD (Figure 3D). Since the SH2 domain of NCK 
interacts with phosphotyrosines in the nephrin cytoplasmic domain (NCD) (Jones et al., 
2006; Verma et al., 2006), we examined whether ROBO2 formed a complex with nephrin 
through NCK using a co-precipitation assay. To establish proof of principle, we co-
expressed ROBO2 and nephrin in HEK cells with Fyn kinase to increase nephrin 
phosphorylation (Verma et al., 2006). Pull-down of His-myc-ROBO2 (but not of His-
myc-ROBO2-ΔNBD) from the HEK cell lysates with Ni-NTA beads co-precipitated 
NCK and nephrin when Fyn was expressed (Figure 3E). In the reverse order, pulling 
down His-myc-nephrin co-precipitated NCK and ROBO2 when Fyn kinase was 
expressed (Figure 3F). Furthermore, the precipitates prepared with the anti-NCK 
antibody contained both ROBO2 and nephrin when Fyn was over-expressed (Figure 4A). 
These data suggest that nephrin, NCK, and ROBO2 form a complex in vitro.  
To validate these findings in vivo, we immunoprecipitated ROBO2 from newborn 
mouse kidney lysates and found that NCK and nephrin were co-precipitated (Figure 3G). 
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Conversely, the precipitates prepared with the anti-nephrin antibody also contained NCK 
and ROBO2 (Figure 3H). Since nephrin is uniquely expressed in podocytes of kidney 
lysates, and NCK and ROBO2 are also localized in these cells in the kidney, these results 
indicate that nephrin, NCK, and ROBO2 are able to form a complex in podocytes.  
To determine the role of SLIT2 in the formation of the ROBO2-NCK-nephrin 
protein complex, His-myc-ROBO2, nephrin, and Fyn were co-expressed in HEK cells 
that were stimulated with SLIT2 conditioned medium or control conditioned medium 
without SLIT2 prior to co-precipitation (Figure 3I). We observed that SLIT2 stimulation 
increased ROBO2 binding to NCK and complex formation with nephrin. Both ratios of 
NCK1 versus ROBO2 and nephrin versus ROBO2 were increased after SLIT2 
stimulation (Figure 3J). Consistent with this finding, we observed that SLIT2 was also 
expressed in newborn and adult mouse glomeruli (Figure 4B and 4C). 
SLIT2-ROBO2 Signaling Inhibits Nephrin-Induced Actin Polymerization 
Since SLIT binds ROBO to recruit Dock and srGAPs, thereby inhibiting actin 
polymerization (Fan et al., 2003; Wong et al., 2001), we wondered if ROBO2 might also 
recruit NCK to inhibit actin polymerization in mammalian cells, an opposite role to 
nephrin that promotes actin polymerization. To address this question, we studied actin 
polymerization by analyzing F-actin tails in cells expressing the CD16/7-NCD chimeric 
protein as previously described (Jones et al., 2006; Verma et al., 2006). This model 
utilizes the extracellular and transmembrane domains of the human immunoglobulin Fc 
receptors CD16 and CD7 fused to the nephrin cytoplasmic domain (NCD). CD16/7-HA, 
in which NCD was replaced by an HA tag, was used as a negative control. These 
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chimeric proteins were co-expressed with ROBO2 in HEK cells and clustered by 
treatment with anti-CD16 antibody and a secondary antibody conjugated to rhodamine.  
We first examined if clustering of the nephrin cytoplasmic domain could recruit 
ROBO2 in the presence of SLIT2. We observed that engagement of CD16/7-NCD moved 
nephrin into the ROBO2 complexes since most of the ROBO2 colocalized with the 
CD16/7-NCD clusters (Figure 4D, 4E, 4F). However, no colocalization of the ROBO2 
was observed either with the CD16/7-HA control (Figure S2D’) or with the ROBO2-
ΔNBD construct (Figure 4E’), in which the ROBO2 NCK binding domain (NBD) was 
deleted. Interestingly, in the absence of SLIT2, colocalization of CD16/7-NCD and 
ROBO2 was significantly reduced (Figure 4F’).  
These data provide further evidence that the nephrin cytoplasmic domain is able 
to complex with the ROBO2 intracellular domain in the presence of SLIT2 and validates 
the model to determine if the formation of a ROBO2-NCK-nephrin complex affects actin 
polymerization.  
HEK cells expressing CD16/7-NCD and ROBO2 were stimulated with SLIT2 or 
control conditioned medium while clustered by the anti-CD16 antibody. Actin 
polymerization was evaluated by quantifying the number of HEK cells with visible F-
actin tails (Rivera et al., 2004). We observed that ~80% of the CD16/7-NCD clustered 
cells formed F-actin tails that could be revealed by phalloidin staining as previously 
reported (Jones et al., 2006; Verma et al., 2006). Upon SLIT2 stimulation, however, the 
number of cells with F-actin tails was significantly reduced to approximately 40% 
(Figure 5A and 5C). Only a few cells were observed to contain F-actin tails when the 
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control CD16/7-HA proteins were clustered (Figure 5B and 5C).  
To further investigate whether this inhibition of actin polymerization required 
NCK, we repeated this assay using ROBO2 without NCK binding domain (ROBO2-
ΔNBD) to determine if blocking of NCK binding to ROBO2 would prevent SLIT2-
ROBO2 inhibition on nephrin-induced actin polymerization. CD16/7-NCD was co-
expressed with either full-length ROBO2 (Figure 6A) or ROBO2-ΔNBD (Figure 6B) in 
HEK cells. We observed that deletion of the NCK binding domain in ROBO2 
significantly compromised SLIT2-ROBO2 inhibition on nephrin-induced actin 
polymerization (Figure 6C).  
A previous study shows that nephrin is linked to the F-actin cytoskeleton (Yuan et 
al., 2002). To determine if SLIT2-ROBO2 signaling could inhibit the association of F-
actin and nephrin, we immunoprecipitated CD16/7-NCD and CD16/7-HA with anti-
CD16 antibody and examined the amount of F-actin in the precipitates by Western blot. 
We observed that the abundance of F-actin associated with nephrin was significantly 
reduced upon SLIT2 stimulation (Figure 5D and 5E). Conversely, in vivo 
immunoprecipitation assay showed that F-actin associated with nephrin 
immunoprecipitated by an anti-nephrin antibody from ROBO2 newborn null mouse 
kidneys was significantly increased compared with that from wild type or ROBO2 
heterozygous mouse kidneys (Figure 5F and 5G). Taken together, these results indicate 
that SLIT2-ROBO2 signaling inhibits nephrin-induced actin polymerization. 
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Figure 5: SLIT2-ROBO2 signaling inhibits nephrin-mediated actin polymerization.  
(A) CD16/7-NCD is co-expressed with ROBO2 in HEK cells, which are treated with 
anti-CD16 antibody and rhodamine-conjugated anti-IgG antibody in the presence of Slit2 
conditioned medium (Slit) or control conditioned medium (CTL). Cells are then fixed 
and stained with FITC-conjugated phalloidin to reveal F-actin. Scale bar, 5 µm. NCD: 
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nephrin cytoplasmic domain. 
(B) A similar assay as (A) except that CD16/7-NCD is replaced by CD16/7-HA and is 
used as a control assay. 
(C) The percentage of cells with F-actin tails over total cells with CD16/7 clusters in each 
group is quantified. Data are represented as mean ± SEM, *p < 0.01, n=5. 
(D) CD16/7-NCD in (A) is immunoprecipitated by anti-CD16 antibody after Slit2 
conditioned medium stimulation (lanes 1 and 3) or control conditioned medium (lanes 2 
and 4). Note reduced F-actin in lane 1. CD16/7-HA is used as a negative control.  
(E) Intensity quantification of (D). Data are represented as mean ± SEM; n=4, *p < 0.05 
compared with the control, paired student’s t-test.  
(F) Immunoprecipitation of nephrin from ROBO2 knockout homozygous (ROBO2-/-), 
heterozygous (Robo2+/-), and wild-type (Robo2+/+) mouse kidneys using the anti-nephrin 
antibody. Note increased F-actin in lane 3. 
(G) Intensity quantification of (F). Data are represented as mean ± SEM; n=4, *p < 0.05 
compared with the wild-type and heterozygous, ANOVA analysis. See also Figure 3. 
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Figure 6:  Deletion of Nck binding domain in ROBO2 compromises SLIT2-ROBO2 
inhibition on nephrin-induced actin polymerization.  
Related to Figure 3.  
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(A) CD16/7-NCD and ROBO2 were co-expressed in HEK cells, clustered with anti-
CD16 antibody and rhodamine-conjugated anti-IgG antibody in the presence of Slit2 
conditioned medium (Slit2) or control conditioned medium (CTL). Cells were then fixed 
and stained with FITC-conjugated phalloidin to reveal F-actin fibers. Clusters of CD16/7-
NCD and F-actin fibers were examined using confocal microscopy. Scale bar, 5µm. 
NCD, nephrin cytoplasmic domain. 
(B) CD16/7-NCD and ROBO2-ΔNBD were co-expressed in HEK cells. Scale bar, 5µm. 
NBD, Nck binding domain.  
(C) The percentage of cells with F-actin tails over total cells with CD16/7-NCD clusters 
in each group was quantified. Data are represented as mean ± SEM, *p = 1.436x10-5, 
**p = 6.32x10-5, n=5, ANOVA. 
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Loss of Robo2 in Podocytes Causes Altered Foot Process Structure in Mice 
We and others have previously shown that almost all Robo2 homozygous null 
mice in mixed genetic background die shortly after birth due to a severe CAKUT 
phenotype (Grieshammer et al., 2004; Lu et al., 2007; Wang et al., 2011). After breeding 
mice with a Robo2del5 (also called Robo2-) mutant allele for five generations onto 
C57BL/6 genetic background, mating of Robo2del5/+ heterozygous parents revealed three 
Robo2del5/del5 homozygous mice that survived to 3 weeks (among a total of 160 mice 
analyzed at weaning). To determine if Robo2 is required for podocyte foot process 
formation during development, we examined the ultrastructure of glomeruli in Robo2 null 
mice at birth and 3 weeks of age. Although the podocyte body, foot processes and slit-
diaphragm were formed at birth, transmission electron microscopy showed focal foot 
process effacement in newborn Robo2del5/del5 homozygous mice (Figure 8A-8F). By 
scanning electron microscopy, we observed irregular interdigitating foot processes in 
Robo2del5/del5 homozygous null mice at birth and 3 weeks of age (Figure 8A-8H). These 
findings suggest that ROBO2 plays a role in normal podocyte foot process patterning 
during kidney development. 
To examine the role of ROBO2 in the maintenance of foot process structure in 
mature glomeruli, we generated podocyte specific Robo2 knockout mice by crossing 
conditional Robo2flox/flox mice with Robo2del5/+;TgNphs2-Cre/+ heterozygous mice carrying a 
podocin-Cre transgene. Twenty podocyte specific Robo2 mutant mice with 
Robo2del5/flox;TgNphs2-Cre/+ genotype and 20 littermate control mice were analyzed up to 
one year of age. Podocyte specific Robo2 knockout mice were viable and fertile. 
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However, they displayed unusually broad podocyte foot processes and focal segmental 
foot process effacement at one month (Figure 7I-7M). At 6 weeks of age the mutant mice 
developed microalbuminuria, which was detected by both ELISA and Western blot 
analyses (Figure 4N and 4O).  
In addition, scanning electron microscopy revealed foot process patterning 
changes in Robo2 podocyte specific knockout mice. Instead of orderly zipper-like 
interdigitating secondary foot processes in the wild-type, Robo2 podocyte specific 
knockout mice displayed irregular and disorganized foot process interdigitation patterns 
at one month (Figure 8G-8J). These changes became more obvious over time. At seven 
months of age, overtly disorganized, shorter, and meandering foot processes were 
observed (Figure 8K-8N), which were similar to the phenotype of three-week old Robo2 
null mice. Although Robo2 podocyte specific knockout mice had normal podocyte 
number, matrix deposition was significantly increased in glomeruli (Figure 8O-8T, Table 
1 and 2). These morphological and functional changes suggest that ROBO2 plays a role 
in regulating and maintaining glomerular podocyte foot process structure. 
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Figure 7: Podocyte structural phenotypes in the Robo2 homozygous null, Robo2 
podocyte specific knockout, and Robo2 and Nphs1 double knockout mice. 
(A and B) Representative images of newborn kidneys show podocyte bodies 
(arrowheads) and Bowman’s capsule (arrows) in wild-type (A) and Robo2 homozygous 
null mice (B).  
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(C and D) High magnification images of (A and B) show podocyte foot processes 
(arrows) in the newborn kidney. Scale bar, 1 µm 
(E and F) Representative images of 3-week kidneys at low magnification show podocyte 
cell body (arrowheads) in a Robo2 homozygous null mouse (F) compared to an age-
matched control (E).  
(G and H) Higher magnification images of (E and F) show disorganized shorter 
meandering foot processes (arrow) in a 3-week Robo2 homozygous null mouse (H) 
compared to well-organized zip-like foot processes in the age-matched control (G). Scale 
bars: 2 µm. 
(I and J) Representative transmission electron microscopy images (magnification at 
5000x) depict the focal segmental podocyte foot process effacement (arrow in J) in a one 
month old Robo2 podocyte-specific knockout mouse and the normal phenotype in the 
control (I). Abbreviations: gc: glomerular capillary; us: urinary space. 
(K and L) Higher magnification transmission electron microscopy images (40000x) show 
broader podocyte foot processes (arrow in L) in a two months old Robo2 podocyte-
specific mutant mouse compared with the control (K). Abbreviations: fp, podocyte foot 
process; GBM, glomerular basement membrane.  
(M) Quantification of podocyte foot process width in one month old Robo2del5/flox;TgNphs2-
Cre+ podocyte specific knockout mice (Robo2 KO) and the wild-type littermate controls 
(WT). Data are represented as mean ± SEM, n=333, *p < 0.01. 
  
73 
(N) ELISA assay of spot urine shows an elevated albumin/creatinine ratio in 
Robo2del5/flox;Nphs2-Cre+ (KO) adult mice compared with control wild-type (WT). Data 
are represented as mean ± SEM, n=20, *p < 0.01. 
(O) Western blot analysis shows the presence of albumin in urine; 1µl urine was loaded 
on each well, 0.2µg albumin was used as a positive control. WT, three wild-type 
littermates; Robo2 KO, three individual Robo2del5/flox;Nphs2-Cre+ mice.  
(P and Q) Representative scanning electron microscope images show disrupted 
interdigitating podocyte foot processes that resemble disorganized cellular protrusions 
(arrows) in the Nphs1-/- single homozygous newborn mouse kidney. Scale bars: 1 µm. 
(R and S) Glomeruli from Nphs1-/-Robo2-/- double homozygous newborn mice exhibit 
restored interdigitating foot processes (arrows), indicating alleviation of nephrin null 
phenotype by knocking out Robo2.  
(T and U), Glomeruli from Robo2-/- single homozygous newborn mice display irregular 
and broader foot processes but extensive interdigitating pattern formation (arrows).  
(V and W), Glomeruli from newborn wild type mice with normal regular interdigitating 
pattern of the foot process (arrows). See also Figure 8 and Table 1-4. 
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Figure 8: Glomerular phenotype in the Robo2 homozygous null, Robo2 podocyte 
specific knockout, Robo2 and Nphs1 double knockout mice, and a proposed model 
of ROBO2-Nephrin signaling. 
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Figure 8: Glomerular phenotype in the Robo2 homozygous null, Robo2 podocyte 
specific knockout, Robo2 and Nphs1 double knockout mice, and a proposed model 
of ROBO2-Nephrin signaling.  
Related to Figure 4.  
(A-F) Transmission electron microscopy analysis of glomerular ultrastructure in newborn 
(NB) Robo2del5/del5 mutant mice kidney. (A, C, E) Glomerular ultrastructure from a 
newborn heterozygous Robo2 control mouse at low (A, 2200X), medium (C, 15500X) 
and high (E, 52000X) magnifications. (B, D, F) Glomerular ultrastructure from a 
newborn homozygous Robo2 (-/-) (i.e. Robo2del5/del5) mutant mouse at low (B), 
medium (D) and high (F) magnifications. Arrows indicate focal foot process effacement. 
Abbreviations: gc: glomerular capillary; us: urinary space; GBM: glomerular basement 
membrane. 
(G-N) Abnormal podocyte foot process patterns in Robo2 podocyte-specific knockout 
mice. (G-J) Representative scanning electron microscopy images of glomeruli from one-
month old Robo2del5/flox;Nphs2-Cre+ podocyte-specific knockout mice and aged 
matched Robo2flox/+ control mice. Mild irregularities of the interdigitating podocyte 
foot processes were found in a one month old Robo2 podocyte-specific knockout mouse 
(K and N). At seven months old, Robo2 podocyte-specific knockout mice developed 
markedly irregular foot processes (L and N). Scale bars: 10 µm (G, H, K, L at 2000x 
magnification) and 2 µm (I, J, M ,N at 13000x magnification). 
(O-T) Glomerular morphology in Robo2 podocyte-specific knockout mice. (O-R) 
Periodic acid-Schiff (PAS) staining showed mesangial matrix expansion in the glomeruli 
from 2-month and 6-month old Robo2 podocyte-specific knockout mice (P, R) compared 
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to age-matched controls (O, Q). (S) Quantitative analysis of glomeruli shows mesangial 
matrix expansion in 12-month old Robo2 podocyte-specific knockout mice (MU) 
compared to age matched wild-type (WT) controls. Data are represented as mean ± SEM, 
n=5, *p < 0.01. (T) Robo2 podocyte specific knockout does not affect podocyte numbers. 
Podocyte cells were identified using WT-1 staining. The number of podocytes per 
glomerular cross section was counted in four one-year old Robo2del5/flox;TgNphs2-Cre/+ 
podocyte specific knockout mice (MU) compared to four age-matched wild-type mice 
(WT). Data are represented as mean ± SEM, p = 0.645, t-test; mutant: n=165 glomeruli; 
control: n=166 glomeruli. 
(U-Y) Glomerular phenotype in Robo2 and Nphs1 double knockout mice. (U) H&E 
staining shows glomeruli with characteristic dilatations of the Bowman’s space 
(asterisks) in a Nphs1-/- single homozygous newborn mouse, 400x. (V) Glomeruli from a 
Robo2-/- single homozygous newborn mouse show absence of Bowman’s space 
dilatations; 400x. (W) Normal looking glomeruli without significant Bowman’s space 
dilatations (arrows) are shown in a Robo2-/-;Nphs1-/- double homozygous newborn mouse 
indicating alleviation of Nphs1-/- glomerular phenotype; 400x. (X) H&E staining of 
normal kidney and glomeruli from an age-matched wild-type newborn mouse control; 
400x. (Y) Quantification of glomeruli with dilated Bowman’s space in newborn mice 
show significant reduction of glomeruli with the characteristic dilatation phenotype of the 
Bowman’s space in Robo2-/-;Nphs1-/- double homozygous compared to Nphs1-/- single 
homozygous (Robo2+/-;Nphs1-/-). Data are represented as mean ± SEM, *p < 0.01.. 
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(Z) A proposed model of inhibitory effects of Slit2-ROBO2 signaling on nephrin to 
influence podocyte foot process structure: Under physiological conditions (e.g. during 
foot process development), nephrin intracellular phosphorylated tyrosine domains 
(YDxV-p) recruit Nck through its interaction with the SH2 domain. Nck in turn recruits 
cytoskeleton regulators through its SH3 domains to promote actin polymerization. Slit2 
binds ROBO2 to increase ROBO2 intracellular domain interaction with SH3 domains of 
Nck, which would prevent binding of Nck to cytoskeletal regulators and result in an 
inhibition of nephrin-induced actin polymerization. Balanced actin polymerization is 
maintained during podocyte development for a normal foot process structure. In the 
absence of Slit2-ROBO2 signaling (e.g. when ROBO2 is knocked out), the inhibitory 
effects of ROBO2 on nephrin-induced polymerization is lost. The SH3 domains of Nck 
are able to interact with downstream cytoskeletal regulators to increase actin 
polymerization, which may explain the altered podocyte foot process structure in ROBO2 
mutant mice. Abbreviations: Ig: Immunoglobulin domain; FN3: Fibronectin type 3 
domain; SH2: Src homolog 2 domain; SH3: Src homolog 3 domain; CC0, CC1, CC2, 
CC3: Cytoplasmic Conserved region 0, 1, 2, 3. 
 
Loss of Robo2 Alleviates the Podocyte Structural Defect in Nephrin Null Mice 
Nephrin is capable of inducing localized actin polymerization under physiological 
conditions (Jones et al., 2006; Verma et al., 2006). Nephrin homozygous mice develop a 
characteristic phenotype with dilation of the Bowman’s space, abnormally broad foot 
processes, absence of glomerular slit-diaphragms, and significant proteinuria (Done et al., 
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2008; Hamano et al., 2002). Since ROBO2 formed a complex with nephrin, and SLIT2-
ROBO2 signaling inhibited nephrin-induced actin polymerization, we wondered if loss of 
ROBO2 would modify the podocyte phenotype in nephrin null mice.  
To test this hypothesis of a possible genetic interaction between ROBO2 and 
nephrin, we generated both germline Robo2-/-;Nphs1-/- and podocyte-specific 
Robo2flox/flox;TgNphs2-Cre/+;Nphs1-/- double Robo2-nephrin knockout mice. Like Nphs1-/- 
single homozygote, both Robo2-/-;Nphs1-/-  (4/4, 100%) and Robo2flox/flox;TgNphs2-
Cre/+;Nphs1-/- (3/3, 100%) double knockout mice died within 10 hours after birth. 
Histological analysis, however, revealed that the morphology of glomeruli in the Robo2-/-
;Nphs1-/- double homozygous mice appeared relatively normal compared with the 
phenotype in Nphs1-/- single nephrin homozygous mice, which had a dilated Bowman’s 
space (Figure 8U-8X). The number of glomeruli with dilated Bowman’s space was 
significantly reduced in Robo2-/-;Nphs1-/- double homozygous mice (2/55, 3.6%) 
compared with nephrin single null mice (31/122, 25.4%) (Figure 8Y, and Table 3).  
In addition, analysis of glomerular ultrastructure by scanning electron microscopy 
showed that the interdigitating podocyte foot process structure was observed in only 1 
(6.67%) of 15 glomeruli from nephrin single homozygous mice (Figure 7P and 7Q) 
compared with 100% in Robo2-/- single homozygotes (Figure 7T and 7U) and wild-type 
controls (Figure 7V and 7W).  
Remarkably, the interdigitating pattern of the podocyte foot processes was 
restored in 12 (75%) of 16 glomeruli from Robo2-/-;Nphs1-/- double homozygous newborn 
mouse kidneys (Figure 7R and 7S, Table 4), suggesting that a concomitant loss of Robo2 
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and nephrin alleviated the podocyte foot process structural phenotype in these mice. 
These findings indicate that the ROBO2-NCK-nephrin physical interactions described 
above have a substantial effect on podocyte foot process morphology in vivo when the 
levels of expression of ROBO2 and nephrin are genetically altered.  
  
Discussion 
Podocytes exhibit a remarkable degree of plasticity. During development they 
differentiate from simple cuboidal epithelial cells into the elaborate process-bearing cells 
that we recognize as mature podocytes (Reeves et al., 1978). This plasticity is retained 
after maturation. It is seen most graphically as reversible foot process effacement 
following experimental surface charge neutralization with protamine sulfate and 
restoration with heparin (Seiler et al., 1975) and during relapse and remission of 
proteinuria in children with minimal change disease (Nachman et al., 2008). More subtle 
changes in foot processes probably occur under physiological conditions in response to 
positive and negative signals in the form of hemodynamic, hormonal or paracrine stimuli. 
Given the abundance of F-actin in the foot processes, it is likely that such stimuli bring 
about those subtle changes in response to positive and negative signals transduced to the 
F-actin cytoskeleton. Too much or unbalanced positive signals may lead to disease 
phenotype. Indeed, although a physiological ligand has yet to be identified, it is now clear 
that clustering and phosphorylation of nephrin induces actin polymerization by recruiting 
NCK. This mechanism may be involved in the proteinuria induced in rats by a 
nephritogenic monoclonal antibody to the extracellular domain of nephrin (Topham et al., 
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1999) and in cases of congenital nephrotic syndrome that develop anti-nephrin 
alloantibodies after renal transplantation (Patrakka et al., 2002).  
Our studies reveal another level of negative regulation of podocyte actin 
polymerization in which ROBO2, when bound by SLIT, inhibits nephrin-induced actin 
polymerization. While the precise mechanisms have yet to be defined, we propose that 
SLIT-ROBO2 signaling might inhibit nephrin-induced actin polymerization to maintain 
normal podocyte foot process structure as follows: Under physiological conditions (e.g. 
during foot process development), nephrin engagement leads to phosphorylation of the 
intracellular Y1191/1208/1232 to which the NCK SH2 domain binds (Jones et al., 2006; 
Verma et al., 2006). NCK in turn recruits cytoskeleton regulators such as N-WASP 
through its SH3 domains to promote actin polymerization for podocyte foot-process 
extension or spreading (Figure 8Z). Local secretion and binding of SLIT increases the 
interaction of ROBO2 with NCK through its proline rich region and the first two SH3 
domains of NCK. Sequestering the first two SH3 domains of NCK by ROBO2 would 
inhibit actin polymerization and decrease F-actin associated with nephrin to maintain a 
dynamic and balanced F-actin cytoskeleton and normal podocyte foot process structure 
(Figure 8Z). In addition to direct inhibition of nephrin-induced actin polymerization 
through NCK, SLIT-ROBO2 signaling may inactivate actin polymerization through other 
pathways such as recruiting Ena, Abl, srGAPs to negatively regulate F-actin cytoskeleton 
(Bashaw et al., 2000; Wong et al., 2001). In the absence of SLIT2-ROBO2 signaling (e.g. 
when ROBO2 is knocked out), the inhibitory effect of ROBO2 on nephrin-induced 
polymerization is lost. The SH3 domains of NCK are able to interact with downstream 
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cytoskeletal regulators to increase actin polymerization (Figure 8Z), which may explain 
the altered podocyte foot process structure identified in Robo2 mutant mice.  
Our results thus support the concept that SLIT-ROBO signaling may regulate 
podocyte plasticity by negatively regulating F-actin cytoskeleton, which is similar to the 
role of SLIT-ROBO signaling in axon growth cone pathfinding (Guan and Rao, 2003). 
The pathological finding of increased matrix deposition in the Robo2 mutant mouse 
glomeruli likely represents a secondary response although the mechanisms and 
consequences have yet to be defined.  
Although it is clear from our studies that ROBO2 localizes to the basal surface of 
podocytes and forms a complex with other established foot process slit-diaphragm 
proteins through its intracellular domain, it remains uncertain if it actually forms part of 
the slit-diaphragm itself. Interestingly, the extracellular domain of ROBO2 resembles that 
of nephrin, which has eight immunoglobulin (Ig)-like motifs and one fibronectin domain 
whereas ROBO2 has five Ig-like motifs and three fibronectin domains (Figure 8Z) 
(Tryggvason et al., 2006). We have tested the interaction between the intracellular 
domain of ROBO2 and the cytoplasmic domain of nephrin in the yeast two-hybrid assay 
but did not observe any positive results. Our biochemical data (Figure 3E and 3F) also 
did not support a direct interaction between these two receptors in vitro. However, we 
cannot exclude the possibility that the extracellular domain of ROBO2 may associate 
with the extracellular domain of nephrin in vivo on the cell membranes of adjacent foot 
processes through a trans-interaction in the slit-diaphragm.  
We found that Robo2 knockout mice developed an altered foot process 
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interdigitating pattern, a phenotype that is different from that of the nephrin null mice 
(Done et al., 2008; Hamano et al., 2002). This is not surprising since nephrin and ROBO2 
play opposite roles in regulating the podocyte F-actin cytoskeleton. While nephrin 
signaling induces localized actin polymerization, SLIT2-ROBO2 signaling acts as a 
negative regulator on nephrin induced actin polymerization to maintain podocyte foot 
process plasticity and dynamics. It is noteworthy that a similar foot process organization 
defect is observed in mice in which the actin-depolymerizing factor Cofilin-1, another 
negative regulator of the F-actin cytoskeleton in podocytes, is knocked out (Garg et al., 
2010). This suggests that the absence of either an actin polymerization-promoting factor 
such as nephrin or an inhibitory factor such as ROBO2 will affect the normal structure of 
podocytes. Thus the balance between positive and negative F-actin cytoskeleton 
regulators in podocytes is important to maintain normal foot process structure. Regaining 
this balance by knocking out both positive and negative signals may explain the 
restoration of podocyte foot process interdigitation in the Robo2-nephrin double knockout 
mice. Our studies highlight the dual roles of nephrin as an essential component of the slit-
diaphragm to control glomerular permselectivity on the one hand (Tryggvason et al., 
2006) and as a regulator of foot process morphology through its interaction with the actin 
cytoskeleton (Jones et al., 2006; Verma et al., 2006) on the other. While ROBO2 
signaling clearly counters the positive signaling effects of nephrin on the foot processes, 
it remains to be determined if it also influences slit-diaphragm integrity. 
In summary, we have identified ROBO2 as a new component of the podocyte 
intercellular junction in the kidney. We have demonstrated interactions between ROBO2 
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and nephrin using biochemical, functional, and genetic techniques, and have shown that 
SLIT2-ROBO2 signaling inhibits nephrin-induced actin dynamics. Our results suggest 
that ROBO2 signaling acts as a negative regulator on nephrin signaling to modulate 
podocyte foot process architecture. This study extends our understanding of the role of 
SLIT-ROBO signaling and identifies a novel crosstalk mechanism by which guidance 
cue receptor ROBO might influence F-actin cytoskeleton dynamics. Further studies are 
needed to determine if eliminating or blocking SLIT2-ROBO2 signaling can be used 
therapeutically to restore podocyte foot process structure in those diseases in which 
nephrin expression is reduced (Furness et al., 1999). 
 Overview Experimental Procedures 
Detailed information can be found in the Extended Experimental Procedures in 
Supplemental Information. 
Tissue in Situ Hybridization, Immunohistochemistry, 
and Immunogold Electron Microscopy  
In situ hybridization analysis was performed with digoxigenin-labeled ROBO2 
riboprobes as previously described (Grieshammer et al., 2004). Immunohistochemistry 
was performed on mouse embryonic kidney tissues fixed in 4% paraformaldehyde and in 
adult mouse kidney tissues fixed in methanol. For immunogold electron microscopy, 
wild-type mouse kidneys were dissected and fixed in paraformaldehyde-lysine-periodate 
(PLP). Ultrathin sections of the mouse kidney were prepared and incubated with goat 
anti-ROBO2 antibody (DAKO Corporation) and a secondary antibody coupled to 10 nm 
colloidal gold (Ted Pella). 
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Yeast Two-Hybrid, Co-Precipitation, and Actin Polymerization Assays  
The DupLEX-ATM yeast two-hybrid system (OriGene Tech) was used to 
characterize ROBO2 and Nck1 interaction according to manufacturer’s instructions. Cell 
culture, His-tagged protein co-precipitation, and immunoprecipitation were performed as 
previously reported (Fan et al., 2003). For endogenous immunoprecipitation, mouse 
newborn kidneys were utilized. CD16 antibody-mediated crosslinking of CD16/7 fusion 
proteins and the actin polymerization assay were performed as previously described 
(Jones et al., 2006; Rivera et al., 2004; Verma et al., 2006).  
 Knockout Mouse study, Transmission and Scanning Electron Microscopy,  
and Kidney Glomerular Analysis 
Mouse protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at Boston University Medical Center (#14388). The generation and 
genotyping of Robo2flox conditional allele, Robo2del5 (also called Robo2- 
interchangeably in this paper) germline mutant allele, and Robo2+ wild-type allele were 
described previously (Lu et al., 2007; Wang et al., 2011). To generate Robo2-nephrin 
double knockout mice, Robo2+/- mice were crossed with Nphs1+/- mice that were 
generated previously (Hamano et al., 2002). For transmission electron microscopy, 
kidneys were fixed, incubated in 2% glutaraldehyde in 0.15 M sodium cacodylate, 
dehydrated in graded ethanol, embedded in Epon, sectioned, and stained with uranyl 
acetate and lead citrate. Ultrathin kidney sections were examined using a JEM-1011 
electron microscope. For scanning electron microscopy, kidneys were prepared following 
the standard protocol. For kidney pathological studies, kidneys were fixed in 4% 
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paraformaldehyde, paraffin embedded, sectioned, and stained using standard Periodic 
acid-Schiff (PAS) or eosin hematoxylin (H&E) methods. For quantification of podocyte 
number, WT1 was used as a podocyte nuclear marker and immunoperoxidase staining 
was performed on kidney sections following the standard protocol. WT1 positive 
podocyte nuclei in each glomerular cross section were counted. For proteinuria analysis, 
“spot” urine specimens from 6 weeks old mice were examined using a murine 
albuminuria ELISA quantitation kit (Exocell) according to manufacturer’s instruction and 
urine dipstick (Multistix, Bayer, IN) as a screening method. 
 
Supplemental Information  
Extended Experimental Procedures 
Tissue In Situ Hybridization and Immunohistochemistry  
In situ hybridization analysis was performed with digoxigenin-labeled Robo2 
riboprobes as previously described (Grieshammer et al., 2004). The Robo2 cDNA was 
linearized with NotI and probes were generated using the DIG DNA labeling and 
detection kit (Roche Applied Science). Hybridization was performed on 4% 
paraformaldehyde fixed OCT embedded mouse embryonic kidney frozen sections. 
Immunohistochemistry was performed on mouse embryonic kidney tissues fixed in 4% 
paraformaldehyde followed by 30% sucrose cryoprotection (Mugford et al., 2008) and in 
adult mouse kidney tissues fixed in methanol. Mouse kidneys embedded in OCT 
compound were frozen and sectioned using Cryostat at 8-10 µm. Sections were stained 
with primary antibodies and followed by an appropriate FITC or Cy3 conjugated 
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secondary antibodies. The primary antibodies used in this study include the ones against 
ROBO2 (R&D System, Abnova, Santa Cruz Biotechnology), nephrin (custom 
synthesized) (Topham et al., 1999), Nck (Upstate/Millipore), podocin (Sigma), nidogen 
(Santa Cruz Biotechnology), Pecam1 (BD Biosciences), WT1 (Santa Cruz 
Biotechnology), SLIT2 (Santa Cruz Biotechnology), PDGFR beta (Cell Signaling), 
Synaptopodin (Santa Cruz Biotechnology). Images were obtained using a Perkin Elmer 
UltraView LCI multi-point spinning disc laser-scanning confocal microscope and a Zeiss 
LSM 510 confocal laser scanning microscope with a 60x oil immersion objective. 
Immunogold Electron Microscopy  
Wild-type mouse kidneys were dissected and fixed in paraformaldehyde-lysine-
periodate (PLP) at 4oC overnight. The tissue was washed in 1x PBS and dehydrated in 
graded ethanol and embedded in LR White resin (Electron Microscopy Sciences). 
Ultrathin sections of the mouse kidney were prepared and transferred to Formvar-coated 
gold grids, and blocked with 1% bovine serum albumin and 5% normal goat serum in 1x 
PBS. The sections were then incubated with goat anti-ROBO2 antibody with a 1:50 
dilution in DAKO (DAKO Corporation) at 4oC overnight. Non-immune serum was used 
as a control. After three washes with 1x PBS, sections were incubated with a IgG 
secondary antibody coupled to 10 nm colloidal gold (Ted Pella) for 2 hours at room 
temperature. Sections were finally post-fixed with 1% glutaraldehyde and contrasted with 
uranyl acetate. Sections were examined with a JEM-1011 transmission electron 
microscope (JEOL, Tokyo, Japan) at 80kV, and images were acquired using an AMT 
digital imaging system (Advanced Microscopy Techniques, Danvers, MA.) and imported 
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into Adobe Photoshop. Subcellular localization of ROBO2 stained with gold particles in 
glomeruli was recognized on digital electron micrographs in comparison with control 
micrographs stained with non-immune serum. 
Yeast Two-Hybrid Assay  
The DupLEX-ATM yeast two-hybrid system (OriGene Tech, Rockville, MD) was 
used to characterize ROBO2 and Nck1 interaction. The cDNAs encoding the intracellular 
domain of human ROBO2 and its truncated forms were cloned into the pJG4-5 vector at 
EcoRI/XhoI sites, fusing them to the transcription activation domain of B42. The cDNAs 
of human Nck1 and its truncated forms were cloned into the pEG202 vector at 
EcoRI/XhoI to fuse them to the DNA binding domain of LexA. The lacZ gene in the 
construct pSH18-34 and the LEU2 gene in the EGY48 strain yeast genome were used as 
reporter genes. The pEG202, pSH18-34, and pJG4-5 constructs were co-transformed into 
yeast EGY48 cells. The interaction was considered positive if the yeast cells turned blue 
in the presence of X-gal and grew in the absence of leucine. 
Cell Culture, DNA Constructs, Transfection, Co-Precipitation, and Western Blot 
Analyses 
HEK (293T) cells were transfected at 60% confluency using calcium phosphate 
transfection. To make C-terminal his- and myc- tagged fusion proteins, full-length human 
nephrin and ROBO2 were cloned into pSecTag B vector (Invitrogen) at Hind III/EcoR1 
and EcoR1/Xho1 restriction sites respectively. ROBO2-ΔNBD was obtained by deleting 
the Nck binding domain (Figure 2C) using QuikChange site-directed mutagenesis kit 
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(Strategene) according to manufacturer’s instructions. Non-tagged Robo2 and Nck1 were 
cloned into pCS2 vector (Addgene) at EcoR1/Xho1 sites, nephrin at HindIII/EcoR1 sites. 
Human Fyn and myc- tagged Slit2 constructs have been reported previously (Li et al., 
2008; Wong et al., 2001). CD16/7-NCD and CD16/7-HA constructs were also reported 
previously (Verma et al., 2006). To detect ROBO2 and Nck1 interaction, C-terminal His- 
and myc-tagged human ROBO2 or ROBO2-ΔNBD was expressed in HEK cells. Forty-
eight hour post-transfection, cells were lysed in the lysis buffer (50 mM NaH2PO4, 300 
mM NaCl, 10 mM Imidazole, 0.5% TX100, 1x protease inhibitor [pH 8.0]). Cell lysates 
were centrifuged for 10 min at 4oC; supernatants were incubated with Ni-NTA resin 
(Qiagen) at 4°C for 2 hours to precipitate His-ROBO2, NTA resin without Ni was used 
as a control. The resin was washed three times with washing buffer (50 mM NaH2PO4, 
300 mM NaCl, 20 mM Imidazole, 0.5% TX100 [pH 8.0]) and heated at 95°C for 10 min. 
The precipitates were resolved on SDS-PAGE gels and blotted with rabbit anti-myc, 
rabbit monoclonal anti-Nck1 (Cell Signaling) antibodies at a 1:1000 dilution. To examine 
the triple interaction among ROBO2, Nck1, and nephrin, His-myc-ROBO2 or His-myc-
ROBO2-ΔNBD were co-expressed in HEK cells with human nephrin and human Fyn. 
His-myc-ROBO2 was precipitated with Ni-NTA beads as described above. To confirm 
the triple interaction, His-myc-nephrin was co-expressed with ROBO2, and Fyn in HEK 
cells and His-myc-nephrin was pulled-down by Ni-NTA beads. Precipitates were blotted 
with rabbit polyclonal anti-myc, rabbit monoclonal anti-Nck1, rabbit polyclonal anti-
nephrin, mouse monoclonal anti-ROBO2 (R&D systems), and rabbit polyclonal anti-Fyn 
(Santa Cruz Biotechnology) antibodies at a 1:1000 dilution. For co-immunoprecipitation 
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of endogenous proteins, kidneys from newborn mice were homogenized in the RIPA 
buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium 
deoxycholate, 1 mM Na3VO4, 1 mM NaF, 1x protease inhibitor) on ice. Samples were 
centrifuged for 10 min at 4oC and the supernatant was incubated with 1 µg mouse 
monoclonal anti-ROBO2 antibody (R&D Systems) for 1 hour at 4ºC. The control goat 
IgG (Santa Cruz Biotechnology) was used as a control. Samples were then mixed with 30 
µl of protein A/G Plus agarose bead slurry (Santa Cruz Biotechnology) and further 
incubated for 12 hours at 4ºC. Beads were then washed three times in the RIPA buffer 
and proteins were eluted in 1x protein loading buffer by heating at 95ºC for 10 min. 
Precipitates were resolved on SDS-PAGE gels and blotted with mouse anti-ROBO2, 
rabbit anti-nephrin, and rabbit anti-Nck1 antibodies as described above. Actin was blotted 
with anti-beta-actin mouse antibody from Sigma. Intensity of the bands was measured 
using ImageJ. For proteinuria detection, mice spot urines were collected and diluted with 
1x protein loading buffer at 1:100 dilution. Urine proteins were then resolved on SDS-
PAGE gels and purified albumin was used as a control (MP Biomedicals). Gels were 
blotted with rabbit anti-albumin polyclonal antibody (MP Biomedicals).  
CD16/7-NCD Crosslinking and Actin Polymerization Assay  
CD16 antibody-mediated crosslinking of CD16/7 fusion proteins has been 
described previously (Jones et al., 2006; Rivera et al., 2004; Verma et al., 2006). Briefly, 
CD16/7-NCD or CD16/7-HA was co-expressed in HEK cells with ROBO2. After 24 
hours, cells were transferred and seeded on glass coverslips coated with poly lysine for 
another 24 hours. Cells were then incubated with 1 µg/ml mouse monoclonal anti-CD16 
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(Beckman Coulter) for 30 min at 37ºC, washed once with DMEM, incubated with 
rhodamine-conjugated secondary antibody (Thermo Scientific) diluted in Slit2 
conditioned medium (Wong et al., 2001) or control conditioned medium for 30 min and 
fixed in 4% paraformaldehyde in 1x PBS. F-actin was stained using FITC-conjugated 
phalloidin (Invitrogen) according to manufacturer’s instruction. The newly formed F-
actin bundles stick to the clustered nephrin (CD16/7-NCD) and look like comet tails (i.e. 
actin tails in the main text) under fluorescence microscope. In this experiment, we only 
analyzed the F-actin bundles formed by clustering of CD16/7-NCD and attached to the 
clusters. The cells with F-actin tails were counted and compared to the total CD16/7-
NCD transfected cells. The quantification formula is: Percentage % = (number of 
transfected cells with F-actin tails / total number of cells transfected) × 100. Images were 
obtained using a LSM510 confocal microscope with a 60x oil immersion objective.  
Generation and Characterization of Robo2 Podocyte Specific Knockout Mice and Robo2-
Nephrin Double Knockout Mice 
The generation and genotyping of Robo2flox conditional allele, Robo2del5 (also 
called Robo2- interchangeably in this paper) germline mutant allele, and Robo2+ wild-
type allele were described previously (Lu et al., 2007; Wang et al., 2011). Standard 
breeding scheme was followed to generate Robo2 podocyte specific Robo2del5/flox;TgNphs2-
Cre/+ knockout mice, which carry one Robo2del5 allele and one Robo2flox allele. In this 
compound mutant, podocyte specific Cre recombinase driven by podocin promoter 
deletes only the Robo2flox allele to facilitate the penetrance of a phenotype because the 
other allele, Robo2del5, has been deleted ubiquitously from germline expression. The 
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authenticity of Robo2del5/flox;TgNphs2-Cre/+ mice was determined by tail DNA genotyping 
for the presence of Robo2del5 and Robo2flox alleles as well as TgNphs2-Cre transgene. F2 
littermates Robo2flox/+ mice without Robo2del5 allele and TgNphs2-Cre transgene were used as 
controls. To generate Robo2-nephrin double knockout mice, Robo2+/- heterozygous mice 
were crossed with Nphs1+/- heterozygous mice that were generated previously (Hamano 
et al., 2002). After the generation of Robo2+/-;Nphs1+/- double heterozygous mice, the 
cross of double heterozygous mice was performed to generate Robo2-/-;Nphs1-/- double 
homozygous mice as well as Nphs1-/- single homozygous, Robo2-/- single homozygous, 
and Robo2+/+;Nphs1+/+ wild-type controls. Mouse protocols were approved by the 
Institutional Animal Care and Use Committee (IACUC) at Boston University Medical 
Center (#14388). 
Transmission and Scanning Electron Microscopy 
For transmission electron microscopy, kidneys were dissected from Robo2 
homozygous null mice and podocyte specific knockout mice, fixed in PLP at 4ºC 
overnight, and then incubated in 2% glutaraldehyde in 0.15 M sodium cacodylate for 6 
hours. After washing in 1x PBS, fixed kidneys were dehydrated in graded ethanol, 
embedded in Epon, sectioned, and stained with uranyl acetate and lead citrate. Ultrathin 
kidney sections were prepared and examined using a JEM-1011 electron microscope. 
Wild-type littermates were used as controls. For scanning electron microscopy, kidney 
samples from Robo2 homozygous null mice, podocyte specific knockout mice, nephrin  
homozygous null mice, and Robo2-nephrin double homozygous mice were prepared 
following the protocol described previously (Friedman and Ellisman, 1981) with minor 
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modifications. Briefly, the kidney was perfused with 2.5% glutaraldehyde and 2% 
paraformaldehyde solution in 0.1M cacodylate buffer (Karnovsky’s fixative, Electron 
Microscopy Sciences), and subsequently fixed in the Karnovsky’s fixative for 24 hrs 
followed by postfixation in 2% osmium tetraoxide solution (Electron Microscopy 
Sciences). Kidney samples were cryofractured, dehydrated and dried using 
hexamethyldisilazane (Electron Microscopy Sciences). Kidney samples were imaged 
using an Amray 1000A and Jeol 6340F scanning electron microscopes. Three glomeruli 
from each animal were examined to provide representative images. 
Mice Kidney Pathology Studies, Quantification of Podocyte Number, and Proteinuria 
Analysis  
For kidney pathological studies, kidneys were dissected and fixed in 4% 
paraformaldehyde overnight, and then treated with a graded ethanol series for paraffin 
embedding. The kidney paraffin blocks were sectioned at 4 µm using a MT-920 
microtome (MICROM) and stained using standard Periodic acid-Schiff (PAS) or eosin 
hematoxylin (H&E) methods. The glomeruli were examined and assessed for matrix 
deposition, segmental glomerulosclerosis, and dilatations of the Bowman’s space using 
an Olympus BHT light microscope equipped with a SPOT digital camera system. For 
quantification of podocyte number, WT1 was used as a podocyte nuclear marker and 
immunoperoxidase staining was performed on kidney sections following the protocol 
described previously (Sanden et al., 2003). Briefly, paraffin embedded kidney sections 
from 4 one-year old Robo2del5/flox;TgNphs2-Cre+ podocyte-specific knockout mice and 4 age-
matched wild-type control mice were sectioned at 4 µm and stained with WT1 antibody 
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(Santa Cruz Biotechnology) after microwave antigen retrieval. Biotinylated secondary 
antibody and Vectastain ABC kit (Vector Laboratories) were used to detect WT1 signal. 
WT1 positive podocyte nuclei in each glomerular cross section were counted in total 165 
glomeruli from four mutant mice and 166 glomeruli from four control mice. For 
proteinuria analysis, “spot” urine specimens from 6 weeks old mice were examined using 
a sensitive murine albuminuria ELISA quantitation kit (Exocell) according to 
manufacturer’s instruction and urine dipstick (Multistix from Bayer, IN) as a screening 
method. Urine albumin was normalized with creatinine to provide an albumin/creatinine 
ratio. Creatinine in urine was determined using the creatinine detection kit (Sigma) 
according to manufacturer’s instruction. Urine albumin was also examined by 12% SDS-
PAGE and blotted with anti-albumin antibody (MP Biomedicals). The data from mutants 
and controls were analyzed using one-way ANOVA, Student t-test, and Chi-square test. 
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Table 1. Quantitative Analysis of Glomeruli with Increased Matrix Expansion in 2 
to 9 Months Old Robo2 Podocyte Specific Knockout Mice (Mutant) Compared to 
Controls (Wild type). 
 Related to Results (Figure 8O-8R) 
Genotype Mouse 
ID# 
Age 
(months) 
Total 
glomeruli 
counted 
Glomeruli 
with mesangial 
matrix 
expansion 
% of Glomeruli  
with mesangial 
matrix  
expansion* 
Mutant 4048 2 96 13 12.35% 
Mutant 1721 3 107 18 16.82% 
Mutant 4005 6 103 17 16.51% 
Mutant 1190 7 102 20 19.61% 
Mutant 2396 9 80 14 17.50% 
Mutant 
total 
  488 82 16.80% 
Wild type 4058 2 90 4 4.44% 
Wild type 4052 3 105 6 5.71% 
Wild type 3919 6 107 4 3.74% 
Wild type 1191 7 103 5 4.85% 
Wild type 2385 9 106 5 4.72% 
Wild type 
total 
  511 24 4.70% 
*p < 0.01, n=5, t-test. 
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Table 2. Quantitative Analysis of Glomeruli with Increased Matrix Expansion in 12-
months-old Robo2 Podocyte-Specific Knockout Mice (Mutant) Compared to 
Controls (Wild type). 
 Related to Results (Figures 8S) 
Genotype Mouse 
ID# 
Age 
(months) 
Total 
glomeruli 
counted 
Glomeruli with 
mesangial 
matrix 
expansion 
% of Glomeruli 
with mesangial 
matrix  
expansion* 
Mutant 1844 12 136 17 12.50% 
Mutant 1847 12 125 18 14.40% 
Mutant 1877 12 127 11 8.66% 
Mutant 1878 12 132 20 15.15% 
Mutant 1948 12 142 28 19.72% 
Mutant 
total 
  662 94 14.20% 
Wild type 1901 12 125 5 4.00% 
Wild type 2429 12 179 8 4.47% 
Wild type 2834 12 154 9 5.84% 
Wild type 2836 12 159 7 4.40% 
Wild type 2837 12 124 5 4.03% 
Wild type 
total 
  741 34 4.59% 
*p < 0.01, n=5, t-test. 
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Table 3. Morphology Analysis of Glomeruli with Dilated Bowman’s Space in Nphs1-
/- Single-Homozygous (Robo2+/-;Nphs1-/-) Compared to Robo2-/-;Nphs1-/- Double- 
Homozygous Newborn Mice by Histology. 
 Related to Results (Figure 8U-8Y) 
 
Genotype Total glomeruli 
counted 
Glomeruli with 
dilated Bowman’s 
space 
% of Glomeruli 
with dilated 
Bowman’s space 
Robo2+/-;Nphs1-/- 122 31 25.4% 
Robo2-/-;Nphs1-/- 55 2 3.6% 
Robo2-/-;Nphs1+/- 158 3 1.9% 
Robo2+/+;Nphs1+/+ 271 1 0.4% 
 
Note: The glomerulus was scored as positive with dilated Bowman’s space if the 
glomerulus displayed similar phenotype as shown in Fig 8U was observed, and was 
scored as negative if similar glomerulus as shown in Fig 8V-8X was observed. Three 
mice from each genotype were analyzed. Robo2-/- single homozygous (Robo2-/-;Nphs1+/-) 
and wild-type (Robo2+/+;Nphs1+/+) were used as controls. 
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Table 4. Morphology Analysis of Glomerular Podocyte Interdigitating Foot Process 
(FP) Phenotype in Nphs1-/- Single-Homozygous (Robo2+/-;Nphs1-/-) Compared to 
Robo2-/-;Nphs1-/- Double-Homozygous Newborn Mice by Scanning Electron 
Microscopy. 
 Related to Results (Figures 7P-7W) 
 
Genotype Total glomeruli 
counted 
Glomeruli with 
interdigitating FP 
structure 
% of Glomeruli 
with interdigitating  
FP structure 
Robo2+/-;Nphs1-/- 15 1 6.67% 
Robo2-/-;Nphs1-/- 16 12 75% 
Robo2-/-;Nphs1+/- 13 13 100% 
Robo2+/+;Nphs1+/+ 13 13 100% 
 
Note: Glomerulus was scored as positive if the interdigitating structure was observed 
anywhere within the glomerulus and negative if no interdigitation pattern was noted. 
Three mice from each genotype and more than 5 areas per glomerulus were analyzed. 
Robo2-/- single homozygous (Robo2-/-;Nphs1+/-) and wild-type (Robo2+/+;Nphs1+/+) were 
used as controls. 
  
  
98 
CHAPTER FOUR: Loss of Robo2 in Podocytes Protects Adult Mice  
from Acute Glomerular Injury 
 
Summary 
Neuronal repulsive guidance cue SLIT2 and its receptor ROBO2 play an 
important role during the kidney development. We have recently found that ROBO2 is 
expressed in the mouse kidney glomerular podocytes. However, the role of ROBO2 in 
the adult mouse kidney, particularly under acute injury or chronic kidney conditions, is 
not clear.  
To test the hypothesis whether loss of ROBO2 in glomerular podocytes affects the 
outcome of acute glomerular injury, we applied two in vivo acute glomerular injury 
models, the nephrotoxic serum (NTS) injection and the protamine sulfate (PS) perfusion 
models, in Robo2 podocyte specific knockout mice (Robo2 cKO) and the wild type 
controls. Kidney glomerular ultrastructure was analyzed by electron microscopy after 
injury and in the sham injured mice. The renal function was examined by measuring 
urine albumin and creatinine. Analysis of gene expression was performed using TaqMan 
real time PCR and western blot assays.  
We found that loss of ROBO2 in podocytes protects the mice from short-term 
acute kidney injury. Robo2 podocyte specific knockout mice develop less proteinuria and 
lower albumin/creatinine ratio compared to the wild-type controls after the NTS injury. 
Electron microscopy showed that Robo2 cKO mice have milder foot process effacement 
and less defects in the slit diaphragm induced by either NTS or PS injury. Furthermore, to 
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investigate the potential mechanism of ROBO2 loss in injury protection, we found that 
nephrin, the crucial transmembrane protein on the podocytes membrane, is up-regulated 
in the late stage of heterologous phase of NTS injury as well as in the Robo2 cKO mice. 
Finally, to test if SLIT2-ROBO2 signaling pathway also plays a role in human kidney 
diseases, we analyzed kidney biopsies from the patients with membranous nephropathy 
(MN) and found an increased level of SLIT2 as well as differential pattern of ROBO2 
expression.  
In conclusion, SLIT2-ROBO2 signaling pathway plays an important role in the 
adult mouse kidney podocytes and loss of ROBO2 protects the kidney from acute 
glomerular injury. SLIT2-ROBO2 signaling might have a function in the pathology of the 
chronic kidney disease in humans. 
 
Introduction 
Podocytes are terminally differentiated epithelial cells that extend elaborate net of 
foot processes to tightly wrap around the glomerular capillary vessels. Foot processes 
from one podocyte interdigitate with foot processes from neighboring podocytes and 
connect to each other through the slit diaphragm. Together with fenestrated endothelium 
and glomerular basement membrane, podocytes constitute the crucial component of the 
blood-urine filtration barrier. Podocyte cytoskeleton in foot processes is mostly actin 
based (Faul et al., 2007). In the recent years it was conclusively shown that podocyte foot 
processes exhibit high degree of plasticity in response to physiological and pathological 
stimuli (Endlich et al., 2001; Faul et al., 2007; Mundel and Shankland, 2002; Teng et al., 
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2012). Podocyte shape positively correlates with its function, as various forms of 
experimental podocyte and kidney injury induce severe podocyte foot process widening, 
simplification, and reorganization, known as foot process effacement (Bertani et al., 
1982; Garg et al., 2010; George et al., 2012; Olson et al., 1981; Salant et al., 1989). Foot 
process effacement is also recognized as a hallmark of numerous glomerulus kidney 
diseases in humans (Diez-Sampedro et al., 2011; Singh et al., 2015; Wiggins, 2007).  
SLITS are the family of secreted proteins that serve as ligands for the single 
transmembrane receptors, Roundabout (ROBO) (Dickson and Gilestro, 2006). In 
vertebrates there are three SLIT ligand genes (1-3) and four ROBO receptor genes (1-4). 
SLIT-ROBO signaling pathway was first described to regulate neuronal migration and 
axon pathfinding by means of regulating the neuronal cell cytoskeleton (Dickson and 
Gilestro, 2006; Ypsilanti et al., 2010). SLIT2-ROBO2 signaling is required for kidney 
development and disruption of either the ligand or the receptor results in generation of 
multiple ureteric buds, duplex kidneys, and other anomalies described as congenital 
anomalies of the kidney and urinary tract, or CAKUT (Bertoli-Avella et al., 2008; Lu et 
al., 2007; Wang et al., 2011b).  
We have recently shown that ROBO2 is expressed in the mature podocytes where 
it is predominantly localized to the foot processes. ROBO2 is able to form a complex 
with nephrin through the NCK adaptor protein (Fan et al., 2012). Nephrin is a 
transmembrane protein and crucial to maintain the podocyte structure and function for the 
slit diaphragm. Nephrin phosphorylation triggered by yet unknown ligand induces actin 
polymerization in response to several physiological and pathological stimuli (Lahdenperä 
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et al., 2003; Patrakka and Tryggvason, 2007b; Verma et al., 2006).  We have shown that 
SLIT2-ROBO2 signaling pathway negatively regulates nephrin-induced actin 
polymerization (Fan et al., 2012). However the biological consequence of ROBO2 
expression in podocytes in mature kidneys is still not clear.  
Given their function and location, as well as terminally differentiated status, 
podocytes are prone to injury. Experimental evidence shows that injury to podocytes or 
loss of podocytes, contribute to kidney disease progression and that significant podocyte 
damage is the hallmark of the multiple chronic kidney diseases (Singh et al., 2015; 
Wharram et al., 2005). Therefore understanding factors and mechanisms that regulate and 
modulate podocyte damage is of significant clinical and basic research priority.  
In this study we focused on understanding the function of the ROBO2 receptor in 
podocyte injury. By means of two independent transient acute kidney injury models we 
demonstrated that loss of ROBO2 in podocytes ameliorates podocyte injury and prevents 
podocyte foot process structure damages. We also show that Robo2 podocyte conditional 
knockout mice express higher level of nephrin. Finally we observed that SLIT2 and 
ROBO2 are upregulated at the later stage of kidney injury in the wild type mice and that 
SLIT2 is upregulated in the kidney biopsy samples of membranous nephropathy patients. 
These results support the importance of SLIT2-ROBO2 signaling in podocytes and the 
suggest SLIT2 and ROBO2 as possible targets for pharmaceutical intervention in patients 
with proteinuric kidney diseases.       
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Results 
Loss of ROBO2 in podocytes reduces kidney injury induced by protamine sulfate 
Protamine sulfate (PS) injury is a well-established model to study inducible 
podocyte injury in mice (Asanuma et al., 2005; George et al., 2012; Messina et al., 1989). 
PS is reported to neutralize the negatively charged podocyte glycocalyx, that is 
maintained by the negative charge on ezrin and podocalyxin (Takeda et al., 2001), PS 
infusion is thought to result in calcium influx (Rüdiger et al., 1999) and an increase in 
phosphorylation of tyrosine receptors, including nephrin (Verma et al., 2006). 
Structurally, PS has been shown to cause podocyte foot process effacement (Messina et 
al., 1989). In order to understand the functional consequence of ROBO2 in podocytes, we 
injured Robo2 podocyte specific knockout (Robo2 cKO) mice and their wild type 
littermate controls with protamine sulfate. Using scanning electron microscopy, we 
observed a global qualitative difference in the shape of the podocyte foot processes 
between the Robo2 cKO and wild type mice (Figure 9A). In agreement with the reported 
studies, we observed that PS significantly disorganizes foot process and damages foot 
process arrangement in wild type mice (Figure 9A, upper panels). In contrast, the Robo2 
cKO mice showed little change in global podocyte foot process arrangement (Figure 9A, 
lower panel).  
To better understand and quantify these changes, we applied the transmission 
electron microscopy, and found that foot process width is significantly enlarged in the 
wild type compared to that in the Robo2 cKO after the PS injury (0.42 ±0.02 µm in WT 
versus 0.36±0.008 µm in Robo2 cKO mice; n=6 per group; p= 0.026; Figure 9B and 9C). 
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Slit diaphragm density is the surrogate marker to evaluate the integrity of the glomerular 
filtration barrier. Decreasing slit diaphragm density was shown to have clinically 
predictive value in a number of human proteinuric diseases (Lahdenkari et al., 2004). The 
slit diaphragm density in wild type mice showed a significant 29.5% reduction after the 
PS insult (2.83 ±0.17 in sham injured WT versus 1.99±0.16 in PS injured WT mice; n=6 
per group; p= 2.22x10-5;), whilst it was statistically unchanged in the Robo2 cKO mice 
(Figure 9D), indicating a preservation of both the foot process width and the glomerular 
filtration barrier integrity when ROBO2 receptor is absent in podocytes. 
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Figure 9: Genetic ablation of Robo2 in podocytes reduces foot process damage 
caused by protamine sulfate injury. 
A- Representative scanning electron micrographs showing the global foot processes in 
the wild type and Robo2 cKO mice following PS injury. Arrows point to representative 
individual foot processes; asterisks mark representative effaced foot processes. N=6 
kidneys in each experimental group. Original magnification, 7000X.  
B- Representative high magnification transmission electron images illustrating the global 
foot processes in the wild type and Robo2 cKO mice following PS injury. Arrow points 
to the foot processes and asterisks indicate foot process effacement. N=6 kidneys in each 
experimental group. Original magnification, 25000X.  
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C- Quantification of the foot process width in the wild type and Robo2 cKO mice 
following PS injury. N=6 kidneys in each experimental group. Results shown as means 
+/- SEM. *p < 0.05; N=6 kidneys in each group.  
D- Quantification of the density of slit diaphragms. Results shown as means +/- SEM. *p 
< 0.05; N=6 kidneys in each experimental group. 
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Robo2 cKO mice are resistant to FP effacement and  
filtration barrier damage induced by NTS injury  
To better understand the significance of the observed protective effect in ROBO2 
cKO mice, we used another induced podocyte acute injury model, nephrotoxic serum 
injury (NTS). NTS is a spectrum of mix anti-glomerular antibodies derived in sheep. 
Systemic nephrotoxic serum injection is a model of human glomerular diseases and 
injection of the NTS antibodies into mice or rats has been shown to cause proteinuria and 
direct injury to podocytes accompanied by podocyte foot process effacement (Chugh et 
al., 2001; Lin et al., 2002; Salant, 2013). NTS injury is categorized as a transient model 
of induced podocyte injury, the progression of injury includes the heterologous and 
autologous phases (Salant and Cybulsky, 1988). In the heterologous phase the injury 
occurs due to the effects of injected NTS antibodies targeting the glomerular antigens, 
interfering endogenous signaling pathways, and neutralizing the targeted proteins. 
Conversely in the autologous injury phase, the damage is dependent on host’s immune 
system that reacts to the NTS antibodies and involves significant complement-dependent 
damages.  
In order to detect primary podocyte injury, we performed the intravenous 
injection of gamma-1 sub-fraction of the NTS serum and analyzed podocytes and 
proteinuria at the heterologous NTS injury phase at 1, 6 and 24hrs post injection (Figure 
10A). We ascertained that NTS antibody is equally delivered and distributed in the wild 
type and the Robo2 cKO mice by immunohistochemistry (Figure 10B). One hour post 
NTS injury, the wild type mice develop detectable high proteinuria (n= 6; 0.33± 0.02 
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milligrams albumin per milligram creatinine) that is getting higher at 6 hours (n= 6 ; 0.8± 
0.06 milligrams albumin per milligram creatinine), 24 hours (n= 6 ; 9.76± 1.14 
milligrams albumin per milligram creatinine), and reaches extremely high level on day 7 
(n= 5 ; 93.24± 12.44 milligrams albumin per milligram creatinine; Figure 10C and 10D).  
Previously we reported that the Robo2 cKO mice have very mild micro-
albuminuria (Fan et al., 2012). However, the Robo2 cKO mice show strong resistance to 
NTS insult (0.19±0.01 milligrams albumin per milligram creatinine at 1 hour; 0.13±0.02 
milligrams albumin per milligram creatinine at 6 hour; 1.34±0.01 milligrams albumin per 
milligram creatinine at 24 hour, and 7.88± 5.26 milligrams albumin per milligram 
creatinine at 7 days post injury). Their levels of proteinuria are significantly reduced at 
any time points examined compared to the wild type (Figure 10C and 10D); suggesting 
that loss of ROBO2 in podocytes has protective effects on the podocytes and slit-
diaphragm filtration barrier.  
In order to examine the podocyte morphology after NTS injury, we utilized the 
scanning electron microscopy. We found that there is progressively worsening foot 
processes effacement in wild type mice at 1-, 6- and 24-hour time points (Figure 11A). In 
contrast, podocyte foot processes in Robo2 cKO mice do not show effacement after NTS 
injury. In order to further quantify and analyze this phenotype, we did transmission 
electron microscopy. After NTS injury, the wild type mice develop a progressively 
worsening foot process effacement that is evident in increasing in foot process width at 1, 
6, and 24 hours (Figure 11B and 11C). Robo2 cKO mice have relatively wider foot 
processes compared to the wild type before injury but their width does not significantly 
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increase after NTS injury. At 24 hours post injury, the difference in foot process width is 
the most striking. The average foot process width in Robo2 cKO mice remains around 
0.475± 0.02 µm whiles it reaches 0.82± 0.08µm in the wild type controls, which is a 58% 
increase of foot process effacement between the two groups (Figure 11C).  
To assess the effect of NTS injury on slit diaphragm integrity, we next measured 
the number of slit diaphragms per micrometer length of the glomerular basement 
membrane in wild type and the Robo2 cKO and found a significant preservation of slit 
diaphragm density in Robo2 cKO mice (1.66± 0.1 versus 2.42± 0.06 at 1 hour, 1.53± 0.04 
versus 2.27± 0.1at 6 hours, and 1.25± 0.1 versus 2.13± 0.08 at 24 hours after the NTS 
injury in wild type versus Robo2 cKO mice, respectively; Figure 11D). 
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Figure 10: Loss of Robo2 in podocytes attenuates the proteinuric effects of NTS 
injury. 
 
A- Experimental strategy to compare the responses to NTS injury in wild type and Robo2 
cKO mice. 
B- Representative images of NTS deposition detected by immunohistochemistry. NTS 
antibodies are equally localized to the glomeruli of injured Robo2 cKO and wild type 
animals at indicated experimental time points. Original magnification, 60X. 
C- Coomassie blue stained gel showing the amount protein excreted in the urine of the 
Robo2 cKO and wild type mice at the indicated time points post NTS injection. Robo2 
cKO, N= 7; WT mice, N=6.  
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D- Quantification of the albumin to creatinine ratio showing decreased albuminuria in 
injured Robo2 cKO mice as compared to the wild type mice at each time point after NTS 
injury. Results are represented as mean ± S.E.M. *p<0.0005. 
 
 
  
111 
 
Figure 11: Loss of Robo2 in podocytes ameliorates architectural damage in podocyte 
foot processes after NTS injury. 
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A- Representative scanning electron micrographs showing the foot process morphology 
at different time points after NTS injection. Foot processes effacement is evident in NTS 
treated wild type mice beginning at 1hr post injection. In contrast, the foot processes in 
Robo2 cKO mice are morphologically normal. Minimum of 5 different regions of each 
glomerulus and 3 glomeruli were analyzed for each animal. Arrows point to foot 
processes; asterisks indicate areas of effacement. Original magnification, 7000X.   
B- Representative transmission electron micrographs showing foot process 
reorganization, evident of foot process enfacement in NTS treated wild type mice 
beginning at 1hr and continuing at 6hrs, and 24hrs post injection. Foot processes 
morphology is preserved in Robo2 cKO. Minimum of 5 different regions in each 
glomerulus and 3 glomeruli were analyzed for each animal. Arrows point to 
representative individual foot processes; asterisks point to representative effaced foot 
processes. Original magnification, 25000X  
C- Quantification of foot process effacement pictured in panel B in Robo2 cKO and wild 
type mice. Foot processes width was measured at indicated time points. Result shown as 
means +/- SEM. * indicates p< 0.05, compared to the control. NS: No Significant 
difference. 
D- Quantification of slit diaphragms per µm length of underlying GBM was measured at 
0, 1, 6 and 24 hrs post NTS injection. Results shown as means +/- SEM. * indicates p< 
0.05, compared to the control;  N= 6 or more per experimental group. NS: No Significant 
difference. 
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Loss of ROBO2 in podocytes increases nephrin expression 
Molecular impairing in the slit diaphragm is the hallmark of podocyte injuries. In 
particular, nephrin has previously been shown to be down-regulated in NTS induced 
injury and down-regulation of nephrin correlates with podocyte injury (Luimula et al., 
2000; Yogavijayan Kandasamy, 2014; Yuan et al., 2002). Nephrin loss in podocyte injury 
is known to occur on the mRNA as well as on the protein levels due to the several distinct 
mechanisms (Dai et al., 2009; Harita et al., 2009; Qin et al., 2009; Wang et al., 2001). We 
previously showed that loss of Robo2 in podocytes does not change podocyte number 
(Fan et al., 2012).  
In order to understand the molecular mechanism underlying the different 
responses in podocytes reacting to injury, we decided to analyze the expression of 
nephrin, ROBO2, and SLIT2 in the NTS injured Robo2 cKO and wild type mice using 
RT-PCR and Western blot assays (Figure 12). To our surprise we observed that the 
mRNA of nephrin increases nearly 2 fold in Robo2 cKO mice compared to the wild type 
mice before injury (Figure 12A). In order to better understand the function of SLIT2-
ROBO2 signaling pathway in the course of induced podocyte injury, we analyzed the 
expression of nephrin, ROBO2, and SLIT2 after NTS injury in the wild type mice. We 
found that at 24 hours (Day 1) post NTS injury, the mRNA levels of nephrin, ROBO2, 
and SLIT2 are down-regulated (Figure 12A). However these gene expressions are 
significantly up-regulated at day 7 post NTS injury (Figure 12A). In Robo2 cKO mice 
with the absence of ROBO2 in podocytes, nephrin and SLIT2 display the same 
expression patterns as they do in the wild type (Figure 12A).   
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To better understand if the mRNA levels translate to increased protein levels, we 
performed Western blot analysis of nephrin, ROBO2, and SLIT2 in mouse kidney 
cortical lysates and found corresponding increase in protein levels (Figure 12B and 12C).  
Interestingly we found that nephrin protein is presented as two distinct bands on Western 
blot. These dual bands can represent a phosphorylation event or protein degradation, both 
events are known to occur in healthy podocytes and during injury (Harita et al., 2009; 
Meyer-Schwesinger et al., 2009; Qin et al., 2009). 
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Figure 12: Expression of nephrin, Robo2, and Slit2 in Robo2 cKO and wild type 
mice before and after podocyte injury.    
A. Quantitative real-time RT-PCR assay showed the mRNA levels of nephrin, Robo2 and 
Slit2 on day 0 (Ctl), day 1 (D1), and day 7 (D7) after NTS injury. Results shown as 
means +/- SEM. N ≥ 5 mice in each group. * p< 0.05; brackets directly indicate 
comparison group; * above the bar indicate comparison with the control group within the 
genotype 
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B. Western blot analysis showed protein levels of nephrin, Robo2, Slit2 in the kidney 
cortex of wild type and Robo2 cKO mice on day 0, 1, and 7 post NTS injury. Actin was 
used for loading control.  
C. Quantification of Western blot results presented in B. Results shown as means +/- 
SEM. N=3 per group, *p< 0.05. 
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The expression patterns of SLIT2 and ROBO2 are changed  
in the membranous nephropathy (MN) patient kidneys   
Since SLIT2-ROBO2 signaling pathway is involved in podocyte structure and 
function, we were particularly interested in the role of SLIT2-ROBO2 signaling in human 
glomerular proteinuric kidney disease. MN is caused by the subepithelial immune 
complex mediated injury to the podocytes that exhibit foot process effacement and most 
MN patients have nephrotic range proteinuria. We performed immunohistochemistry 
assay to detect SLIT2 in kidney biopsy samples from four MN patients. Four kidney 
biopsy samples with thin basement membrane were used as controls. We observed that 
SLIT2 expression is restricted to glomerular peripheral cells and is also moderately 
present in the renal tubules in the control biopsy samples, the pattern similar to the one 
described in the mouse kidney (Chaturvedi et al., 2013). In the MN patient kidney, 
however, SLIT2 is ubiquitously distributed and is present in the podocytes and the 
extracellular space. SLIT2 expression is also upregulated in the renal tubular cells of MN 
kidneys (Figure 13A). 
With respect to the ROBO2 proteins, we have confirmed our previous finding that 
ROBO2 is expressed in normal human glomeruli, with the expression pattern suggestive 
of podocytes, as the cells positive for ROBO2 are outside of the glomerular vasculature 
and located on the glomerular periphery (Figure 13B). In the control samples, ROBO2 
expression is detected in small, well defined perinuclear area in the podocyte. By 
contrast, ROBO2 expression becomes more ubiquitous and spreads across the podocyte 
in the membranous nephropathy kidney samples (Figure 13C). To quantify such 
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subcellular localization shift of ROBO2 expression, we measured the ROBO2 positive 
area inside the podocyte and normalized it to the nuclear area. We found a statistically 
significant increase of ROBO2 expression area inside the podocytes in the MN kidney 
samples in comparison to the control samples (2.17±0.14 versus 0.45±0.06, respectively; 
n=3 per group; p= 0.013, Figure 13D). These data suggest that the expression patterns of 
both ROBO2 and its ligand SLIT2 are changed in MN patient kidneys.       
  
  
119 
Figure 13: The expression patterns of SLIT2 and ROBO2 are changed in human 
membranous nephropathy kidneys. 
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Figure 13: The expression patterns of SLIT2 and ROBO2 are changed in human 
membranous nephropathy kidneys.  
A. Representative immunohistochemistry images for SLIT2 in human kidney biopsy 
samples from control kidneys (n=4) and membranous nephropathy kidneys (n=4). 
Arrows indicate representative SLIT2 positive cells. Arrowheads indicate the diffuse 
areas of SLIT2 positivity. Original magnification, 200x.   
B. Representative immunohistochemistry images of ROBO2 stained kidney biopsy 
samples from control kidneys (n=4) and membranous nephropathy kidneys (n=4). 
Arrows indicate representative ROBO2 positive cells. Original magnification, 200x.  
C. Representative high power images of ROBO2 positive cells showing difference in the 
intracellular ROBO2 distribution pattern. Arrows indicate positive ROBO2 signals.   
D. Quantification of ROBO2 distribution pattern between control and MN biopsy 
samples in C. Results are shown as means +/- SEM. N=3 per group, *p< 0.05. 
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Discussion 
Podocytes are the last layer of the glomerular filtration barrier and podocyte 
function is highly correlated to podocyte morphology. A multitude of researches have 
shown that podocytes are capable of significant foot process remodeling in adaptation to 
environmental factors (reviewed in (Mundel and Shankland, 2002). Due to their location 
and terminally differentiated status, podocytes are particularly vulnerable to injury. It is 
believed that podocytopathy is an initiating event in kidney diseases of diverse etiology. 
Several experimentally induced podocyte injury models as well as multiple clinical 
kidney diseases have a hallmark of podocyte dysfunction, presenting with foot process 
widening and flattening, known as foot process effacement (Wiggins, 2007). Therefore 
understanding factors that affect podocyte outcome during injury is of critical importance 
from the biological as well as clinical perspectives.  
Nephrin is crucially important in maintaining podocyte structure and function in 
most species including mammals (Patrakka and Tryggvason, 2007a). We have previously 
demonstrated that ROBO2 complexes with nephrin through the adaptor protein NCK. 
SLIT2-ROBO2 signaling down-regulates nephrin-induced actin polymerization to 
regulate the F-actin cytoskeleton in podocytes. We further showed that concomitant loss 
of ROBO2 and nephrin partially rescues the structural podocyte defects observed in 
single Nphs1 knockout mice (Fan et al., 2012). After acute injury, podocytes likely 
require molecules such as nephrin to positively regulate F-actin cytoskeleton for recovery 
(Yuan et al., 2002). In order to better understand the significance of ROBO2 in 
podocytes, we thus decided to challenge Robo2 podocyte specific conditional knockout 
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mice to induce podocyte injury and thus active cytoskeleton reorganization. In this study 
we applied two independent short course podocyte specific injury models: the charge 
mediated protamine sulfate injury and the immune based nephrotoxic serum injury. Both 
models showed that loss of ROBO2 in podocytes is protective to podocyte injury at 
podocyte ultrastructure level. These data support our previous observation that SLIT2-
ROBO2 signaling has negative impact on podocyte biology (Fan et al., 2012). Like in the 
Nphs1 null mice, SLIT2-ROBO2 signaling acts again as a detrimental factor during 
acquired charge or immune medicated podocyte injury.   Loss of SLIT2-ROBO2 
signaling thus confers podocytes more resistant to different types of injurious stimuli.   
In this study we observed that loss of ROBO2 up-regulates nephrin expression. 
This is of great interest since loss and down-regulation of nephrin is extensively 
documented as injurious to the podocyte function and a factor correlated with kidney 
disease pathology (Li et al., 2015; Yogavijayan Kandasamy, 2014). The effects of 
nephrin up-regulation on podocyte biology are not well studied. Our work has shown that 
despite increased nephrin levels in the ROBO2 null podocytes, increased foot process 
width and mild microalbuminuria develop in Robo2 cKO under non-injurious conditions 
(Fan et al., 2012). However, increased nephrin levels likely help protect podocytes during 
injury conditions. NTS insult also results in an increase of ROBO2 expression in the wild 
type mice. This increased ROBO2 might impair the recovery, which could be another 
reason why the Robo2 cKO mice are resistant to the NTS damage. 
While classically described role of SLIT-ROBO signaling involves regulation of 
neuronal migration, pathfinding and positioning in the nervous system, additional 
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functions of SLIT-ROBO signaling were described recently. SLIT-ROBO2 signaling was 
shown to affect processes such as cell proliferation or fate decision (Biteau and Jasper, 
2014; Macias et al., 2011). More evidence suggests that SLIT-ROBO signaling pathway 
recruits beta-catenin pathway regulate gene expression in neurons (Dai et al., 2009; 
Macias et al., 2011; Prasad et al., 2008; Rhee et al., 2007; Rhee et al., 2002). Beta-catenin 
pathway is of particular interest to podocyte biology as it was described as detrimental to 
podocyte structure and function, and increased beta-catenin signaling correlates with 
podocyte injury (Dai et al., 2009; Kato et al., 2011; Wang et al., 2011a). Therefore, it is 
possible that SLIT2-ROBO2 signaling pathway recruits beta-catenin in the podocyte to 
regulate gene expression that is detrimental to podocyte structure and function.  
Previous reports indicate that SLIT-ROBO signaling pathway might be involved 
in human kidney disease. ROBO2 mRNA levels were found to be downregulated in 
glomeruli of patients with diabetic nephropathy (Lindenmeyer et al., 2010). Querying the 
publically available Nephromine database of gene expressions in renal diseases 
(Nephromine, 2015), we found that SLIT2 is up-regulated in collapsing FSGS, but not in 
FSGS or minimal change disease whilst ROBO2 level is not changed in the above 
mentioned diseases (Nephromine, 2015). While these results appear contradictory, in the 
light of our results that SLIT2-ROBO2 plays a derogatory role in transient podocyte 
injury, it became apparent to us that this signaling pathway might be important in specific 
subset of chronic kidney diseases characterized by significant podocytopathy, such as the 
membranous nephropathy. While there is no direct readout assay to assess the SLIT2-
ROBO2 activation status in podocytes, immunohistochemistry on biopsy samples 
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revealed a significant up-regulation and more ubiquitous expression pattern of SLIT2 
expression in the glomeruli of the MN patients. Furthermore, immunostaining pattern of 
ROBO2 receptor indicates changes in the subcellular distribution of the ROBO2 from the 
more perinuclear compartments towards more ubiquitous and possibly membranous 
localization. These data, together with our observation from the mouse injury studies, 
prompt us to speculate that SLIT2-ROBO2 might be involved in clinical pathology of the 
glomerular kidney disease and as such might be a novel target for pharmaceutical 
intervention in patients with proteinuric kidney diseases. 
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Materials and Methods 
Protamine sulfate (PS) injury model 
All PS injury studies were approved and performed in accordance with Boston 
University Medical Campus IACUC protocols. Robo2 podocyte specific knockout mice 
were generated as previously reported (Fan et al., 2012). The mice used in the kidney 
injury were 8-12 weeks old of both sexes. Mouse kidney perfusion with protamine sulfate 
was performed as previously described (Verma et al., 2006). Briefly, mice were 
anesthetized with tribromoethanol (Sigma) and kept at constant 37oC throughout the 
procedure using the heating pad. All solutions were delivered through the aortal 
perfusion. Mice were initially perfused with warm HBSS (Mediatech, Inc.) for 2 minutes 
to wash out the body fluid. Then 2 mg/ml protamine sulfate solution (MP Biochemicals) 
or the HBSS vehicle solution (MP Biochemicals) was delivered using the perfusion pump 
at 8 ml/min rate for 15 minutes. After delivery of either solution, additional perfusion 
with HBSS was performed and individual kidneys were promptly dissected and preserved 
for further analysis.   
Nephrotoxic serum injury model 
All NTS injury studies were approved and performed in accordance with Boston 
University Medical Campus IACUC protocols. Nephrotoxic serum was kindly provided 
by Dr. Salant. Nephrotoxic serum used in this study was obtained by immunization of 
sheep with rat glomerular extracts (Salant et al., 1980; Salant and Cybulsky, 1988). 
Gamma1 fraction of the sheep serum was obtained as described (O'Meara et al., 1992). 1 
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mg of IgG1 fraction of NTS antibody or 1 mg of innate sheep IgG1 (MP Biochemicals) 
was injected in 200ul volume into 8-12 week old mice through the tail vein. Animals 
were allowed to recover with unrestricted access to food and water and their kidney 
samples were collected at the indicated time points.  
For the gene and protein expression analysis, 5 animals in each experimental 
group were sacrificed on day 1 and day 7 post NTS injection.   
Proteinuria measurement 
Spot urine was collected according to the standard protocol (Kurien and Scofield, 
1999). To quantify proteinuria post NTS injury, we used Coomassie blue assay. To 
normalize urines from different animals we measured urine creatinine concentrations in 
Jaffé reaction (Creatinine Companion kit; Exocell Inc.). Urine samples were diluted with 
protein loading buffer (Boston Bioproducts) based on creatinine concentrations and 
samples were resolved on 12% SDS-PAGE gel and each line of the gel was loaded with 
urine amount containing 1mg creatinine. Coomassie Brilliant Blue reagent (Boston 
Bioproducts) was then applied in accordance with the standard protocol to visualize total 
protein content. 2 mg standard albumin (Fisher Scientific) was included in each gel as a 
reference control. Cleared gel images were digitally captured using the HP scanner and 
densitometry measurements were taken using ImageJ software (version 1.47v; National 
Institutes of Health). 
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Scanning electron microscopy (SEM)  
Samples were prepared following the general protocol described in (Friedman and 
Ellisman, 1981). Kidney samples designated for the SEM study were fixed in 
Karnovsky’s fixative (2% paraformaldehyde, 2.5% glutaraldehyde and 0.1M phosphate 
buffer) (Electron Microscopy Sciences) and postfixed with 2% OsO4 (Electron 
Microscopy Sciences) in 0.1M cacodylate buffer, cryofractured and subjected to osmium-
tetrahydrazide impregnation procedure OTOTO procedure. Subsequently specimen were 
dehydrated in a series of graded alcohols and critically dried in HMDS. Images of gold 
coated samples were captured using the Joel 6340F scanning electron microscope 
equipped with a digital camera. The operator was blinded as to the genotype and the 
injury status of the animals at the time of image collection and analysis.   
Transmission electron microscopy 
Fresh kidney samples were fixed in Karnovsky’s fixative and processed according 
to the standard protocol (Graham and Orenstein, 2007). In brief, samples were postfixed 
in 1% osmium tetroxide (Electron Microscopy Sciences), dehydrated, embedded in 
propylene oxide/Epon resin and sectioned at thickness of 60-90 nm using the ultratome. 
Collected sections were poststained with uranyl acetate and lead citrate according to the 
routine protocol (Graham and Orenstein, 2007). Images were obtained using the Joel 
JEM-1011 transmission electron microscope equipped with a Erlangshen ES100W digital 
camera (Gatan). The operator was blinded as to the genotype and the injury status of the 
animals at the time of image collection and analysis.   
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RT-PCR Assay 
Kidney samples were preserved in RNAlater RNA stabilization reagent (Life 
Technologies). Total RNA was isolated using the Qiagen RNA extraction kit (RNeasy 
Mini Kit; Qiagen), according to the manufacturer’s instruction. RNA was measured using 
NanoDrop (Thermo Scientific) and equal amount of RNA was used for the conversion to 
cDNA (Verso cDNA Synthesis Kit; Thermo Scientific). TaqMan real time PCR was used 
to compare the relative amount of the following transcripts: ROBO2, nephrin, and SLIT2. 
Mouse GAPDH TaqMan probe was used as the housekeeping gene normalizer. Data was 
obtained using the 7500Fast Real Time PCR instrument from Applied Biosystems (Fisher 
Thermo Scientific). 
Human samples collection 
De-identified human kidney samples were obtained from discarded biopsy tissues 
at Boston Medical Center. The study was reviewed by the IRB at BUMC and exempted 
because the tissues were deidentified of all HIPPA identifiers. Basic patient data is 
presented in Table 5.  
Kidney immunohistochemistry 
Immunohistochemistry on human biopsy specimen using SLIT2 antibody (Life 
Span Biosciences) and ROBO2 antibody (Novus Biologicals) was performed on formalin 
fixed and paraffin embedded specimen using the IntelliPath Automated Slide Stainer 
(BioCare Medical). Shortly, paraffin slides were baked, deparaffinized, rehydrated, 
blocked with Biocare peroxidase 1 solution (Biocare) and Biocare Background Sniper 
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(Biocare). Primary antibody was applied at room temperature. For secondary antibody we 
used the Biocare Mach 4 Human Kit (Biocare), according to manufacturer’s 
recommendations. DAB (Fisher Scientific) was used as a chromogenic substrate. 
Sections were counterstained with hematoxilin (Fisher Scientific).  
Foot process width and slit diaphragm density measurement 
ImageJ software (version 1.47v; National Institutes of Health) was used to 
manually trace and measure the width of foot processes adjacent to per unit length of the 
GBM on high magnification transmission electron images (Inoki et al., 2011). To 
measure the slit diaphragm density, number of slit diaphragms was measured and divided 
by the length of the underlying GBM (Shea and Morrison, 1975).  More than 3 glomeruli 
per specimen and four or more areas per glomerulus were analyzed. All measurements 
were taken blindly and analyzed using the Excel software (Microsoft Corporation).   
Western blot assay  
To measure the in vivo protein levels in the kidneys, the cortical portions of fresh 
frozen kidney samples were used. Equal amount of starting specimen was used for each 
animal. Tissues were homogenized in RIPA buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 
0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 1 mM Na3VO4, 1 mM NaF, 1x 
protease inhibitor) on ice. Lysed tissues were centrifuged for 10min at 4oC.  The 
supernatants were added with 6x protein loading buffer (Boston Bioproducts) to 1x and 
denatured at 95oC for 20 min. Proteins were resolved on 10% SDS-PAGE gels, and 
blotted with mouse anti-ROBO2 (MABN122, Millipore Corporation), rabbit anti S2 (sc-
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16619, Santa Cruz Biotechnology), rabbit anti-nephrin (sc-28192, Santa Cruz 
Biotechnology) and mouse anti-actin (A1978, Sigma) antibodies. Appropriate HRP- 
conjugated secondary antibodies were used (GE Healthcare) and the HRP signals were 
detected using the Amersham ECL Prime Western Blotting Detection Kit (Fisher) on 
radiography film (Denville Scientific). Images were digitalized and the intensity of the 
bands was measured using ImageJ software (version 1.47v; National Institutes of Health). 
Statistical analysis 
Different treatment groups were compared using the unpaired student t test, two-
tailed.  The Mann-Whitney U was used for the albuminuria analysis, as the data was not 
normally distributed.  Two Way Analysis of Variance with All Pairwise Multiple 
Comparison Procedures (Holm-Sidak method) was used for the podocyte foot process 
effacement data.  All statistics were performed using Microsoft Excel or SigmaPlot 12.5 
(Systat, San Jose, USA) with P < 0.05 considered as statistically significant. 
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Table 5: Basic membranous nephropathy patients and thin membrane control 
kidney data.  
ID Age Sex Diagnosis 
Subject 1 72 M Membranous nephropathy,  stage II 
Subject 2 45 M Membranous nephropathy,  stage II 
Subject 3 39 F Membranous nephropathy,  stage III 
Subject 4 74 M Membranous nephropathy,  stage II 
Subject 5 19 F Thin basement membrane kidney - Control  
Subject 6 49 F Thin basement membrane kidney - Control 
Subject 7 27 F Thin basement membrane kidney -Control 
Subject 8 30 F Thin basement membrane kidney -Control 
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CHAPTER FIVE: Generation of ROBO2 Transgenic Mice 
 
Summary 
Significant insight into the function of the gene can be obtained by analysis of the 
phenotype resulting when the gene is either ablated or overexpressed. We have shown 
that ROBO2 is expressed in podocytes and that the protein is localized to the basal and 
lateral side of the foot processes. In the course of my thesis work, I have gained 
significant insight into the function of SLIT2-ROBO2 signaling in podocyte biology 
using Robo2 knockout mice. To extend our knowledge of ROBO2 function in the 
developing and mature mammalian kidney, we set out to generate ROBO2 transgenic 
mice. The effect(s) of ROBO2 overexpression have not been described in the mouse 
model. To achieve spatial and temporal control of ROBO2 expression, we aimed to 
generate a line of conditional transgenic mice with inducible overexpression of full length 
human ROBO2 in the podocytes.  
 
Introduction  
The first transgenic mouse was generated in 1974 by injecting the blastocysts with 
viral DNA fragments encoding the Simian virus 40 (Jaenisch and Mintz, 1974). Since 
then significant technical advances have been made to ensure the gene transmission and 
precise control over pattern of transgene expression and the usage of transgenic mice has 
become a common practice in biology to ascertain the function of the protein in the in 
vivo context. Now the transgenic techniques have been adopted to allow genetic 
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modification of the gene expression in other species for a wide variety of purposes 
(Houdebine, 2005).  
Normal expression pattern of ROBO2 
ROBO2 has been shown to be expressed in all species tested to date including the 
major experimental species, including D. melanogaster, C. elegans, M. musculus, as well 
as in human (Kidd et al., 1998; Piper et al., 2000; Zallen et al., 1998). In human and 
mouse, ROBO2 is expressed in the nervous, gastro-intestinal, respiratory, endocrine, 
cardiovascular systems, and in the male and female reproductive systems as well as in the 
kidney (Lu et al., 2007; Uhlen et al., 2010; Uhlén et al., 2015). Polymorphisms or 
mutations in ROBO2 have been associated with several diseases, such as congenital 
anomalies of the kidney and urinary tract (CAKUT) and VUR. ROBO2 is widely 
expressed in the early metanephric kidney as evidenced by the in situ hybridization assay 
that show ROBO2 message in the metanephric mesenchyme during initial stages of 
ureteric bud invasion and branching (E13.5). During later stages of nephrogenesis, 
ROBO2 signal is detected in the proximal end of the S-shaped bodies (Piper et al., 2000), 
which then contributes to the development of glomeruli. Our study further showed that 
ROBO2 is expressed in the glomeruli, specifically in the podocytes (Fan et al., 2012). 
Immunohistochemistry staining has confirmed the expression of ROBO2 protein in the 
glomeruli and tubular structure in the adult human kidney (proteinatlas.org).  
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 Transgenic mouse approach  
We aimed to generate the ROBO2 transgenic mice with spatial and temporal 
control of ROBO2 overexpression.  In order to best extrapolate knowledge obtained from 
analysis of this model to the human kidney development, podocyte and kidney diseases, 
we chose our transgene to be the full length of the human ROBO2 gene.  
Ablation of either Robo2 or Slit2 result in severe architectural defects in the 
kidney (Grieshammer et al., 2004). To understand the effects of the ROBO2 
overexpression during the development, we decided to ubiquitously express ROBO2 
during gestation. We specifically wanted to target expression to podocytes as this is the 
cell type that naturally expresses ROBO2 in the mature kidney (Fan et al., 2012) and we 
wanted to avoid the possible confounding effects of the ectopic ROBO2 expression. In 
this project, temporal control over the ROBO2 expression has been applied to study the 
effects of ROBO2 in the mature kidney, without affecting the developmental processes, 
and to study the effects of ROBO2 overexpression at different stages of kidney disease.  
Tet-On system  
We used the Tet-On system to overexpress ROBO2 ubiquitously by expressing 
transgene from the Rosa26 locus (Soriano, 1999) or by targeting its expression to 
podocytes using the podocin promoter (Saleem et al., 2002).  
The Tet-On system is based on the principles of regulated and inducible 
tetracycline resistance gene expression seen commonly in bacteria, as reviewed in (Speer 
et al., 1992). Tetracycline (Tet) is the broad-spectrum antibiotic that works through 
inhibition of protein translation. Since its clinical introduction, many bacteria have 
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developed resistance to it by evolving elaborate tetracycline resistance mechanisms, 
which can broadly be categorized as induction of tetracycline efflux, ribosomal 
protection, and biochemical tetracycline modification (Chopra and Roberts, 2001; 
Nguyen et al., 2014). Constitutive production of the proteins for these protective 
mechanisms would be energetically taxing and redundant therefore bacteria evolved 
ability to timely induce these gene expressions only in the presence of tetracycline. For 
these purposes, bacteria constitutively express the tetracycline repressor, or tetR. In 
general, the genes involved in tetracycline response are grouped into a transcription unit, 
or operon, which have common transcriptionally regulatory motifs. When tetracycline is 
absent, tetR is repressing gene expression by binding to the tetO sequences present in the 
promoter region of downstream Tet resistance genes (Speer et al., 1992). Tetracycline is 
capable of penetrating the cell membrane via specialized porin channels (Chopra and 
Roberts, 2001). When tetracycline is present it binds to TetR with high specificity and 
sensitivity (Chopra and Roberts, 2001). Tetracycline-TetR complex has diminished 
binding affinity to tetO sequences and thus the transcription repression is abolished and 
the expression of the tetracycline resistant genes proceeds (Speer et al., 1992).  
These principles have been used to gain artificial control and regulate genes in 
mammalian cells (Gossen and Bujard, 1992). It involves introduction of three crucial 
elements into the mammalian genome: regulatory protein tetR repressor, a response 
plasmid encoding tetO regulatory sequences upstream the gene of interest, as well as 
introduction of the tetracycline or analog antibiotic, doxycycline. Commercially available 
kits exist to assist the use of this technique in cells and organisms. The one we used to 
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generate ROBO2 overexpressing transgenic mice is from Clonetech Tet-On system. In 
this system, ROBO2 was cloned under control of the minimal CMV promoter (Pmin 
CMV), which also contains seven tetO sequences. Regulatory protein rtTA (reverse 
tetracycline transactivator) is based on the original tetR repressor protein (TA) modified 
at four amino acid positions to only turn on the response gene transcription in the 
presence of doxycycline. Tet-On system has been successfully used previously to 
generate inducible podocyte-specific transgenic mice (Jones et al., 2009; Wang et al., 
2008). Our approach to generate transgenic animals is presented in Illustration 4. 
Splicing variants of Robo2 
In the human genome, ROBO2 is located on Chromosome 3 and was determined 
to encode at least 26 exons (Yue et al., 2006). Isoforms described in literature, denoted 
ROBO2A and ROBO2B, differ in the 5’ end as they encode cDNA with alternative 
starting codons, codon 1 and codon 2, respectively (Yue et al., 2006). In 2007 the Maas 
laboratory described another variant of ROBO2 that differed from publically deposited 
sequence by inclusion of the additional intron between introns 24 and 25, denoted exon 
24B (Lu et al., 2007). Presence of both isoforms, with and without exon 24B has been 
documented in the developing and mature kidneys. Sequencing of both isoforms revealed 
that exon 24B is 273 nucleotides long, and contains the conserved cytoplasmic region 
CC3 in the protein (Lu et al., 2007). Moreover, it is in frame with the starting codon and 
encodes 91 amino acids of ROBO2 sequence. As presented in the introduction, the CC3 
domain is a highly conserved sequence that is a proline-rich region and serves as the 
docking site for the downstream signaling molecules in the SLIT-ROBO signaling 
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pathway (Fan et al., 2003; Fan et al., 2012; Wong et al., 2001). Therefore presence of 
both isoforms in the kidney poses the intriguing possibility that co-expression of both 
isoforms might represent additional regulatory mechanism of SLIT-ROBO signaling. 
Besides the original report of the existence of ROBO2+24B and ROBO2-24B isoforms, 
no study has been conducted to elucidate their relevance in the kidney. In order to address 
this question, we generated two lines of transgenic mice to overexpress the two isoforms, 
denoted ROBO2+24B and ROBO2-24B.    
Results 
Quantitation of the message RNA of ROBO2 and ROBO2 isoforms in the murine kidney 
during development 
As mentioned previously, SLIT2-ROBO2 signaling pathway is necessary for the 
proper ureteric bud outgrowth from the Wolffian duct, which happens on embryonic day 
10.5 in mouse (Dressler, 2006). I used a ROBO2 specific TaqMan reverse transcription 
assay (Figure 14A) to measure the amount of ROBO2 expression and showed that the 
window of ROBO2 expression in the kidney starts at E12.5 and continues into adulthood. 
The highest level of ROBO2 expression occurs at E12.5 and gradually declines to 10% of 
its peak level as the kidney matures. The decrease in the expression has been confirmed 
by immunostaining analysis of the ROBO2 protein (Fan et al., 2012). Using the ROBO2 
isoform specific probes (Figure 14B), we discovered that while both isoforms are present 
during kidney development, the relative amounts of both isoforms are equal in abundance 
until E16.5, thereafter the -24B isoform becomes more abundant.   
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Figure 14: Amount of ROBO2 mRNA expressed in the kidney decreases as kidney 
matures. 
A- Quantitative RT-PCR assay showed the total mRNA levels of Robo2 during mouse 
kidney development. Kidneys from multiple mice were pooled at E12.5 (n=18), E13.5 
(n=22), E14.5 (n=24), E16.5 (n=15), E17.5 (n=12), E18.5 (n=15), newborn (n=7) and 
adult (n=4). Amount of Robo2 mRNA is normalized to GAPDH and compared to Robo2 
expression at E12.5. Results shown as means +/- SEM.  
B- Quantitative RT-PCR analysis of mRNA abundance for Robo2-24B and Robo2+24B 
during development in pooled kidney samples. Results shown as means +/- SEM.  
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ROBO2 transgenic constructs are expressed in HEK293 cells and their  
expression is upregulated in the presence of doxycycline   
ROBO2 cDNA encoding either ROBO2-24B or ROBO2+24B constructs were 
sub-cloned into the pTRE2 vector and their molecular identity confirmed by restriction 
digestion pattern (Figure 15). While the pTRE2 construct has been shown to be 
successfully expressed in mammalian cells, we needed to confirm ROBO2 expression 
and doxycycline inducibility in an in vitro kidney cell model. To do so, we chose to use 
HEK293 as the cellular model because it is embryonic kidney origin and easy to be 
transfected. To test if the cells express endogenous ROBO2 or rtTA, we examined the 
untransfected cell lysates and found no detectable endogenous ROBO2 protein (Figure 
16). To test if doxycycline on its own stimulates the transcription of either ROBO2 or 
rtTA, we treated untransfected HEK293 cells with doxycycline and found no effects of 
doxycycline on either ROBO2 or rtTA expression. The cells co-transfected with both 
ROBO2 and rtTA express basal levels of these two genes. However, when cells were 
treated with doxycycline, ROBO2 expression was upregulated indicating that in this 
model system the Tet-on system was functioning as anticipated (Figure 16).   
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Figure 15: Verification of the pTRE2-ROBO2-24B and pTRE2-ROBO2+24B 
constructs used to generate transgenic mice. 
Restriction enzyme digestion to verify the purity and identity of the constructs. DNAs 
were cut by EcoRI and 0.5-1µg DNA fragments were resolved on the 1% agarose gel and 
visualized by ethidium bromide staining. Lane 1, pTRE2 empty vector; Lane 2, pTRE2-
ROBO2+24B; Lane 3, pTRE2-ROBO2-24B. 1kb DNA ladder on the left side; 100bp 
DNA ladder on the right. 
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Figure 16- Western blot assay to examine the inducible expression of pTRE2-
ROBO2-24B and pTRE2-ROBO2+24B transgenic constructs in HEK293 cells  
A- Representative western blot results showing the expression of the pTRE2-Robo2-24B 
in transiently transfected HEK293 cells. No endogenous Robo2 expression is detected 
with or without doxycycline treatment (right two lanes). Cells co-transfected with 
pTRE2-Robo2-24B and rtTA plasmids express basal levels of ROBO2-24B in the 
absence of the doxycycline, and the expression is upregulated when cells are stimulated 
with doxycycline (left two lanes).  All experiments were performed in triplicates.  
B- The same experiment as A except the expression construct is pTRE2-ROBO2+24B.  
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Generation of ROBO2 transgenic mice  
The pTRE ROBO2+24B and pTRE ROBO2-24B constructs were purified and 
submitted to the Transgenic Core Facility at Boston University. The first round of the 
pronuclear injections and implantations resulted in approximately 30% transgene positive 
pups in ROBO2-24B line and 24% transgene positive pups in ROBO2+24B line, for the 
total of 7 ROBO2-24B and 8 ROBO2+24B animals of both sexes. As expected, pups 
were born without any gross anatomical abnormalities and progressed into maturity 
undistinguished from their wild type littermates. Mice were fertile and didn’t show gross 
kidney or urinary tract abnormalities or albuminuria at 3 months of age (data not shown).    
Establishment of founder lines 
For each of the ROBO2-24B and ROBO2+24B transgenic lines, transgene 
positive mice were bred to the transgene negative littermates to confirm the transgene 
germline transmission. Out of 7 mice in the ROBO2-24B, four animals showed transgene 
transmission into F1 generation. Out of 8 mice in the ROBO2+24B, three animals 
showed transgene transmission into F1 generation. These animals were used for further 
experiments. 
Creation of double transgenic mice  
The overall scheme of creation of the double transgenic mice is presented in 
Figure 17 and Illustration 4. As mentioned, the ultimate goal of this project is to analyze 
the effect of ROBO2 overexpression in podocytes, but to initially establish 
developmental effects of ROBO2 overexpression on the kidney structure and function, 
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we bred our ROBO2 transgenic mice with strain ubiquitously expressing rtTA from the 
ROSA26 locus (strain B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J), allowing for global 
overexpression of ROBO2 in double positive mice treated with doxycycline. Mice were 
born at expected Mendelian ratios without any discernible phenotype between ROBO2 
transgenic mice and their wild type littermates at 3 months of age, suggesting no 
deleterious effect of either single or double ROBO2 transgene during development and 
adulthood.     
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Figure 17: Transgenic creation scheme.    
Schematic illustration of crucial elements needed to induce ROBO2 expression in 
transgenic mice. Transactivator protein rtTA is expressed under control of ubiquitously 
expressed ROSA26 locus. ROBO2-24B and ROBO2+24B are expressed under control of 
minimal CMV promoter and tetO sequences. Doxycycline is delivered in the drinking 
water solution. 
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ROBO2 transgene is not expressed in transgenic mice 
The germline transmitting transgene positive lines were bred with the rtTA 
positive mice to generate the double positive transgenic mice. These mice, together with 
their single transgene positive littermates were exposed to doxycycline and the resulting 
ROBO2 transgene expression was analyzed by genotyping (Figure 18A, 18B, 18C), 
mRNA quantification (Figure 18D, 18E), immunofluorescence (Figure 18F) and Western 
blot assays (data not shown) in the 4 months old progeny from each founder animals, for 
at least one mouse per each founder animal. To determine if there is human ROBO2 
transgene expression, we used human ROBO2-specific TaqMan assay to probe for 
ROBO2 transgene message in the cortical portion of the kidneys from mice with the 
ROBO2 transgene on and off doxycycline therapy. Taqman probes used are presented in 
Table 3. We found low levels of ROBO2 message but unfortunately this was present even 
in the absence of Doxycycline or the rt-TA indicating that the ROBO2 transgene was 
leaky and could not be regulated by Doxycycline nor definitively targeted to podocytes. 
We were also unable to demonstrate ROBO2 protein expression, by immunofluorescence 
analysis and western blot assay, either on or off Doxycycline in the double transgenic 
mice (Figure 18 and data not shown).    
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Figure 18: Transgenic ROBO2 constructs are successfully inserted into the mouse 
genome and transcribed but no proteins can be detected. 
A. Representative agarose gel showing successful detection of the ROBO2-24B 
transgene (expected product size is 381bp) in the tail samples from transgene positive 
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(lines 1, 4, 6, 11) and transgene negative (lines 2, 3, 5, 8, 9, 10) mice. Line 12 represents 
negative control using wild type mouse DNA. Line 13 represents positive control using 
DNA from transgene positive mouse.   
B. Representative agarose gel showing successful detection of the ROBO2+24B 
transgene (expected product size is 150bp) in the tail samples from transgene positive 
(lines 2, 5, 8, 9, 11, 12) and transgene negative (lines 1, 3, 4, 6, 7, 10) mice. Line 13 
represents wild type mouse DNA.  
C. Representative agarose gel showing successful detection of the rtTA knock-in gene. 
Expected product size is 340bp for the mutant allele, 650bp for the wild type allele; 
heterozygous animals display the presence of both alleles. Line 6 represents negative 
control using wild type mouse DNA.  
D. RT-PCR TaqMan assay showed the mRNA levels of endogenous mouse ROBO2 
(mROBO2), transgenic human ROBO2-24B (hROBO2-24B) and mouse NEPHRIN 
(mNEPHRIN) after doxycycline treatment on five littermate mice of the following 
genotypes: animal 1: Rosa-rtTAtg/+; animal 2: tetO-ROBO2tg/+;Rosa-rtTAtg/+; animal 
3: tetO-ROBO2tg/+; animal 4: Rosa-rtTAtg/+; animal 5: tetO-ROBO2tg/+;Rosa-
rtTAtg/+. Results shown as means +/- SEM.  
E. RT-PCR TaqMan assay showed the mRNA levels of endogenous ROBO2 
(mROBO2), transgenic ROBO2+24B (hROBO2+24B) and mouse NEPHRIN after 
doxycycline treatment on five littermate mice of the following genotypes: animal 1: 
Rosa-rtTAtg/+; animal 2: tetO-ROBO2tg/+;Rosa-rtTAtg/+; animal 3: tetO-
  
148 
ROBO2tg/+;Rosa-rtTAtg/+; animal 4: tetO-ROBO2tg/+; animal 5: tetO-
ROBO2tg/+;Rosa-rtTAtg/+. Results shown as means +/- SEM.  
F. Representative images of immunostaining for transgenic ROBO2 on mouse kidney 
sections. No hROBO2 is detected. Both, endogenous and transgenic ROBO2 are 
recognized by the antibody. Arrows point to the location of the location of the glomeruli. 
Magnification, 200x. 
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Discussion  
During the course of my research, we had extensively made use of the global 
Robo2 knockout or Robo2 podocyte specific conditional knockout mice. Using these 
models, we had described the consequence of ROBO2 deletion in podocytes and 
confirmed the effect of ROBO2 on nephrin induced actin polymerization. Based on the 
data obtained using the Robo2 deficient mice, we concluded that SLIT2-ROBO2 
signaling pathway is detrimental to podocyte health (Fan et al., 2012). In order to confirm 
deleterious nature of ROBO2 function in podocytes, we chose to generate the spatially 
and temporally controlled transgenic ROBO2 overexpression mouse model. Spatial 
control was achieved by using either globally or selectively expressing rtTA model. 
Temporal control resulted from timing of doxycycline administration.  
Both in the developing and mature kidney, ROBO2 has been shown to exist as 
two isoforms, differing by the presence of alternatively spliced exon 24B in the 
intracellular domain of the receptor. We decided to elucidate the role of two distinct 
ROBO2 isoforms that are expressed in the kidney – the ROBO2-24B isoform including 
the 26 exons, devoid of the 93aa fragment encoding the CC3 domain and the 
ROBO2+24B isoform including the alternatively spliced exon 24B. As we know that the 
CC3 domain of ROBO receptor is an important signaling motif that serves as the binding 
site for several downstream molecules, such as the Slit-Robo GTPase proteins (srGAPs) 
(Fan et al., 2003; Fan et al., 2012; Wong et al., 2001), therefore both isoforms could 
respond to the presence of SLIT ligand possibly by recruiting distinct signaling pathways. 
It is conceivable that ROBO2-24B without the CC3 motif can act as less efficient 
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receptor for the SLIT-ROBO2 signaling in the kidney. Such a regulation mechanism of 
the ROBO signaling pathway by alternative splicing has been documented in literature 
for ROBO3. In the commissural axons two isoforms of ROBO3 coexist and have 
opposite functions – ROBO3.1 favors axonal midline crossing whiles ROBO3.2 
suppresses it (Chen et al., 2008). 
We found that the expressions of both ROBO2 isoforms are tightly controlled 
during normal kidney development. Significance of the two isoforms have never been 
researched and thus we decided to create two transgenic mice models, one with and one 
without exon 24B to better understand their contribution to podocyte biology and kidney 
development. To the best of our knowledge, our efforts represented the first attempt to 
create ROBO2 overexpression mouse model.   
Our goals were to (1) understand overall effects of ROBO2 overexpression and 
specific effects of ROBO2 isoform overexpression and (2) to understand the effects of 
ROBO2 overexpression in podocytes, particularly focusing on the cell architecture, foot 
process structure and kidney function, during development and in mature kidneys under 
normal physiological conditions as well as during podocyte injury. As the preliminary 
step, we decided to induce and analyze global ROBO2 overexpression.  
We generated two transgenic mouse lines- one expressing ROBO2-24B and one 
expressing ROBO2+24B, with multiple animals showing transgene transmission in each 
line. However, after these lines were crossed with animals carrying rtTA and treated with 
doxycycline to induce the ROBO2 expression, we could not observe the expression of the 
transgene, indicating that the transgenic mice were not successfully generated.  
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Possible reasons for failure to generate transgenic mice 
As shown, ROBO2 expression during kidney development is tightly regulated and 
levels of ROBO2 expression in adult kidneys are a fraction of levels present in the early 
kidney. As mentioned, to generate transgenic mice, the human ROBO2 construct was 
injected into pronuclei of fertilized eggs. We can detect presence of transgene in different 
generations and thus we know that the gene was successfully integrated into genome, but 
mRNA is of very low abundance and proteins are undetectable. Most probable reasons 
for this phenomenon could be attributed to positional effect of transgene insertion, or 
posttranslational and posttranscriptional regulatory mechanisms.  
Posttranslational mechanisms are known to regulate ROBO receptor abundance in 
different systems. Research on ROBO signaling in cancer showed that ROBO levels can 
be regulated by microRNAs (Alajez et al., 2011). Most recently miR-218 has been shown 
to downregulate ROBO1 levels in cancer as well as ROBO1 and ROBO2 during heart 
development in zebrafish  (Fish et al., 2011). Another microRNA, miR-145, was 
demonstrated to specifically downregulate ROBO2 in mouse primary neuronal culture 
model (Zhang et al., 2011). During the development of nervous system, midline crossing 
is coordinated by SLIT-ROBO signaling (Long et al., 2004). In drosophila, commissural 
axons express high levels of ROBO1 on their growth cone surface before approaching 
midline, low levels of ROBO1 protein during crossing and again high ROBO1 receptors 
post-crossing (Kidd et al., 1998). This oscillation in ROBO levels is attributed to 
interaction of ROBO and commissural, or Comm protein, which specifically destines 
ROBO receptor for endocytic clearance (Keleman et al., 2002; Keleman et al., 2005; 
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Kidd et al., 1998). Furthermore, overexpression of Comm results in overall lower levels 
of ROBO (Kidd et al., 1998).  
Whether any of these mechanisms plays a role in ROBO2 regulation during 
kidney development and maintenance, and could thus contribute to our failure to generate 
ROBO2 overexpression model, is not known. Taken together there is sufficient evidence 
that multiple regulatory mechanisms exist for tight regulation of roundabout receptors 
abundance and thus our failure to artificially induce ROBO2 overexpression might be 
prevented by biological regulatory mechanisms as much as due to technical obstacles.  
 
Future directions 
While lack of success in generating ROBO2 overexpression model are 
discouraging, reasons for creating transgenic ROBO2 mice are still valid and one future 
direction will be to create these mice with modified strategy to improved detection and 
technical accuracy of the model. In these experiments, we plan to use the new generation 
of response plasmid pTRE backbone available from Clonetech (Tet On 3G system). It is 
redesigned for higher doxycycline sensitivity and induction fold as well as lower 
background expression (Loew et al., 2010). Moreover, it includes the bi-directional 
promoter, allowing for reliable expression of two independent proteins. Ideally we would 
be able to simultaneously express ROBO2 and a fluorescent protein (i.e. GFP) for fast 
and reliable detection of expression.  
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Experimental Procedures  
Embryonic kidney tissue collection  
Endogenous ROBO2 mRNA abundance during kidney development was 
evaluated in time pregnant CD-1 mice that were ordered from Charles River laboratories. 
Two pregnant dams were used per each of the embryonic stages: E12.5 (n=18 embryos), 
E13.5 (n=22 embryos), E14.5 (n=24 embryos), E16.5 (n=15 embryos), E17.5 (n=12 
embryos), E18.5 (n=15 embryos). For the newborn time point newborn mice (n=7) from 
two litters was used. For the adult time point samples from 4 adult mice were used. For 
kidney tissue collection from embryos at earliest time points, great care was taken to 
isolate only the budding ureteric buds with surrounding metanephric mesenchyme 
(E12.5-E14.5). At later developmental time points (E16.5-adult), entire kidney tissues 
were collected. Samples at each time point were pooled and collected in RNAlater RNA 
stabilization reagent (Life Technologies).  
DNA constructs and cloning used to generate the transgenic constructs 
Two distinct human ROBO2 cDNA constructs have been custom generated by 
our lab for the purpose of this study. First one, 4.1kb long, encoding the cDNA of 1378 
aa protein product is devoid of exon 24B and is denoted ‘ROBO2-24B’. Second ROBO2 
cDNA construct, 4.4kb long, encodes 1469 aa human ROBO2 protein with new exon 
24B and is referred to as ‘ROBO2 + 24B’.  
In order to clone ROBO2-24B and ROBO2+24B cDNA sequences into pTRE2 
vector, the original restriction sites in MCS had to be modified to allow for the blunt end 
  
154 
ligation using blunt end ligation with the High-Fidelity DNA Polymerase (New England 
Biolabs), following manufacturer recommended protocol (NEB). Resulting pTRE2-
ROBO2-24B and pTRE2-ROBO2+24B constructs were confirmed by restriction enzyme 
digestion and releasing 7.9 kb and 8.2kb fragments.   
TaqMan assays 
Pooled kidney samples were preserved in RNAlater RNA stabilization reagent 
(Life Technologies). Total RNA was isolated using the Qiagen RNA extraction kit 
(RNeasy Mini Kit; Qiagen), according to the manufacturer’s instruction. RNA was 
measured using NanoDrop (Thermo Scientific) and equal amount of RNA was used for 
the conversion to cDNA (Verso cDNA Synthesis Kit; Thermo Scientific). For detection 
of ROBO2 during development, mouse specific TaqMan probes for detection of total 
ROBO2, ROBO2+24B and ROBO2-24B were used.   
For the testing of human ROBO2 expression in transgenic mice, following 
transcripts TaqMan probes were used: mROBO2 for endogenous expression detection, 
and custom designed hROBO2+24B, and hROBO2-24B. Mouse GAPDH TaqMan probe 
was used as the housekeeping gene normalizer. Data were obtained using the 7500Fast 
Real Time PCR instrument from Applied Biosystems (Fisher Thermoscientific) 
following standard manufacturer’s protocol.  
Antibodies 
The following commercially available primary antibodies were used: rabbit anti-
ROBO2 (MABN122, Millipore Corporation), anti-ROBO2 clone K18 (Santa Cruz), 
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mouse anti-TetR (631131, Clonetech) and mouse anti-actin (A1978, Sigma). Rabbit anti 
ROBO2+24B antibody was custom made (Alpha Diagnostic International) to recognize 
the mouse ROBO2+24B antigen in mouse.  
Immunohistochemistry 
Immunostaining for the human ROBO2 on mouse tissues has been performed in 
accordance with the standard protocol for IF detection on paraformaldehyde fixed kidney 
tissues (Fan et al., 2012). In brief, kidney sections were dissected and fixed in freshly 
prepared 4% PFA solution in PBS buffer (Sigma) for ~12 hours. Fixed tissues were 
cryoprotected in sucrose solution (Sigma), embedded in the OCT mounting solution 
(Tissue-Tek) and cut at the cryostat at 4µm thickness. Prepared sections were blocked 
and permeabilized with 1% FBS, 0.1% Tri-X solution in PBS for 30 minutes at room 
temperature. Sections were incubated with Robo2 antibody (K-18, Santa Cruz) or 
antibody–free dilution buffer (0.5% FBS, 0.1% Tri-X solution in PBS) ON at 4oC. 
Sections were washed in PBS and incubated with rhodamine-conjugated secondary 
antibody (Alexa Fluor). At the end of the staining protocol slides were mounted in 50% 
glycerol/50% PBS solution.       
Cell culture and transient transfection 
Human embryonic kidney (HEK) 293 cells were grown in the high glucose 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% of tetracycline- 
or doxycycline- free FBS (Gibco), 2nM glutamine (Gibco) and 1x Pen-Strep (Gibco).  
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In order to ensure that transgenic pTRE2 constructs can be expressed in the kidney cells, 
HEK293 cell line, pTRE2-ROBO2-24B or pTRE2-ROBO2+24B constructs were 
transiently co-transfected with pTet-On® Advanced vector encoding rtTA and Venus 
protein to monitor for transfection efficiency. Transient transfections were performed in 
low confluent HEK293 cells using the calcium phosphate transfection method, as 
described previously (Wigler et al., 1977) and resulted in approximately 90-95% 
efficiency as judged by presence of the Venus signal. Doxycycline treatment was 
supplemented at the final concentration of 1µg/ml as indicated. Transfection schemes are 
presented in the Table 6. Experiments were performed in triplicates.  
Western blot analysis   
One day post transcription cells were lysed in RIPA buffer (50 mM Tris [pH 7.4], 
150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 1 mM Na3VO4, 1 
mM NaF, 1x protease inhibitor) on ice. Cell lyses were centrifuged for 10min at 4oC.  
The supernatants were added with 6x protein loading buffer (Boston Bioproducts) to 1x 
and denatured at 95oC for 20 min. Proteins were resolved on 10% SDS-PAGE gels, and 
blotted with rabbit anti-Robo2 (MABN122, Millipore Corporation), rabbit anti 
Robo2+24B (custom made, Alpha Diagnostic International), mouse anti-TetR (631131, 
Clontech) and mouse anti-actin (A1978, Sigma) antibodies. Appropriate HRP- 
conjugated secondary antibodies were used (GE Healthcare) and the HRP signals were 
detected using the Amersham ECL Prime Western Blotting Detection Kit (Fisher) on 
radiography film (Denville Scientific). Images were digitalized and the intensity of the 
bands was measured using ImageJ software (version 1.47v; National Institutes of Health). 
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Generation of ROBO2 transgenic mice 
Transgenic mice carrying the response plasmid were generated in the Transgenic 
Core Facility at Boston University. Briefly, pTRE2-ROBO2-24B and pTRE2-
ROBO2+24B constructs were purified and microinjected into the pronuclei of fertilized 
wild type C57BL/6J mouse eggs, as per standard operating procedure (Cho et al., 2009). 
Micromanipulated embryos were transferred into pseudopregnant foster females. 
Multiple microinjected zygotes were implanted into multiple pseudopregnant females to 
increase likelihood of successful generation of transgenic mice. Pups were delivered 
within 19 days post implantation. For pTRE2-ROBO2-24B microinjection 7/24 pups 
were tested transgene-positive. For pTRE2-ROBO2+24B microinjection 8/29 pups were 
tested transgene-positive. No growth retardation or congenital anomalies were noted in 
the litters.  
To identify the founder lines with germline transmission, transgene positive 
animals were mated with wild type B6 mice and resulting litters were analyzed for 
transgene presence. Genotyping primers are shown in Table 7. In the pTRE2-ROBO2-
24B line 4 lines showed germline transmission and were used for further studies. In the 
pTRE2-ROBO2+24B line, 3 lines showed germline transmission and were used for 
further studies. 
Characteristics of rtTA element containing mice  
Knock-in mice overexpressing the rtTA were obtained from Jackson Laboratories 
(Stock # 006965; Strain name: B6.Cg-Gt (ROSA) 26Sortm1 (rtTA*M2 Jae/J). Per 
supplied information, target gene expression was detected in liver, bone marrow, 
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stomach, intestine, and skin, with lower levels in the heart, lungs, kidney, spleen, and 
thymus; no expression is detected in the brain and testes’ (Jackson Laboratories, 
http://jaxmice.jax.org/strain/006965.html).  
Genotyping used to identify transgenic mice  
Tail samples for the initial generation of were collected from 15-21 days old mice 
to determine transgene and rtTA status. Genotyping was performed using the PCR 
thermocycler with following settings: for the ROBO2-24B/+24B line: initial DNA 
denaturation at 95ºC for 3 minutes, followed by denaturation at 95ºC for 30 seconds, 
annealing at 58/54ºC for 30 seconds, extension at 72ºC for 1 minute and 45 seconds, 
repeated for 35 cycles, followed by the final 10 minutes extension at 72ºC. Primers used 
for genotyping are presented in Table 7. rtTA genotyping was carried using PCR primers 
and conditions recommended for the B6. Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J strain 
by the Jackson Laboratories.   
In vivo Doxycycline treatment scheme 
To study effects of ROBO2 overexpression in mice, double transgene positive and 
rtTA positive mice (n≥4) and their control single positive (either for transgene or rtTA) 
littermates (n≥4) were housed together to minimize environmental effects on subsequent 
analyses. Doxycycline (4mg/ml) was delivered in drinking water to all mice. In order to 
increase the water consumption doxycycline solution was supplemented with 5% sucrose, 
as previously described (Jones et al., 2006). Due to the relative instability of doxycycline 
  
159 
at room temperature and light exposure, the doxycycline solution was administered in 
brown bottles for light reduced environment and solutions were changed twice a week. 
Designing the TaqMan probes to detect human ROBO2 mRNA expression 
Transgene specific TaqMan primers and probes were designed using Beacon 
Designer™ software (Premier Biosoft International) and probe sequences are detailed in 
Table 8. 
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Table 6: Transient transfection scheme in 293 cells  
 
       To test: 
 
 
To introduce: 
Dox 
sensitivity 
Dox 
independent 
expression 
Dox effect on 
gene 
expression 
Basal 
expression of 
Robo2  and 
rtTA 
Robo2 construct + + - - 
rtTA construct + + - - 
Doxycycline + - + - 
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Table 7: Genotyping primers used to identify ROBO2 transgene positive mice 
 
Name Sequence 5’-3’ 
hRobo2-24B frwd CGACGACGAAGAGGAAGCTTTA 
hRobo2-24B rev ACCTCGGTTTTCCTAGGTCC 
hRobo2+24B frwd AATGACAGATGATCTTCCACCACC 
hRobo2+24B rev AAGCTGGATGCATGTTGTCTC 
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Table 8: TaqMan probes and primers for detection of ROBO2 transgenic constructs 
 
TaqMan Primer/Probe  
hRobo2-24B frwd AAGGGAAGGAATGACAGATGAGG 
hRobo2-24B rev CTTAGAAGAAGCTGTTCCTGATGAG 
hRobo2-24B probe AGCAAGCCCAGTTTCCCATCTCCAG 
hRobo2+24B frwd CTCATTGGATTGTCCAGCTAGAAC 
hRobo2+24B rev CTCCTCTGATCCGACACCTTG 
hRobo2+24B probe TCCCTAGAGTGGCAGCGACAAACCC 
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CHAPTER SIX: Summary and Conclusions 
The goal of my study was to identify the expression pattern, signaling mechanism, 
and significance of the SLIT2- ROBO2 pathway in the kidney during the late stage 
development as well as in adult. This study additionally sought to understand the 
consequence of ROBO2 ablation during induced podocyte injury in mice and to 
understand whether the SLIT2-ROBO2 expression, and thus signaling pathway is 
changed in chronic proteinuric kidney disease in humans.  
The main findings are extensively summarized in the specific chapters: Chapter 3 
(Inhibitory Effects of ROBO2 on nephrin: A Crosstalk between Positive and Negative 
Signals Regulating Podocyte Structure), Chapter 4 (Loss of ROBO2 in Podocytes 
Protects Adult Mice from Acute Glomerular Injury) and Chapter 5 (Generation of 
ROBO2 Overexpressing Transgenic Mice). I hereunder will list the major discoveries we 
have made:  
1. ROBO2 is a podocyte protein localized to the basal cell surface of podocyte foot 
processes.  
2. ROBO2 and nephrin form a complex through NCK in podocytes. 
3. SLIT2-ROBO2 signaling reduces nephrin induced actin polymerization. 
4. Loss of Robo2 partially rescues Nphs1 null mouse glomerular phenotype. 
5. Loss of Robo2 in podocytes protects adult mice from glomerular injury. 
6. Loss of ROBO2 in podocytes increases nephrin expression. 
7. ROBO2 and SLIT2 expression are upregulated during podocyte injury. 
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8. SLIT2 and ROBO2 are over-expressed in the glomeruli of membranous 
nephropathy patients. 
9. Human ROBO2 transgene was able to integrate into the mouse genome but its 
overexpression was not successful. 
With our findings, we can better understand the complex picture of the SLIT2 and 
ROBO2 signaling and their functions in the kidney, from early development to 
adulthood. Initially, SLIT2 and ROBO2 are required for the ureteric bud outgrowth 
during the early stage of kidney development. Thereafter, both the ROBO2 receptor and 
the SLIT2 ligand are expressed during the late stage of kidney development, first in the 
condensing mesenchyme and then in the podocytes. We were first to show that SLIT2-
ROBO2 negatively regulates local actin polymerization in the podocytes and is the novel 
signaling pathway to counterbalance nephrin signaling.   
Our data indicates that the amount of ROBO2 expressed in adult mouse kidney is low 
under physiological normalcy. Moreover, loss of Robo2 in podocytes appears to have 
only minor functional consequence, as unchallenged Robo2 cKO mice have 
unremarkable kidney phenotype. However, under conditions of an acute podocyte injury, 
there is upregulation in SLIT2 and ROBO2 expression in wild type mice. Under these 
circumstances, loss of Robo2 in podocytes significantly protects podocyte structure, and 
glomerular filtration barrier function from acute glomerular injury.   
Translational aspect of my research, namely the finding that ROBO2 and SLIT2 
expression are upregulated in the membranous nephropathy patients, is suggestive that 
SLIT2-ROBO2 might play a role in the proteinuric kidney disease in humans.  This 
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knowledge will hopefully stimulate further research, which will provide better 
understanding of the pathologic mechanisms involved in the proteinuric kidney disease. 
From our data we speculate that SLIT2-ROBO2 signaling pathway might be an attractive 
therapeutic target for patients with proteinuric kidney diseases, such as membranous 
nephropathy. Future tests for ROBO2 and SLIT2 expression in wider panel of glomerular 
nephropathies will be an exciting extension of our studies and might provide new insights 
for the role of ROBO2 and SLIT2 in wider spectrum of the glomerular kidney diseases.  
Interestingly our failure to generate ROBO2 over-expression in the transgenic mice 
could further support the pathogenic role of SLIT2-ROBO2 in kidney physiology. We 
ascertained that the transgene integrates into the mouse genome, transgenic mRNA is 
expressed, albeit at low levels, but that ROBO2 protein cannot be detected. This could 
indicate the existence of the complex biological mechanisms to prevent excess of 
ROBO2 expression. In Drosophila as well as in mammalian cancer cells, there are 
complex and not yet fully understood mechanisms to tightly regulate ROBO expression, 
suggesting that evolutionary conserved protective mechanisms might exist to prevent 
ROBO2 over-expression under physiological conditions. 
In conclusion, my thesis research provides comprehensive mouse genetic, 
biochemical, and cell biological evidence for the involvement of the SLIT2-ROBO2 
pathway in the podocyte biology and kidney pathophysiology. More importantly, it 
provides the foundation for future studies on SLIT2-ROBO2 pathway in proteinuric 
kidney disease in humans. 
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